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Abstract 
 
Mammalian cell cultures are intrinsically heterogeneous at different scales (from 
the molecular to bioreactor level). The cell cycle is at the centre of capturing 
heterogeneity since it plays a critical role in the growth, death, productivity and 
product quality of mammalian cell cultures. Attempts to model the cell cycle 
heterogeneity are not new and have proved to be challenging both experimentally 
and computationally. Most current cell cycle models rely on biological variables 
(mass/volume/age) that are non-mechanistic and difficult to experimentally quantify 
to describe cell cycle transition and to capture the culture heterogeneity. 
In this thesis, the development of integrated modelling and experimental 
approaches that facilitates the study of cell cycle subpopulations in cell cultures is 
presented. The recently proposed closing the loop framework (Kiparissides et al., 
2011) is employed to facilitate the development of cell cycle models with biological 
relevance and applicable to real life problems (industrial and clinical). The work 
herein presents a novel experimental-modelling platform whereby experimental 
quantification of key cell cycle metrics (cell cycle timings, cell cycle fractions, and 
cyclin expression determined by flow cytometry) is used to develop a cyclin and DNA 
distributed model for the industrially relevant GS-NS0 cell line. The cell cycle model 
captured the population heterogeneity, which further enables in silico studies of the 
complex system. It is envisaged that this modelling approach will pave the way for 
model-based developments of industrial cell lines and clinical studies. A second cell 
cycle model was developed to assist the industrially relevant selection of 
temperature profiles in mammalian cell cultures. The combined experimental-
mathematical approach avoided unnecessary experimentation and guided the model 
development for the temperature selection. The model was successfully validated by 
predicting different temperature profile scenarios. The presented contributions assist 
the development of meaningful mathematical models with predictive capabilities 
accounting for the cell cycle heterogeneity in bioprocesses.   
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CHAPTER 1 
1. Introduction 
Over the last years, the biotechnology industry has reported a continuous and 
rapid growth (18% in 2012, US market) led by the introduction of several monoclonal 
antibodies (mAbs) and diabetes products (Aggarwal, 2014). In 2011 and 2012, the 
mAbs market perceived a double digit growth rate, maintaining their ranking as the 
highest selling class of biologics. Therefore, the mAbs production, which represents 
a fraction of the biotech sector, is facing the challenge to meet the growing demand 
of these products. These biologics are commonly produced by mammalian cell 
culture systems due to their ability to perform human compatible post-translation 
modifications (glycosylation) of proteins. However, batch to batch variability, low 
product yields, and poor product quality are common problems associated with the 
bio-processing of these products. The intrinsic difficulties of the mammalian cell 
factories are reflected in their complex production systems, where productivity and 
product quality are controlled by a large number of coordinated metabolic reactions 
influenced by culture parameters. Most importantly, mammalian cell culture systems 
are intrinsically heterogeneous at all scales from the genetic to bioreactor level 
(Davies et al., 2013; Du et al., 2013; Pichler et al., 2011). The key underlying source 
of heterogeneity is the cell cycle segregation (Karra et al., 2010; Pilbrough et al., 
2009) being at the centre of cellular growth, death, and productivity, which varies 
during the different cell cycle phases. Therefore, a better understanding and 
knowledge of the cell cycle timings, transitions, and associated production profiles 
can aid the development (modelling, control, and optimisation) of these industrially 
relevant systems (Dutton et al., 2006). 
Mathematical models and computational tools can avoid unnecessary 
experimentation and facilitate our understanding of the biological systems (Bailey, 
1998). However, as Bailey (1998) argued, “even the simplest living cell is a system 
of such forbidding complexity that any mathematical description of it is an extremely 
modest approximation”. Thus, the formulation of mathematical models for biological 
systems requires a balance between the model description (both in structure and 
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computational solution times) and the required experimental measurements for 
quantification/validation. Furthermore, careful consideration needs to be taken since 
the employed experimental tools and errors play an important role in the model 
validation (Sidoli et al., 2005). However, the bio-industry needs to adopt more 
accurate and biologically significant quantification techniques (Kuystermans et al., 
2012), which will inherently require efficient computational tools to analyse the data. 
Therefore, the task of representing the biological systems adequately using relevant 
mathematical models and experimental quantification techniques is rather 
challenging. Towards this direction, the biological model development framework 
(Kiparissides et al., 2010a) facilitates the formulation of high fidelity models that 
capture the biological functions, while remaining tractable in order to be further used 
in model-based control and optimisation. Hence, the development of mathematical 
models that capture the heterogeneity of the cell population, both at the biophase 
and at the cellular level, can aid the study of these complex systems. 
1.1. Aims and Objectives 
The aim of this thesis is the development of integrated modelling and 
experimental approaches that facilitates the study of cell cycle subpopulations in cell 
cultures with individual growth/metabolic and productivity characteristics. The model 
development combines cell models that account for growth, death, metabolism, and 
productivity of segregated cell cultures; whereas the experimental approaches focus 
on the determination of key cell cycle features for the mathematical model 
development, such as population distribution, cyclin expression, and transition 
profiles. The proposed approach captures the heterogeneity of the system, relies on 
experimentally measurable/quantifiable process variables, and employs model 
analysis tools for model refinement and approximation. Overall, the goal is to 
systematically develop accurate mathematical cell cycle models for biological 
systems with predictive power.  
The thesis is structured in three sections: Introduction, Literature Review and 
Materials/Methods (chapter 1-3), Experimental approaches (chapter 4 & 5),  
Mathematical modelling (chapter 6 & 7), and Conclusions/Future directions (chapter 
8). The following scientific objectives have been set in order to study the cell cycle 
heterogeneity. 
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 Introduction (chapter 1) 
The central subject addressed in this thesis is introduced, as well as the key 
aims and objectives for the following chapters.  
 Review of key scientific contributions (chapter 2) 
First, an overview of the biological principles underlying the studied system is 
presented with an emphasis on the cell cycle. Secondly, a critical review of 
relevant modelling approaches in the field is performed. Finally, the biological 
model development framework is introduced. 
 The materials and methods used are described (chapter 3) 
The materials and experimental assays are described, as well as the 
modelling analysis method is presented.  
 Identification of the cell cycle blueprint for the GS-NS0 cell line   
(chapter 4) 
The proposed experimental approach which aims to elucidate the cell cycle 
blueprint for the GS-NS0 cell line is presented. The cell cycle blueprint 
encompasses the characteristic cyclin profiles, timings, and thresholds. 
The expression of three cyclins (D1, E1, and B1), is studied under both 
disturbed and undisturbed growth, by flow cytometry in batch cultures of GS-
NS0. The disturbed growth cases involved two different DNA synthesis 
inhibitors, thymidine and dimethyl sulfoxide (DMSO). Both control runs 
(established in parallel to the disturbed cases) and a proliferation assay 
(tracking a specific cell population that was active at DNA synthesis) were 
used as undisturbed growth cases.  
 Study of the effect of culture conditions on the GS-NS0 cell cycle 
(chapter 5) 
The effect of temperature and medium shifts is presented both for the cell 
cycle and cell programmed death (apoptosis). The studies aimed to provide 
insight on the cell cycle regulation and its link with apoptosis (for future model 
development), while varying key culture conditions (i.e. temperature and 
nutrient variations).  
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 Development of a first principles cyclin distributed and DNA model for 
GS-NS0 cultures (chapter 6) 
A biologically-relevant cell cycle model for the GS-NS0 cell line based on the 
experimentally derived cell cycle blueprint is presented in this chapter. The 
model is developed employing the mathematical modelling framework based 
on the experimental observations. A first principles mathematical model to 
describe the cell cycle using cyclin E1 for G1/G0 phase, DNA for the S phase, 
and cyclin B1 for the G2/M phase is proposed. The model description includes 
the cell growth, basic metabolism, and cell cycle specific mAb production. The 
model structure is studied by global sensitivity analysis (GSA) identifying 
parameters with a significant effect on the model output. After, the significant 
parameters are re-estimated using the data from a set of control batch 
experiments. Finally, the model predictions are compared to experimental 
data of disturbed (after cell arrest release) and undisturbed cell growth. 
 Development of an unstructured temperature and metabolic dependant 
model for a hybridoma cell culture (chapter 7) 
In this chapter, the model development framework is used to formulate a 
(fed)-batch temperature dependent cell cycle model for a mAb producing 
murine hybridoma cell line. An unstructured cell cycle model accounting for 
the distribution of proliferating (G1, S, G2/M) and arrested cells (G0) in (fed)-
batch culture is developed and applied to predict temperature shifts from 37 
°C to 33 °C. The model describes viable cell concentration, basic metabolism 
and antibody concentration. The model is validated experimentally at different 
temperature conditions, both for batch and fed-batch cultures. 
 Identification of future directions & improvements (chapter 8) 
Finally, in chapter 8 the main findings and conclusions are reviewed. In 
addition, suggestions for future research directions in this field are proposed. 
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CHAPTER 2 
2. Literature Review 
The most relevant contributions and state-of-the-art for the topics addressed in 
this thesis are presented in this chapter. Initially, the fundamentals of cell biology are 
introduced, followed by an overview of the cell cycle. Then, the cell cycle regulatory 
machinery is reviewed. Subsequently, key scientific contributions in the field of 
mammalian cell modelling are discussed. Finally, the biological modelling 
development framework is outlined. 
2.1. Fundamentals of Mammalian Cell Biology 
Mammalian cell culture systems are commonly used for the production of mAbs 
due to their ability to perform human compatible post-translation modifications 
(glycosylation) of proteins. The cell structure is elaborate and complex, highly 
compartmentalised, containing a variety of organelles with different functions. Since 
the focus is on mammalian cell culture systems, the fundamentals of their biology 
are presented herein.  
2.1.1. Cell structure 
The cell is a complex entity able to carry out elaborate synthesis processes. 
These complex systems resemble to chemical plants, where different units known as 
organelles perform specific functions to convert and transport biochemical 
components. Mammalian cells are eukaryotic (Figure 2.1), which are differentiated 
by the presence of a membrane-bound structure known as the nucleus. The nucleus 
or nuclear envelop occupies 10% of the total volume (Alberts et al., 2008) and 
contains the DNA organised in chromosomes. Its main function is to maintain the 
integrity of the genes in the chromosomes and control the activity of the cell by 
means of regulating the gene expression. The nucleus is connected to the 
endoplasmatic reticulum (ER). The ER is a membrane network that is found 
throughout the cell. The ER can occur as rough or smooth. The rough ER is named 
after its appearance due to bound ribosomes, which are responsible for protein 
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manufacturing. The smooth ER is responsible for synthesis of lipids and steroids, 
among others. 
 
Figure 2.1. Eukaryotic cell structure. Organelles: 1)nucleolus, 2) nucleus, 3) ribosome, 4) vesicle, 5) rough 
ER, 6) Golgi apparatus, 7) cytoskeleton,8) smooth ER, 9) mitochondria, 10) vacuole, 11) cytoplasm, 12) 
lysosome, 13) centriole, 14) chromatin. [Adapted from: 
http://commons.wikimedia.org/wiki/File:Biological_cell.svg]. 
Nearby to the ER is found the Golgi apparatus. The Golgi apparatus is a 
membrane-bound structure that is integral in modifying, sorting, and packaging the 
different macromolecules previously synthesised in the ER. Another important unit is 
the mitochondria, responsible for the chemical energy production (adenosine 
triphosphate – ATP). The cell contains several other organelles, e.g. lysosomes, 
vacuoles, which are not included here as they are not relevant for the discussion. 
2.1.2. Cell metabolism 
The cell is not only physically structured but also chemically structured, and is 
constituted of different biochemical components. In order to maintain itself (growth, 
reproduction, structure maintenance, and adaptation to the environment), the cell 
undergoes a large number of chemical reactions and processes, known as 
metabolism.  
Two major classes of processes are encountered: anabolic processes – where 
energy is used to build components (e.g. proteins) and catabolic processes – where 
compounds are broken down in order to produce and collect energy. The cell goes 
through different anabolic and catabolic processes in series, parallel or cyclic, which 
are known as metabolic pathways. 
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Catabolism 
During catabolism molecules are broken down in order to produce usable energy 
by the cell (ATP). The main process where energy is produced mammalian cells is 
divided in 4 steps: glycolysis, oxidative decarboxylation of pyruvate, tricarboxylic acid 
cycle (TCA), and oxidative phosphorylation. 
Glycolysis is the catabolic process where glucose is converted into two molecules 
of pyruvate in order to release free energy in the form of ATP and reduced 
nicotinamide adenine dinucleotide (NADH). The net yield of the process is 2 ATP 
and 2 NADH molecules. Subsequently, in the absence of oxygen, the pyruvate is 
fermented into lactic acid or ethanol. However, in the presence of oxygen, a more 
efficient path is followed to completely oxidise the pyruvate into carbon dioxide. 
First, the pyruvate is decarboxylated and coenzyme A is coupled to the acetyl 
molecule to produce Acetyl-CoA and carbon dioxide, while producing 1 NADH 
(which will produce 3 ATP by oxidative phosphorylation) per pyruvate. The resulting 
Acetyl-CoA (per pyruvate) enters (coupling with oxaloacetate) the TCA inside the 
mitochondria and is converted in a series of steps back into oxaloacetate. During the 
cycle a total of 3 molecules of carbon dioxide, 3 NADH, 1 flavin-adenine dinucleotide 
(FADH), and 1 guanosine triphosphate (GTP) per pyruvate molecule are produced. 
Further the NADH and FADH undergo oxidative phosphorylation, where 3 ATP are 
formed per molecule of NADH, 2 ATP are formed per molecule of FADH, and 1 ATP 
is formed per molecule of GTP. 
The anaerobic route (only glycolysis and fermentation) results in the production of 
only 8 ATP molecules per glucose, whereas the aerobic route gives a total of 38 ATP 
molecules from the same glucose molecule. The produced ATP is to be used as 
chemical energy for anabolism.  
The amino acid metabolism is closely linked to the above described catabolic 
processes. Several of the carbon skeletons of the amino acids come from the 
intermediates of glycolysis and TCA. Similarly, some of the amino acids can pass 
from the cytosol into the mitochondria to be converted into intermediates of the 
aforementioned catabolic processes. The amino acids not used in biosynthesis can 
be oxidized to generate metabolic energy, whereas their nitrogen atoms are carried 
through various forms (e.g. ammonia, urea).  
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Anabolism 
During anabolism key components are biosynthesised in several energy requiring 
reactions. Among the most important components are pentoses, nucleic acids, 
nucleotides, amino acids, proteins, fatty acids, and lipids. 
 Pentoses, Nucleotides, ,Nucleic Acids, and Nucleotide Sugar Donors: The 
monomeric units of 5 carbon sugars, called pentoses, are common in the cell. 
These are present in the backbone of the cell (RNA and DNA) as ribose and 
deoxyribose. Pentoses are formed by oxidizing and decarboxilating glucose. This 
process generates nicotinamide adenine dinucleotide phosphate (NADPH) and a 
key intermediate, ribulose-5-phosphate. From the latter, ribose and deoxyribose 
are formed to be used for the synthesis of nucleic acids. The pentose phosphate 
pathway is not only an important anabolic pathway for the production of pentoses 
but also a catabolic pathway. Nucleic acids are made of nucleotides, which are 
monomeric units. These are synthesised by a complex number of steps and are 
literally constructed atom by atom. Another important biosynthetic process 
involves the activation of monosaccharide (e.g. glucose) to nucleotide sugars 
donors (NSDs), which play a key role as substrates in the post-translational 
modifications to proteins. The metabolic synthesis of NSDs is closely related to 
the central carbon metabolism and glutamine as a nitrogen source. 
 Fatty Acids and Lipids: The fatty acids are key molecules used for energy storage 
and cell structure. Fatty acids are synthesised by two carbons at a time and 
comprise the successive addition of an acetyl unit. Fatty acids are added to a 
glycerol molecule for the final assembly of lipids. Usually, the third carbon in the 
glycerol backbone contains a polar group. This particular constitution allows the 
lipids to form cell structure compounds (membranes). 
 Proteins and Amino Acids: Amino acids are either obtained from the environment 
or synthesised. There is a total of 20 amino acids commonly found in cells and 
can be can be grouped into families according to their carbon skeleton. The 
amino acids that cannot be synthesised by the cells are known as essential 
amino acids, which are cell line dependent and need to be supplied in the culture 
medium. The amino acids that can be synthesised usually are derived from 
intermediates of either glycolysis or TCA, whereas the amino group present in the 
amino acids is derived from inorganic sources in the environment (e.g. ammonia).  
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The proteins are constituted of amino acids and protein synthesis is achieved in a 
series of steps. First the DNA is transcribed in the nucleus into a chain of 
messenger RNA (mRNA). The single strand of mRNA leaves the nucleus and 
migrates to the cytoplasm. In the cytoplasm, particularly in the rough RE, where 
the ribosomes are present, the translation step takes place. Each triplet of 
consecutives nucleic acids (known as codon) corresponds to a specific amino 
acid. The translation of mRNA is done by an anticodon (known as tRNA). The 
tRNA is the corresponding pairing triplet of the codon, which carries the 
corresponding amino acid. The sequence of anticodons will give rise to the 
sequence or chain of amino acids forming the protein. Subsequently, the protein 
folds to assume its structure. Many proteins undergo an additional step referred 
as post-translational modifications. This step is initiated at the ER and finalised in 
the Golgi apparatus. The protein is modified by the attachment of functional 
groups (mainly sugars), which induce the formation of new links within the 
structure. This is a key step for the production of mAbs. 
2.1.3. Antibodies 
Antibodies are proteins used by the immune system to identify and neutralise 
foreign objects (or antigens) such as bacteria and viruses. The antibody recognises 
and binds specifically to (deactivating) the antigen. Antibodies are made of four 
polypeptide chains: two identical heavy chains and two identical light chains. Each 
chain is composed of structural domains. The chain contain domains are constant or 
variable, the latter being the one which gives the specificity to the antibody. The 
domains have a three dimensional structure defined by the intermolecular forces and 
disulphide bonds, which are formed in the rough ER (where the oxidizing 
environment is key for this process). The four chains come together to give a Y-
shaped structure (Figure 2.2). 
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Figure 2.2. Antibody structure. Notation: C = constant regions, V = varaible regions, S-S = disulphide bonds, 
pupple circles = glycosylation. 
The antibody production is exactly as for a protein; however, these compounds 
do required the post-translation modification in order to be functional. Glycosylation 
is the principal post-translational modification, which consists of the covalent addition 
of oligosaccharides on the protein. There are two possible structures for the addition: 
N – linked glycosylation or O – linked glycosylation. The N – linked refers to the 
covalent binding of the N-acetylglucosamine to the amide groups (asparagine) in the 
protein; while the O – linked refers to binding  of N-acetylgalactosamine to  the 
hydroxyl groups (serine, threonine, or hydroxylysine) of the protein (Alberts et al., 
2008). 
Antibodies are produced by B lymphocytes cells, which have a limited life-span. 
Due to the importance of antibodies, their production is of great interest. Therefore, 
ways to immortalise the producing cells have been envisaged and applied. Usually, 
the B lymphocyte cell (producing the antibody of interest) is fused with an 
immortalised B lymphocyte tumour cell, creating a hybridoma cell. These hybrid cells 
are a permanent and stable production platform for the industrial production of 
antibodies (known as monoclonal antibodies since they are all derived from the 
same parent cell). 
2.1.4. Glutamine, glutamate and glutamine synthetase 
Glutamine and glutamate are non-essential amino acids, as they can be 
synthesised by a large variety of cells (Barnes et al., 2000). Specifically, the 
glutamine synthetase (GS) enzyme catalyses the formation of glutamine (Figure 
2.3), however the endogenous levels of the GS enzyme can be very low in some cell 
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lines. Even so, the role of glutamine is crucially important for mammalian cells. 
Among the most important roles is its metabolism, which provides a source for 
nitrogen, protein synthesis, biosynthesis of amino acids, and more (Meister, 1985). 
Similarly, glutamine serves as an energy source for cells (Reitzer et al., 1979).  
 
 
Figure 2.3. Glutamine synthetase reaction. [Adapted from: (Barnes et al., 2000)]. 
Using recombinant DNA technology is possible to create a plasmid vector 
containing the GS gene and a heterologous protein. A biochemical selection marker 
was built given the key role of glutamine for the cells survival (Butler and Jenkins, 
1989) and the low levels of the GS enzyme in some cells (Bebbington et al., 1992). 
Thus, cells with low levels of endogenous GS that are transfected with the plasmid 
vector and exposed to glutamine-free media, which allow selecting the cells with 
expression of the gene of interest. The survival of transfected cells in a glutamine-
free media plus increasingly concentrations of methionine sulfoxamine (MSX, which 
binds to the GS enzyme and prevents the production of glutamine), ensures the cells 
are stably expressing at high levels the GS gene and hence the heterologous protein 
(working as a biochemical selection marker). This system is commercially used for 
the production of antibodies. 
2.2. The Cell Cycle 
The structure and the metabolism of the cell have been reviewed in the previous 
sections. However, a key process in the cell is the sequence of events taking place 
between the time a cell is born until it divides to give birth to two daughter cells, 
repeating the process all over again. This series of events are defined as the cell 
cycle. The cell cycle comprises four main phases, which follow a time sequence 
(Figure 2.4). The main events taking place on each phase are described. 
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 First gap (G1): this phase is characterised by an increased physiological activity 
comprising growth and synthesis. The cell synthesises different organelles, 
functional proteins, and enzymes that will be required for the DNA replication. 
The cell has a control mechanism to ensure that is ready for DNA synthesis 
(known as the restriction point) and progress to the synthesis (S) phase. The G1 
phase has a variable length, which have been reported to be as short as 4h in 
CHO cells (Sitton and Srienc, 2008) but also approximately 9h in a typical human 
cell proliferating (Alberts et al., 2008). However, when conditions (internally or 
externally) are not favourable for DNA synthesis the cells enter a resting 
quiescent state known as G0 (Pardee, 1989). The cell can remain in this state for 
a variable period of time (between days to years) before it resumes proliferation 
or undergoes programmed death (apoptosis). 
Cell death is triggered extracellularly or intracellularly (Alberts et al., 2008). 
Known extracellular factors that trigger the process are the exhaustion of 
nutrients (particularly survival factors – e.g. certain amino acids) or the 
accumulation of toxic metabolites (e.g. ammonia and lactate). The internal factors 
that could lead to cell death usually are linked to quality control (e.g. abnormal, 
non-functional cells) or when the cells are stressed. 
 Synthesis (S): DNA replication occurs during this phase while cell growth 
continues. The chromosome duplication process has been reported to last 
approximately 6 hours (Sitton and Srienc, 2008). Once the cell has completed the 
DNA replication enters a second gap (G2). 
 Second gap (G2): throughout this phase the cell continues growing and control 
(Murray, 1994) that everything is ready for the next phase Mitosis (M) in order to 
divide. Typically this is a short gap of about 3h including division (Sitton and 
Scrienc 2008).  
 Mitosis (M): the cell cycle is completed by giving birth to two daughters cells. In 
this phase, cellular energy is focused on the division and cell growth has stopped. 
The first part of this process consists on the division of the nuclear envelop in two 
parts, each of which contains one genome. In mammalian cells the division is 
completed in less than an hour.  
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Figure 2.4. The cell cycle. 
Although the length depends on the cell type and its environment, mammalian 
cells complete the cycle in about 24h (Alberts et al., 2008).  
2.2.1. Cyclins 
The transition from one phase to another of the cell cycle is a highly regulated 
process. There are two key classes of regulatory molecules, cyclins and cyclin-
dependent kinases (CDKs) (Darzynkiewicz et al., 1996). The cyclins act as 
regulatory units and have no catalytic activity. The CDKs are catalytic subunits and 
are inactive in the absence of their partner cyclin (with which they form a 
heterodimer). The heterodimer coordinates the entry into the next phase. This is 
achieved by activating or inactivating target proteins, e.g. proteins and enzymes 
required for DNA replication in the S phase. The presence of CDKs remains constant 
through the cycle (Morgan, 1995), while the cyclins amount varies in a cyclical 
fashion (in response to molecular signals or checkpoints). 
Progression between the G1-S checkpoint has been reported to be regulated by 
two cyclins, cyclins D and E (Turchi et al., 2000). Cyclin D1 is expressed early in G1, 
associates with CDK4 and CDK6, and is responsible for the phosphorylation of the 
retinoblastoma protein (pRb), which is essential for progression to the S phase. 
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However, cyclin D expression is reported to remain invariable or at low level in 
normal proliferating cells (Gong et al., 1994; Gong et al., 1995). In addition, cyclin D 
is reported to be regulated by extracellular signals (Sherr, 1993), accumulating as a 
response to extracellular growth factors and declining rapidly in their absence. Cyclin 
E1 is expressed in mid-G1 and associates to CDK2 (Figure 2.4). The cyclinE1-CDK2 
complex is bounded with other promoters, such as p33, phosphorylates histone H1 
and other proteins in late G1 and early S phase. Cyclin E1 expression is reported to 
peak at the G1-S transition and to degrade through the S phase progression (Gong 
et al., 1994). Cyclins D and E together are responsible for carrying the cell through 
the restriction point between the G1-S phases.  
Similarly, cyclin B1 is reported to regulate the cell’s entrance into mitosis (Gong 
et al., 1993). Cyclin B1 expression initiates in late S phase, accumulates to a 
maximum between the G2-M transition and rapidly degrades in late M phase. Cyclin 
B1 forms a heterodimeric complex with CDK1 (Figure 2.4) forming the Maturation 
Promoting Factor (MPF), which activity is essential to trigger the entrance to mitosis 
(Darzynkiewicz et al., 1996). Cyclin expression patterns are, in general, reproducible 
in normal cells of different lineages; alas, tumour cell lines display different 
expression patterns (Gong et al., 1994). The expression of cyclins is cyclic and 
specific to cell cycle points (Figure 2.5).  
 
Figure 2.5. Cyclin expression pattern. [Adapted from: 
http://en.wikipedia.org/wiki/File:Cyclin_Expression.svg]. 
The cell cycle events are positively regulated by the cyclin-CDK complexes, 
whereas negative control is regulated by cyclin-dependent inhibitors (CDI) on the 
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cyclin-CDK complexes. For instance the cyclinE-CDK2 complex is targeted by two 
CDIs (i.e. p27 and p21), as well as other G1 complexes, in order to inactivate them. 
The inactivation of the complexes can induce cell arrest in the corresponding cell 
cycle phase, or trigger other cell events such as apoptosis. Evidence supports that 
apoptosis and the cell cycle are intimately linked, or even cell-cycle specific 
(Meikrantz and Schlegel, 1995). The two processes, cell cycle progression and 
apoptosis, depend on the balance of cyclins, CDKs, and CDIs. A key regulator is 
p53, which is a transcription factor that induces apoptosis or cell cycle arrest genes 
in response to various stress signals, such as DNA damage, heat shock, or hypoxia 
(Seth et al., 2006). Therefore, it can be considered as a switch between the cell 
cycle progression and the onset of apoptosis (Fussenegger and Bailey, 1998). 
2.2.2. Cell Death 
The cells can undergo programmed cell death (apoptosis) or necrosis. Apoptosis 
is irreversible and is activated in response to the accumulation of non-lethal stresses 
(e.g. nutrient depletion, growth factor deprivation, toxic metabolite accumulation) 
(Seth et al., 2006). Apoptosis is characterized both by morphological changes (e.g. 
cell shrinkage, membrane blebbing, disruption of membrane structure) and 
intracellular events that lead to cell destruction. There are two main pathways that 
result in apoptosis: the death receptor and the mitochondrial pathway. The death 
receptor pathway is dependent on the binding or lack of binding of ligands. This will 
trigger the expression of Caspase 8 and Caspase 3, which are proteins considered 
as initiators and final executors of cell death. The mitochondrial pathway is triggered 
by the controlled release of pro-apoptotic factors that are sequestered in the 
mitochondria intermembrane space. Both pathways involved a series of pro-
apoptotic and anti-apoptotic factors that control the event; whereas necrosis is the 
premature cell death due to violent changes in the environment (e.g. mechanical 
stresses). After cell death, the cell lyses resulting in the disintegration of the cell due 
to membrane breakage. 
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2.3. Cell Culture Systems 
Cell culture processes for the production of antibodies can be classified as batch 
or continuous. The most relevant culture systems are described below. 
Batch cultures are characterized by the consumption of nutrients in time with the 
concurrent toxic metabolite accumulation. The batch process is largely hindered 
either by the exhaustion of a nutrient or high levels of toxic metabolites, hence 
resulting in low cell densities. An advantage of this cultivation system is the low 
control requirements. The nutrient limitation is usually overcome by operating on a 
fed-batch mode. Therefore, the addition of a concentrated fed at specific time 
intervals avoids the nutrient deprivation, although the fed regime is constrained by 
the reactor working volume. In addition, since the medium is not withdrawn from the 
culture, the accumulation of toxic metabolites is inevitable. Fed-batch culture 
systems are characterized by longer cultivation times as well as higher cell densities, 
though require a higher level of control and monitoring. 
Continuous cultures are usually chemostat or perfusion systems. Chemostat 
cultures are continuously fed with fresh medium at a given flowrate, which is 
simultaneous and equal to the removal rate of the cell containing medium 
maintaining constant volume. Thus, a steady state operation can be achieved, with a 
constant cell density in the bioreactor by controlling the flowrate. The constant 
medium addition and toxic metabolite removal prolong the culture time, but the 
removal of proliferating cells limits the achieved cell densities and product titre. 
Perfusion cultures are also characterized by a constant feed of fresh medium and 
removal at the same rate of cell-free medium. This operation mode overcomes the 
cell density issues of the chemostat. The disadvantages of this system are the 
complex control and operation.  
2.4. Cell Culture Modelling 
The use of mathematical models can provide a systematic means to study 
complex systems (Bailey, 1998), such as cell cultures. The complexity arises from 
several aspects such as the structure of the cells (compartmentalization, chemical 
structure), the heterogeneity at different scales (bioreactor, cell cycle, genetic), and 
their metabolism (adaptability to changing environments). The previous mentioned 
aspects have made of the cell culture modelling to be grouped on two major areas. 
33 
 
The first area is related to the segregation of the cell population and the second area 
is the structure of the cell description. A final aspect that has been taken into account 
in the modelling is the probabilistic nature of events (i.e. deterministic versus 
stochastic). Despite the plethora of models and advancement in modelling 
techniques, cell culture models can be still classified using the systematic framework 
introduced by Fredrickson et al. (1970). 
In Figure 2.6, segregation refers to taking into account the heterogeneity of the 
cell population. Cell cultures are rarely synchronised and therefore, each cell 
possesses individual characteristics (either from a structural or functional point 
stand). Alternatively, an unsegregated model considers the cell population as a 
lumped biophase and deals with it as an average cell (homogeneous). Structure can 
arise from a physical space distribution (e.g. compartments) or from a biochemical 
point stand. The latter provides a detailed description of the cell components (e.g. 
metabolites, proteins, among others) and their interaction (in an attempt to capture 
the complex biological system). The unstructured model treats the cell as a single 
component “biomass”, and minimal structure is provided (more of a black-box 
approach). Whereas the most common approach for the event description is the 
deterministic approach (the progression of events is known), the stochastic approach 
allows introducing randomness and uncertainty into the processes. 
 
Figure 2.6. Classification of biological models according to Fredrickson et al. (1970). 
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The unsegregated/unstructured/deterministic models can be seen as simple 
representations, while the segregated/structured/stochastic models are complex and 
computationally intensive representations of the system. Each model has 
advantages and drawbacks (e.g. formulation time, parameter estimation/availability 
and computational time) and the end use should drive the selection criteria. The 
biological modelling literature is vast, thus an attempt to summarise the most 
significant contributions – emphasising in the cell cycle modelling – is presented. 
2.4.1. Structured Models 
The evolution from unstructured to structured models has been (and will be) 
tightly linked to the development of analytical techniques. The development of 
detailed analytical techniques has enabled the elucidation of the structure and 
function of biological systems. Hill (1910) and Michaelis and Menten (1913) 
described different systems with a similar mathematical expression. The Hill function 
was reported describing the binding of oxygen to haemoglobin (Hill, 1910), whereas 
Michaelis-Menten showed that the rate of an enzyme catalysed reaction (v) is 
proportional to the concentration of the enzyme-substrate complex ([S]), Equation 
(2.1).  
𝑣 = 𝑉𝑚𝑎𝑥
[𝑆]
𝐾𝑚 + [𝑆]
 
(2.1) 
Similarly, Monod (1949) applied an identical function as Michaelis and Menten to 
describe microbial growth. These contributions shaped the foundations of biological 
modelling and are still used widely in unstructured models. The underlying concept is 
that cell growth and metabolic pathways are ultimately limited by enzyme catalysed 
reactions. Further attempts to describe and predict cell cultures made use of 
Monod’s model to describe growth based on multiple substrates. One of the first 
attempts to include structure in the modelling of mammalian cells was reported by 
Batt and Kompala (1989), where metabolic detail (mechanisms) was introduced. In 
order to keep the model tractable, the intracellular constituents were lumped into a 
number of metabolic pools. The formulated dynamic model consisted of a set of 
differential equations, which described main substrate consumption, byproduct 
formation, cell growth, and antibody production. Further contributions in the field of 
antibody synthesis and secretion were presented in the work of Bibila and Flickinger 
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(1991). The authors included in their model the structure of the antibodies (heavy 
and light chain assembly) and also metabolic pathways (Bibila and Flickinger, 1992a, 
1992b). An important feature of their work was the use of factorial design analysis to 
identify the most significant parameters in the antibody secretion rate. The increasing 
structural detail in the models leads to complex formulations to capture the cell 
biology. Models of high metabolic and compartmentalisation detail are referred as 
Single Cell Models (SCM). One of the most comprehensive structured models for 
animal cells is the one proposed by Sanderson et al. (1999). The model includes 50 
components, over three regions of the cell culture (i.e. medium, cytoplasm, and 
mitochondria). The metabolic description featured glycolysis, TCA, production and 
use of fatty acids/amino acids, membrane transport, product formation, and cell 
growth/death. It is an extraordinary attempt to capture the cell’s complex functioning 
and in principle it can be extended and applied to a variety of animal cell cultures. 
Further, the model is used for the optimisation of the medium initial conditions and 
feeding strategies. The incorporation of high biological detail supported the better 
understanding and design of processes, though at a clear expense (i.e. validation 
issues, parameter estimation, and computational cost).  
In order to overcome the difficulties associated with SCM, a new type of models 
called “hybrid models” were proposed. Hybrid models consisting of both unstructured 
and structured elements brought a trade-off between detail and computational cost. 
A hybrid model consisting of an unstructured (i.e. nutrient uptake, metabolite 
production, cell growth, and death) and structured (antibody production) elements 
(Ho et al., 2006) was compared to a SCM (Sanderson et al., 1999) adapted for the 
study of GS-NS0 cell line. Ho et al. (2006) highlighted the difficulties in extending the 
SCM due to the over parameterised nature of it (with over 350 parameters), while the 
hybrid model successfully predicted the experimental data with less than 30 
parameters. Similarly, a hybrid model considering an unstructured growth and death, 
but accounting for glucose and 19 amino acids metabolism has been proposed 
(Kontoravdi et al., 2007b). The model requires 68 parameters, which can be modified 
to account for different cell lines. More recently, the attention in the inclusion of 
structure in mammalian cell modelling has been directed towards product quality (i.e. 
glycosylation). In this area, the dynamic model of the Golgi apparatus compared to a 
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plug flow reactor (Jimenez del Val et al., 2011), can potentially be coupled to a NSDs 
metabolic model in order to predict and optimise glycosylation patterns in mAbs. 
2.4.2. Structured-Segregation 
In order to account for the cell culture heterogeneity, it is required to segregate 
the population. This represents a major challenge due to the difficulties to 
experimentally measure and validate such heterogeneity. Particularly, mammalian 
cell culture heterogeneity ranges from the genetic to the bioreactor level. Therefore, 
published mammalian cell segregated models are less common than unsegregated 
models (Bailey, 1998; Sidoli et al., 2004). Two main trends capture the heterogeneity 
in the cell population: Cell Ensemble Models (CEMs) and Population Balance 
Models (PBMs), both will be discussed. CEMs capture the heterogeneity or 
segregation by including a large number (cluster) of SCMs that differ according to 
key cellular properties. The approach is based on the assumption that a sufficiently 
large number of individual cells will represent the behaviour of the population. 
Domach and Shuler (1984) used this approach to predict steady state and transient 
distributions of E. coli cultures with 250 modelled cells. Similarly, Henson (2005) 
investigated the synchronisation and cell cycle oscillations of continuous cultures of 
yeast S. cerevisiae with a CEM of 10,000 modelled cells. A total of six intracellular 
species (defining the heterogeneity) were included in the model. The reported 
computational time of an ensemble model for one hour of dynamic modelling 
involving 1,000 cells required about 200s on a Pentium IV 1.4GHz processor with 
64MBs of memory. An important advantage of the CEM approach is the ability to 
incorporate SCMs with computational feasibility. On the other hand, the number of 
cells included in the model will limit the resolution of the obtained distributions, as 
well as the possibility to perform computational demanding in silico experiments 
(model-based control and optimisation). 
2.4.3. Population Balance Models (PBMs) 
An alternative to model segregation in cell culture systems is based on the 
population balance equation (PBE). PBE describes the number distribution of 
internal cell states (e.g. age, mass, DNA) as a function of time. Such equations are a 
number balance on a population with respect to certain number of properties of 
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interest. This type of formulation allows incorporation of information about stage-to-
stage transition (e.g. cell cycle) and partition of cell material upon cell division. 
Therefore, PBMs are the most accurate way of describing the cell culture 
heterogeneity. PBMs can be classified as follows (Mantzaris et al., 2001a): 
 Single or Multi-variable: depends on the number of cell properties used to 
describe the state of a single cell at a given time. Multi-variable models are more 
detailed and can describe the cell state with more accuracy. 
 Single or Multi-staged: depends on the number of cell cycle stages that are 
included in the formulation. Each stage will require and additional PBE to 
describe the number balance within that stage (and transitions from it). 
 Mass or Aged structured: if the cell state is described by properties obeying mass 
conservation – the model is considered mass structured, while if age is used to 
differentiate cells – the model is considered age-structured. 
PBMs were introduced in biological systems by Fredrickson et al. (1967). 
However, their application to bioprocesses has been limited by two main challenges: 
1) the difficulties of solving a partial-integro-differential equation and 2) 
experimentally determining distribution data (Villadsen, 1999). The first challenge is 
further amplified since PBMs are coupled with the ordinary integro-differential 
equations accounting for the cell metabolism, substrate uptake and/or product 
formation, which add further complexity. The second challenge relies on the need to 
determine the intrinsic physiological state functions (e.g. growth rates, stage 
transition, division, death rates), which is rather experimentally challenging. 
The generic structure of a cell PBE is presented in Equation (2.2). Cells are 
considered heterogeneous on a basis of a state variable “x” (either single or multi-
variable). Therefore, the number of cells with a particular state at a particular time is 
tracked. This is referred as the number distribution on the stage “i” (if the model is 
multi-staged) and is denoted as Ni(x,t). This quantity will vary in time and reflects the 
accumulation of cells in stage i with state x (first term on the LHS Equation (2.2)). 
Changes on the number of cells are given due to different events related either to the 
metabolism or cell cycle transition. The second term on the LHS Equation (2.2) 
accounts for the loss of cells due to their transition to other states with rate ri(x,S) 
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where S reflects the substrate dependence. This term is mainly related to 
metabolism, e.g. single cell growth. 
∂Ni(x, t)
∂t
+
∂
∂x
[𝑟𝑖(𝑥, 𝑆)𝑁𝑖(𝑥, 𝑡)]
= −i(𝑥, 𝑆)𝑁𝑖(𝑥, 𝑡) + j(𝑥, 𝑆)𝑁𝑗(𝑥, 𝑡) − 𝐷𝑁𝑖(𝑥, 𝑡) − 𝑘𝑑(𝑆)𝑁𝑖(𝑥, 𝑡)
+ 2 ∫ j(𝑦, 𝑆)𝑝(𝑥, 𝑦, 𝑆)𝑁𝑗(𝑦, 𝑡)
𝑥𝑚𝑎𝑥
𝑥𝑚𝑖𝑛
𝑑𝑦 
(2.2) 
The other events varying the cell number are related to stage changes (terms on 
the RHS Equation (2.2). The first term on RHS stands for the cells leaving stage i 
(e.g. cell division or cell cycle transitions) with a rate Гi(x,S). The second term on 
RHS is associated with the number of cells that might enter stage i coming from 
stage j, such as cell cycling (but different from cell birth). The third term on the RHS 
accounts for the dilution depending on the reactor operation mode. The fourth term 
on the RHS accounts for the death of cells in stage i with rate kd. Cell birth is 
represented by the last term on the RHS as a parent cell of state y dividing to give 
birth to two daughter cells of state x. The partition function p(y,x,S) expresses the 
probability of a mother cell with state y will give birth to a cell of state x (if assumed to 
be independent on the substrate p(y,x) ). Cells in stage i are being born through the 
division of cells in stage j. Since cells can be at different states of the state 
continuum, in order to include all parent cell divisions, integration is required for all 
possible parent cells ranging from a minimum, xmin, to a maximum, xmax. The 
formulation is completed by specifying the physiological state functions r, Г, kd, and p 
indicated in Equation (2.2). The growth r and death kd rates are usually coupled with 
a cell (un)-structured model. The transitions between stages Г, is either modelled 
deterministically (if well understood) or allowed to include randomness when this fits 
best knowledge. The partition function usually accounts either for equal partition or 
for symmetric distribution (e.g. Beta) centred at equal partition allowing for the less 
probable unequal partition. Further, it should be noted that there are several points of 
coupling between the population balance, the cell model and overall mass balances. 
The presented formulation gives rise to the aforementioned challenges. Therefore, 
most of the available PBMs in cell cultures are coupled to unstructured models in 
order to reduce the computational burden. The computationally intensive nature of 
the formulation is demonstrated in several studies (Fadda et al., 2012b; Mantzaris et 
al., 2001a; Mantzaris et al., 2002; Pinto et al., 2007; Sidoli et al., 2006; Stamatakis, 
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2013) with increasing complexity (i.e. number of stages, number of variables or level 
of structure). Although the development and improvements in computer power is 
also perceived in these studies (Karra et al., 2010; Pinto et al., 2007). 
Two main features characterise the existing model formulations: age or 
mass/volume based PBMs. Early reports used age as the sole distribution variable. 
Cazzador and Mariani (1993) modelled the growth and productivity of mAbs in 
hybridoma cells. The model is multi-staged (3 cell cycle phases) and age structured. 
It considered a stochastic transition to the G0 phase and different productivities 
throughout the cell cycle stages. Hatzis et al. (1995) formulated a multi-stage (3 
stages not correlated with the cell cycle) and multi-variable (mass and age structured 
depending on the stage) PBM for ciliate growth. The transition rates were assumed 
to be random and dependent either on age or mass. Martens et al. (1995) proposed 
a three stages PBM for the hybridoma cell cycle and unstructured metabolism 
including energy considerations. Cells were considered to die after a fixed time in the 
apoptotic stage. More complex formulations were reported (Cain and Chau, 1998; 
Rounseville and Chau, 2005) using age and an additional intracellular property (e.g. 
product, RNA). However, the age-based PBM formulations have the disadvantage 
that age as a distributed variable is difficult to experimentally quantifiable. 
Consequently, mass/volume based PBMs attempted to overcome the difficulties 
of using age as the distributed variable. Mantzaris et al. (2002) presented a mass 
structured PBM with 2 stages (with product produced in the 2nd stage). The model 
assumed no cell death and cells were cultured in a chemostat (with a linear growth 
rate w.r.t. mass and substrate inhibition). The PBM model was used to design a 
controller to operate the bioreactor showing its potential industrial relevance 
(although it was not experimentally validated). The authors aimed to control 
productivity by manipulating the feed substrate concentration, which affects the 
population growth and productivity. The unique coupling of a PBM with a SCM was 
reported by Sidoli et al. (2006). The multistaged (2 lumped cell cycle phases:  G0/G1 
and S/G2/M) mass based PBM was coupled to a SCM (Sanderson et al., 1999). The 
transitions between stages were assumed to occur randomly after a critical mass 
checkpoint. However, the detailed formulation demonstrated the computational 
intensive nature of the PBM-SCM description (with over 700 parameters). Liu et al. 
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(2007) formulated a multistaged (3 stages: G1, S, and G2/M) and multi-variable (DNA 
content and cell volume) PBM. The transition from G1 to S and division from G2/M 
was considered to be dependent on the cell’s volume, while the transition from S to 
G2/M was determined by the DNA content. Cell death could occur at any of the 
stages and the cell metabolism was unstructured. The authors suggest that some of 
the model prediction discrepancies were due to the unstructured model used for 
single cell growth. Recently, Karra et al. (2010) formulated a multistage (3 stages: 
G0/G1, S, G2/M) mass structured PBM with unstructured metabolism for mammalian 
cell culture processes. The authors were able to perform parameter estimation using 
simulated annealing due to the low computational requirements. The obtained 
results showed a reasonable fit with a minimum computational requirement (single 
run ~9s). Recently, Fadda et al. (2012a) proposed a PBM based on cell size and 
DNA content to describe the proliferation of adherent cells inside a Petri dish. The 
authors showed the advancement of the computational power by using the model for 
fitting parameters, although reference was made (Fadda et al., 2012b) to the 
prohibitively increasing computational solution time when increasing the number of 
grid points to increase the accuracy of the solution. Similarly, the theoretical study of 
a volume-based PBM to investigate the dynamics of a single gene with feedback 
suggested that to solve the full model compared to proposed reduced-model for the 
same number of cells it would take 100 times more computation time (Stamatakis, 
2013). 
PBMs present an accurate description of cell culture heterogeneity, although with 
clear experimental challenges. Mass/volume-based PBMs aimed to resolve the 
experimental disadvantages of the age formulation; however it still misses the 
biological and mechanistic relevance to truthfully capture the mammalian cell cycle. 
Consequently, the utilization of biomarkers can address the experimental challenges 
and to rigorously capture the cell cycle heterogeneity (Munzer et al., 2013). 
2.4.4. Unstructured-Segregation 
Both, the computational and experimental challenges of CEMs and PBMs have 
been avoided by models using ordinary differential equations. This type of models 
avoids the computational burden of CEMs and PBMs as its solution is fast. 
Moreover, it avoids some of the validation issues of over parameterised models (as it 
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tends to be rather unstructured). Similarly, the cell cycle transitions are based on the 
assumption of a steady state observed during exponential of growth (also referred as 
balanced exponential growth). Thus, Watanabe and Okada (1967) expressed the 
expected cell cycle fractions as a function of the cell cycle times. Such expressions 
were used by Suzuki and Ollis (1989) to explicitly formulate a cell cycle model for 
antibody production in chemostat cultures. Linardos et al. (1992) used Suzuki’s 
model to study cell death, linking it to the fraction of cells in G1. Further Uchiyama 
and Shioya (1999) adapted the cell cycle model for the industrial amylase fed-batch 
production. The authors fully exploited the cell cycle segregation and included cell 
cycle specific productivities. Similarly, an unstructured model comprising different 
macromolecules was presented by Jang and Barford (2000). Specifically, the model 
accounted for the production of macromolecules (e.g. lipids, DNA, RNA), monoclonal 
antibodies, and basic metabolism (glucose/glutamine consumption, producing 
lactate/ammonia) both in batch and fed-batch. The model features the division of the 
cell population in two groups: viable and arrested cells, including segregation into the 
model. Recently, Lam et al. (2008) proposed a model for (fed)-batch hybridoma 
culture accounting for the cell cycle segregation (3 phases) and specific cell cycle 
productivity. The authors used the model for model-based optimisation proving the 
computational advantages of the modelling approach. The unstructured segregation 
of the cell cycle presents clear computational advantages over more complex 
formulations. The unstructured segregation provides fast computational times and 
enables it to be used for model-based applications. However, the model formulation 
based on characteristic times to complete every cell cycle phase limits once again its 
biological relevance. 
2.4.5. Boolean models 
The computational advantages of the ordinary differential equation models using 
kinetic rates are evident, while its validation is limited by experimental challenges of 
determining the kinetic constants. This limitation applies to any cell cycle model 
using a reaction network. Therefore, another modelling strategy is the use of 
Boolean switching networks. Boolean functions provide the state of a variable (e.g. 
active, inactive), neglecting the notion of rates. This type of modelling is useful to 
study concepts of the cell cycle, but has limited applicability as it is not quantitative 
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and cannot be used for prediction purposes. However, recent contributions 
(Singhania et al., 2011) aimed to combine Boolean networks with quantifiable 
continuous variables. 
The presented cell cycle model contributions provide an overview of the state of 
the art. The key (dis)advantages of each modelling approach were discussed. 
Overall a balance between the model detail in terms of structure and segregation 
regulates the computational intensive nature of the system. Similarly, the inclusion of 
detail introduces experimental challenges for the model validation. Ultimately, the 
selection of the cell cycle modelling approach is subjected to all these conditions, as 
well as the final intended model application. 
2.5. Mathematical Framework 
The mathematical models presented in this thesis were developed using the 
recently proposed biological model development framework (Kiparissides et al., 
2011; Kontoravdi et al., 2010). The framework aims at the systematic development 
of biological models based on first principles and further refinement of the models by 
using model-based tools in order to avoid unnecessary experimentation. 
 
Figure 2.7. Model development framework for biological systems. [Adapted from:(Kiparissides et al., 2011) ]. 
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The framework follows a closed-loop approach that can be recursively applied for 
model development. Briefly the framework consists of 4 main steps: 
1. Model development. During this step the model type (i.e. structure, 
segregation) and the model equations are define through first principles. 
2. Model analysis. The uncertainty introduced by the model parameters is 
evaluated against the outputs in order to identify the most significant or 
sensitive parameters. 
3. Model validation. The significant parameters are estimated from tailor-made 
experiments or available existing experiments, whereas the insignificant 
parameters are set to their nominal values. The model validity is tested 
against a set of independent experiments of varying conditions. This 
procedure can be recursively repeated until satisfactory prediction. 
4. Model-based optimisation and control. Optimise or control the model inputs 
towards a desired goal. 
2.5.1. Sensitivity Analysis 
Model analysis techniques aim to study the model structure as well as the 
parameter-output relations. Particularly, parameter sensitivity analysis studies the 
variation of the model outputs by using the parameters as sources of uncertainty. 
This type of quantitative analysis allows selecting the most significant parameters (or 
with greater effect on the outputs), thus reducing the number of parameters to be 
(re)-estimated experimentally. There are three categories of sensitivity analysis 
methods: screening, local, and global (Saltelli et al., 2000). 
Screening methods evaluate one factor at a time, which makes them 
computationally efficient and attractive to be used when there are a substantial 
number of input factors. However, the results are rather qualitative as the method 
ranks the results in order of importance. Further, the analysis is limited to only first 
order interactions, due to the-one-factor-at-a-time variation, lacking precision when 
used in non-linear models (Saltelli et al., 2000). Local methods evaluate the impact 
of a factor on the model output by computing the derivatives of variation of the output 
with respect to the input factors. Local methods are limited by the different order of 
magnitudes of the uncertainties and therefore are not suitable for non-linear models 
(Saltelli et al., 2000). Global sensitivity analysis (GSA) methods provide quantitative 
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results varying all parameters simultaneously, while the sensitivity is measured over 
the entire range of each input factor. Therefore, this is the preferred method when 
dealing with non-linear models and with input factors of varying order of magnitudes 
(Saltelli et al., 2000). 
Biological models usually contain parameters of different orders of magnitude 
and are non-linear. These characteristics make GSA the most appropriate tool for 
studying biological models. The simultaneous variation of parameters allows 
accounting for the different orders of magnitude as well as for higher order 
interactions. GSA can aid the model development process by identifying the most 
significant parameters on the variability of model outputs. Thus, the output 
uncertainty is efficiently reduced and the model predictability improved, if the 
uncertainty on the identified significant model inputs (parameters) is reduced. A 
number of GSA techniques are available such as the Sobol’s method (Saltelli et al., 
2000; Sobol, 2001), the derivative-based global sensitivity measures (Kucherenko et 
al., 2009), and high dimensional model representation (Rabitz and Alis, 1999; Ziehn 
and Tomlin, 2009), among others. A key aspect to consider when selecting the GSA 
method is the computational effort of the models and methods (Kiparissides et al., 
2009; Ziehn and Tomlin, 2009).  
2.5.2. Parameter Estimation and Model Validation 
Parameter estimation is carried out either using already existing data or from 
tailor-made experiments. Existing data can be a good source for parameter 
estimation, particularly if the experiments cover a range of conditions. However, the 
optimal experimental design is meant to be used as a tool to maximize the 
information content of experimental data (Kontoravdi et al., 2010). Specifically, the 
optimal experiment is tailored for the re-estimation of the parameters identified as 
most significant in the sensitivity analysis. The experiment design aims to determine 
the optimal settings (conditions) and measurements times to minimize the 
confidence of the estimated parameters.  
After parameter estimation, the model can be validated against a set of 
independent data or experiments with varying conditions. The model development 
sequence of designing experiments, performing it, and use of the generated data 
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can be done iteratively until satisfactory agreement between the model prediction 
and the experimental data is achieved (Kiparissides, 2012; Kiparissides et al., 2011; 
Kontoravdi et al., 2010). Once the model is validated it can be used for model-based 
applications (optimisation, control). The biological model development framework 
presents an approach to develop high fidelity models from initial conception through 
its experimental validation and application. 
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CHAPTER 3 
3. Materials and Methods 
The materials and methods used at the experimental and modelling level are 
reported in this section. A series of batch and fed-batch cell culture experiments 
covering different cell lines and culture conditions were carried out. The key 
experimental conditions are outlined in this chapter, while further details are reported 
within each experimental chapter (4 & 5). Similarly, the general features of the 
different data and model analysis methods are introduced herein, whereas further 
detail is presented in the corresponding chapters. 
3.1. GS-NS0 cultures 
3.1.1. Cell Culture 
GS-NS0 cells (kindly provided by Lonza; passage 5) with expression of a 
chimaeric B72.3 IgG4 antibody were cultured. Cells were cultured in suspension in a 
NU-5500E (Triple Red) humidified incubator set at 37 °C and 5% CO2. Mixing was 
accomplished using a Stuart SSL1 orbital shaker (Bibby Scientific) at 125rpm. The 
culture medium consisted of glutamine free advanced-DMEM (Invitrogen), 2X MEM-
Vitamins (Gibco), 1X Non-Essential Amino Acids (Sigma-Aldrich), 2X MEM-Amino 
Acids (Gibco), 2X GS-Supplement (SAFC), 1X Penicillin/Streptomycin (Gibco), 4.5 
g/L MSX (Sigma-Aldrich) and 10% (v/v) fetal bovine serum (Gibco) or 10% (v/v) 
dialyzed fetal bovine serum (Gibco). 
3.1.2. Cell bank 
A cell bank for the cell line was previously created (Kiparissides, 2012). Briefly, 
cells from the master cell bank were expanded in 250mL Erlenmeyer flasks 
(Corning) prior to long term storage in a liquid nitrogen tank. Cells from cultures in 
mid-exponential growth – with over 85% viability – were centrifuged at 800rpm for 
5min and the supernatant was aspirated. Cells were re-suspended in a medium mix 
containing fresh medium and 7.5% (v/v) DMSO (Sigma-Aldrich) to reach an end 
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concentration of 1*107 cells/mL. Subsequently 1mL aliquots were transferred to 
cryovials (Corning) and stored in a 5100 Cryo 1 °C Freezing Container (Nalgene) at -
86 °C overnight, and finally the cryovials were transferred to long term storage to the 
liquid nitrogen tank. 
Cryovials removed from the liquid nitrogen storage were thawed in a 37 °C water 
batch for 2-4min. The contents of the cryovial were transferred to 10mL of fresh 
warm medium (37 °C) and centrifuged at 800rpm for 5min. The supernatant was 
aspirated and the cell pellet re-suspended in 10mL of fresh warm medium before 
being inoculated at 2*106 cells/mL in a 125mL Erlenmeyer (Corning) with 25mL 
working volume. Cells were passaged 3-4 times before starting an experiment. 
3.1.3. Batch experiments 
GS-NS0 cells were cultured in triplicate in 1L Erlenmeyer flasks (Corning) with 
200mL working volume at a seeding cell concentration of 2.5*105 cells/mL or 6.5*105 
cells/mL in a humidified incubator containing 5% CO2. At the start of the batch 
experiments the temperature was set to 37 °C, and in some cases shifted to 35 °C or 
39 °C after 30h. Mixing was accomplished using a Stuart SSL1 orbital shaker (Bibby 
Scientific) at 125rpm. 
The medium shift experiments of the GS-NS0 cells were cultured in triplicate in 
250mL Erlenmeyer flasks (Corning) with 50mL working volume at a seeding cell 
concentration of 5*105 cells/mL in a humidified incubator containing 5% CO2. The 
temperature was set to 37 °C and mixing was accomplished using a Stuart SSL1 
orbital shaker (Bibby Scientific) at 125rpm. 
3.2. HFN 7.1 cultures 
HFN 7.1 murine hybridoma cell cultures were conducted as part of a collaborative 
effort between the Biological Systems Engineering Laboratory (BSEL) at Imperial 
College and The Morbidelli Group at ETH Zurich. Specifically, Marija Ivarsson (PhD 
candidate) and Dr. Miroslav Soos (Senior Scientist) from ETH were involved in the 
fed-batch experiments. Similarly, Chonlatep Usaku (PhD candidate) from BSEL was 
involved in the batch experiments. 
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3.2.1. Cell Culture 
HFN 7.1 murine hybridoma cells (ATCC CRL-1606) (Schoen et al., 1982) 
adapted to the chemically defined, protein- and peptide-free culture medium 
TurboDoma TP6 (Cell Culture Technologies) were used. The medium was prepared 
following the vendor’s instruction and supplemented with 4.5g/L D-glucose, 4mM L-
glutamine, and 0.1% (w/v) pluronic F-68. Cells were sub-cultured in suspension for 
14 days at 37 °C in a humidified incubator containing 5% CO2 and subsequently 
used for batch and fed-batch cultivations. 
3.2.2. Cell bank 
A common/joint working cell bank between ETH and Imperial College was built 
for the HFN 7.1 culture studies. Cells from the master cell bank were expanded in 
Erlenmeyer flasks (Corning) prior to long term storage in a liquid nitrogen tank. Cells 
from cultures in mid-exponential growth – with over 95% viability – were centrifuged 
at 660rpm for 3min and the supernatant (conditioned medium) was aspirated. Cells 
were re-suspended in a medium mix containing: 70% (v/v) fresh medium 
(TurboDoma TP6), 20% (v/v) conditioned medium, 10% (v/v) dimethyl sulfoxide 
(DMSO, Sigma-Aldrich) to reach an end concentration of 2*107 cells/mL. 
Subsequently 1mL aliquots were transferred to cryovials (Corning) and stored in a 
5100 Cryo 1 °C Freezing Container (Nalgene) at -20 °C for 2h, then at -80 °C for 2h, 
and finally the cryovials were transferred to long term storage to the liquid nitrogen 
tank. 
Cryovials removed from the liquid nitrogen storage were thawed in a 37 °C water 
batch for 2-4min. The contents of the cryovial were transferred to 10mL of fresh 
warm medium (37 °C) and centrifuged at 660rpm for 3min. The supernatant was 
aspirated and the cell pellet re-suspended in 10mL of fresh warm medium before 
being inoculated at 3*106 cells/mL in a 125mL Erlenmeyer (Corning) with 25mL 
working volume. Cells were passaged 14 days before starting an experiment. 
3.2.3. Batch experiments 
HFN 7.1 cells were cultured in triplicate in 1L Erlenmeyer flasks (Corning) with 
240mL working volume at a seeding cell concentration of 6e5 cells/mL in a 
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humidified incubator containing 5% CO2. At the start of the batch experiments the 
temperature was set to either 37 °C, 35 °C or 33 °C. Mixing was accomplished using 
a Stuart SSL1 orbital shaker (Bibby Scientific) at 125rpm.  
3.2.4. Fed-batch experiments 
HFN 7.1 fed-batch cultures were performed in a parallel bioreactor system 
(DasGip) equipped with online temperature, pH and dissolved oxygen measurement 
probes (Mettler-Toledo), a pitched-blade impeller, and a porous sparger (10 µm). 
Cells were seeded into the bioreactor at a cell concentration of 6*105 cells/mL in a 
working volume of 1L. Dissolved oxygen was controlled at 50% air saturation with a 
constant airflow of 3L/h and an oxygen on demand strategy. pH setpoint 7.2 over the 
whole culture and controlled initially by CO2 sparging and in some cases by base 
addition (2mol/L NaOH) depending on the lactate production of the growing cells. 
Temperature was either set to 37 °C and kept constant throughout the culture or 
shifted to mild hypothermia 33 °C at three different time points (t = 0, 30, 76h) by 
changing the controller setpoint. The time required for the reactor to reach the new 
temperature setpoint was negligible short (<10min). A continuous feed of amino 
acids (RPMI-1640 50x, Sigma), vitamins (RPMI-1640 100x, Sigma), trace elements 
(trace element mix 1000x, Bioconcept), and L-glutamine (64mmol/L) was initiated 30 
hours after inoculation with a constant pump rate of 2.33mL/h. D-glucose feeding 
solution (1mol/L) was fed from the beginning of the culture to keep glucose at a 
setpoint of 20mM.  The pump rate of the glucose solution was adjusted every 12 
hours according to the measured viable cell concentration and specific glucose 
consumption resulting in a semi-continuous feeding mode. 
3.3. Assays 
Specific assays were conducted to measure and infer information from the 
experiments.  
3.3.1. Cell cycle arrest 
The use of different chemical agents was aimed to arrest and synchronise a 
fraction of the cell population. Herein, synchronisation refers to the cell alignment to 
a particular property, which in this case is the DNA content. After releasing the cells 
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from the arrest, the synchronised moving population was tracked using the DNA 
content as a criterion until it was not possible any longer to distinguish the 
population. Two chemical agents were used to synchronise the cultures, thymidine 
and DMSO. The above mentioned arresting agents were used with simultaneous 
control cultures.  
Thymidine. GS-NS0 cell cycle arrest using thymidine (final concentration of 
2mM; Sigma Aldrich) consisted of a double block. Thymidine was added to the 
desired concentration to the culture medium of cells in mid-exponential growth for 
12h, then the cells were washed twice with phosphate buffered saline (PBS; Gibco) 
and re-suspended in the culture medium and incubated for another 12h at which 
time thymidine was added to the medium for a second time (second block) for 12h. 
The cells were then washed twice and re-suspended in culture medium at 2.5*105 
cells/mL and cultured for 6 days. A control group, which included all the 
centrifugation and washing steps without exposure to thymidine, was established. 
Sampling was performed at the beginning and end of each blocking. After the arrest 
release the culture was sampled every 2h for the first 10h, and every 24h afterwards. 
DMSO. GS-NS0 cell cycle arrest using DMSO (final concentration 0.45% v/v) 
consisted of a single block. DMSO was added to the desired concentration to the 
culture medium of cells in mid-exponential growth for 36h, and then the cells were 
washed twice with PBS and re-suspended in the culture medium at 2.5*105 cells/mL 
and cultured for 6 days. A control group, which included all the centrifugation and 
washing steps without exposure to DMSO, was established. Sampling was 
performed at 0, 24 and 36h during the arrest phase and after the arrest release 
every 2h between 12 and 24h, and every 24h afterwards. 
3.3.2. Cell proliferation assay 
Cells were exposed to a DNA nucleoside analogue to thymidine (5-ethynyl-2-
deoxyuridine, EdU) that contains an alkyne, which could be later detected by a 
copper catalysed reaction between the alkyne and an azide-coupled flourochrome. 
Cells in mid-exponential growth were exposed to 30μM of 5-ethynyl-2 ́-deoxyuridine 
(EdU, Invitrogen C10419) for a period of 3 hours. After the exposure, the cells were 
washed twice with PBS and re-suspended in the standard growth medium (in the 
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absence of EdU) and cultured in batch mode for 6 days. A control group, which 
included all the centrifugation and washing steps without exposure to EdU, was 
established. Samples were taken every 2h for the first 20h and every 24h afterwards. 
3.3.3. Sampling, cell counts and viability 
All batch samples were counted manually using a haemocytometer under a Leica 
DM-IL inverted phase microscope (Leica). Viable cell concentration and viability 
were calculated by a dye-exclusion method using Erythrosin-B stain solution 
(ATCC). 
All fed-batch samples were counted using a CedeX cell counter (Innovatis) by the 
trypan blue exclusion method. 
HFN 7.1 samples (1.5-2mL) were taken twice a day and centrifuged at 660rpm 
for 3min. The cell-free supernatant was stored at -20 °C for metabolic profiling and 
antibody (IgG1) titre determination. 1*106 cells were fixed by drop wise addition of 1 
mL of 75% v/v ice-cold ethanol (VWR) for flow cytometry analysis. The fixed cells 
were stored at -20 °C prior to cell cycle analysis. 
GS-NS0 samples (1.5-2mL) were taken and centrifuged at 800rpm for 5min. The 
cell-free supernatant was stored at -20 °C for metabolic profiling and antibody (IgG4) 
titre determination. Flow cytometry samples were prepared by fixing 1*106 cells by 
drop wise addition of 1 mL of 75% v/v ice-cold ethanol (VWR) or 100% v/v ice-cold 
methanol (Sigma) depending on the cyclin to be analysed. If no cyclin analysis was 
performed, 1 mL of 75% v/v ice-cold ethanol (VWR) was used. The fixed cells were 
stored at -20 °C prior to cell cycle analysis. 
3.3.4. Metabolic profiling 
All the batch culture extracellular concentrations of ammonium, lactate, 
glutamine, glutamate, and glucose were measured from the stored supernatant 
samples with the Nova BioProfile 400 Analyzer (Nova Biomedical). 
HFN 7.1 fed-batch glucose and lactate concentrations were measured 
immediately after sampling using a Super GL compact instrument (Hitado). The 
glutamine concentration of fed-batch cultures was measured from the supernatant by 
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HPLC (ZORBAX Eclipse Plus C18 4.6 mm x 150 mm, Agilent Technologies) 
according to Agilent’s application note (5990-3283EN). Prior to the HPLC 
measurement, supernatant samples were filtered at 4000 rcf, 4 °C for 25 min using a 
Vivaspin500 (5 kDa) centrifugation filter (Satorius Stedim). Ammonium 
concentrations were determined using the L-Glutamine/Ammonia (Rapid) Assay Kit 
(K-GLNAM, Megazyme) following the vendor’s protocol. 
3.3.5. Extracellular antibody quantification 
HFN 7.1 cultures monoclonal antibody (IgG1) concentrations were determined 
from the supernatant by standard affinity chromatography using a PA 
ImmunoDetection® Sensor Cartridge (Applied Biosystems) containing immobilized 
protein G. 
GS-NS0 cultures monoclonal antibody (IgG4) quantification was performed using 
a high pressure liquid chromatography (HPLC) Agilent 1260 Infinity system (Agilent 
Technologies). The supernatant was filtered through a 13mm syringe filter with 
0.22µm PTFE membrane (VWR, 28145-491) prior to injection. The affinity column, 
Bio-Monolith Protein A (Agilent Technologies, 5069-3639) was used to quantify IgG4 
antibody in the samples by comparison to a calibration curve. The sample (50uL) 
was injected and loaded into the column at a flowrate of 1mL/min with a 100% PBS 
pH 7.4 mobile phase for 2 minutes. After, a change in gradient was performed to a 
100% acetic acid 0.5M pH 2.6 mobile phase to elute, which was maintained for 5 
minutes. Finally the column was again conditioned with 100% PBS pH 7.4 mobile 
phase for 2 minutes. The elution was monitored with a UV detector at 280 nm. The 
calibration curve was built from triplicate injections of a dilution series of cB72.3 
antibody standard, kindly provided by Lonza biologics.  
3.3.6. Cell cycle analysis 
The cell cycle analysis was performed by flow cytometry. The workflow of the 
sample preparation depended on the assays performed.  
Cell fixation and permeabilisation 
GS-NS0 cells (aprox. 1*106 cells/sample) were harvested, fixed, and 
permeabilised. The fixation agent was a choice depending on the cyclin to be 
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analysed on the sample. Specifically, cells were fixed and permeabilised by drop 
wise addition of 1mL of 75% v/v ice-cold ethanol (VWR) for cyclin E1 analysis or 
100% v/v ice-cold methanol (Sigma) for cyclin B1 or D1 analysis. The fixed cells 
were stored at -20 °C for up to 2 days prior to cyclin analysis or up to 2 weeks 
otherwise. 
HFN 7.1 cells (aprox. 1*106 cells/sample) were fixed and permeabilised by drop 
wise addition of 1 mL of 75% v/v ice-cold ethanol (VWR). The fixed cells were stored 
at -20 °C for up to 2 weeks prior to analysis. 
Prior to flow cytometry analysis, fixed cell samples from the batch culture were 
washed with a rinsing solution with 1% w/v bovine serum albumin (Sigma) and 
0.01% w/v sodium azide (Sigma Aldrich) in PBS. Similarly, fixed fed-batch cell 
samples were washed twice with 1% w/v fetal bovine serum (PAN Biotech GmbH) in 
PBS. The sample preparation continued either with the EdU detection, Ki-67 
proliferation marker, cyclin staining, or DNA staining. 
EdU detection 
The cells were centrifuged, the rinsing solution removed and cell membrane 
permeabilisation was aided with 50μL of a saponin based wash reagent (component 
E, C10419, Invitrogen) following the vendor instructions for 15min at room 
temperature. The EdU was detected by adding 0.5mL of the click-IT reaction cocktail 
(prepared as per the vendor instructions). Incubation was performed for 30min at 
room temperature in the dark, followed by washing with the rinsing solution. The 
workflow continued with the Ki-67 proliferation marker or cyclin staining. 
Ki-67 proliferation marker 
The GS-NS0 cells were centrifuged, the rinsing solution removed and 50μL of a 
saponin based wash reagent was added. Then 20μL of a PE Mouse Anti-Human Ki-
67 or the isotype (BD, 556087) were added to stain for the proliferation marker. 
Incubation was performed for 30min at room temperature in the dark, followed by 
washing with the rinsing solution. The protocol continued with the DNA staining. 
The HFN 7.1 fed-batch cell pellet was re-suspended to a concentration of 1*107 
cells/100µL and 5µL FITC conjugated Mouse Anti-Human Ki-67 antibody was added 
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(556026, BD Pharmingen) for 30 minutes in the dark at room temperature. The 
protocol continued with the DNA staining. 
Cyclins 
The GS-NS0 cells were centrifuged, the rinsing solution removed and 50μL of a 
saponin based wash reagent was added. Antibodies used for cyclin staining were: 
mouse IgG1 anti-human cyclin B1 FITC-labelled (BD, 554108); mouse IgG1 FITC-
labelled isotype control (BD, 554108); rabbit polyclonal IgG FITC-labelled anti-cyclin 
E1 (Bioss USA, bs-0573R-FITC); rabbit polyclonal IgG FITC-labelled anti-mouse 
isotype control (Bioss USA, bs-0296R-FITC); mouse IgG2a anti-human cyclin D1 
FITC-labelled (Invitrogen, AHF0088); mouse IgG2a FITC-labelled isotype control 
(Invitrogen, MG2a01). The antibodies were used according to the supplier 
instructions. Briefly, incubation was performed at room temperature for 30min in the 
dark followed by washing with the rinsing solution. The protocol continued with the 
DNA staining. 
DNA 
The GS-NS0 cells were centrifuged, the rinsing solution removed and 1mL of 
rinsing solution was added. The DNA was stained by adding 1μL of FxCycle violet 
stain (Invitrogen, F10347). Alternately, after centrifugation and removing the rinsing 
solution, 1mL of 50μg/mL propidium iodide (PI; Sigma, P4170), 100μg/mL of 
ribonuclease A (Sigma, R4875) in PBS was added. Incubation was performed at 
room temperature for 30min in the dark.  
The HFN 7.1 batch cell pellet was stained for DNA by adding 1mL of 50 μg/mL 
propidium iodide (PI; Sigma, P4170) and 100 μg/mL of ribonuclease A (Sigma, 
R4875) in PBS at room temperature for 30min in the dark. The HFN 7.1 fed-batch 
cell pellet was washed with 1% w/v fetal bovine serum (PAN Biotech GmbH) in PBS. 
DNA was stained by the addition of 0.5 mL 1 μg/ml propidium iodide (P4864, Sigma) 
and 100 μg/ml ribonuclease A (EN053, Thermo Scientific) in PBS and incubated for 
30 minutes in the dark at room temperature. 
Flow cytometry set-up 
Flow cytometry was performed on a LSRFortessa (BD) at Imperial College. Two 
types of configuration were used depending on the staining. For samples stained for 
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cyclin and PI-stained DNA, or solely PI-stained DNA an excitation wavelength of 488 
nm with a emission 530/30 filter was used for FITC and an excitation wavelength of 
561nm with a emission 582/15 filter for PI. For all other samples using FxCycle-DNA 
stain an excitation wavelength of 405 nm with a emission 450/50 filter was used for 
the violet stain; 488 nm with a emission 530/30 filter was used for FITC; 561 nm with 
a emission 582/15 filter was used for PE; and an excitation wavelength of 640nm 
with a emission 670/14 filter was used for Alexa647. Apart from the isotype controls, 
unstained cell samples were used as negative controls, and single colour controls to 
compensate. 10,000 events/sample were collected. 
At ETH a Calibur flow cytometer (BD) with an excitation wavelength of 488 nm 
was used. The PI was collected on a 585/42 filter and FITC on a 530/30 filter. Single 
colour controls were used for compensation and between 10,000-20,000 
events/sample were collected. 
Table 3.1. Flow cytometers configurations. 
Flow 
Cytometer 
Stains Excitation Laser (nm) Emission filter 
LSRFortessa 
PI-stained DNA 
FITC-stained cyclins 
561 
488 
582/15 
530/30 
FxCycle-DNA stain 
FITC-stained cyclins 
PE-stained Ki-67 
Alexa647-EdU stain 
405 
488 
561 
640 
450/50 
530/30 
582/15 
670/14 
Calibur 
PI-stained DNA 
FITC-stained Ki-67 
488 
488 
585/42 
530/30 
 
3.3.7. Cyclin Quantification 
The flow cytometry data was analysed using FlowJo software (Tree Star Inc). In 
order to analyse the data, a sequence of steps were followed: 
1. First, the cell population was selected from the forward versus side scatter 
plot.  
2. Then, a doublet discrimination analysis was performed based on the peak 
versus area plots of the DNA staining (i.e. PI or FxCycle).  
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3. In addition, the cell cycle (PI or FxCycle) histogram was gated to remove the 
apoptotic cells, debris, and aggregates.  
4. The DNA histogram was de-convoluted using the software platform tool into 
G1/G0, S, and G2/M. 
5. Cyclin expression profiles were extracted from the bivariate plots (cyclin vs 
DNA) by:  
i. First a gate around the isotype-stained sample was applied to exclude 
any non-specific binding.  
ii. Above the non-specific binding region, a cyclin positive expression 
region was defined and gated (Figure 3.1).  
iii. The non-specific binding and cyclin positive region gates previously 
defined i-ii) were applied to each cell cycle phase (subpopulations of 
the DNA deconvolution).  
iv. The cyclin measured fluorescence and the corresponding isotype 
control (fluorescence) was compared for each of the deconvoluted cell 
cycle phases. This treatment standardizes the data to a common 
expression level using the isotype control as a reference. 
v. Finally, the data from step iv) were normalised assuming minimal cyclin 
expression at a corresponding cell cycle phase, which enables the 
cyclin quantification by comparison.  
vi. Overall, the selection of the normalisation is based on the collected 
data as it shows the results coherently. Specifically, cyclin D1 
expression was assumed to be minimal in the S phase, cyclin E1 
expression in G2/M and cyclin B1 in G1/G0.  
The dynamic cyclin expression profile can be re-constructed from the normalised 
cyclin expression vi) and the frequent experimental sampling points. This is done by 
plotting the cyclin content of the cell cycle phase that the partially synchronised 
moving population (after an arrest release) is traversing. Similarly, by plotting the 
cyclin content of the cell cycle phase that the positive or negative EdU population 
(after the copper catalysed reaction for EdU) is traversing, the dynamic cyclin profile 
is elucidated. 
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Figure 3.1. General flow cytometry data analysis for cyclin quantification. 1) Forward vs Side scatter, 2) DNA 
fluorescence area vs height, 3) DNA gating, 4) DNA deconvolution, 5) Bivariate cyclin vs DNA plot. Colour: Red - 
cyclin stained sample, blue – isotype stained sample. 
3.3.8. Apoptosis analysis 
The apoptosis analysis was carried by Chonlatep Usaku (PhD candidate). The 
fraction of early stage apoptotic (ESA) cells, late stage apoptotic (LSA) cells, and 
viable cells were determined by the Annexin-V-FITC (Biolegend, 640906) and 
Propidium Iodine (PI, Sigma-Aldrich, P4170) dual staining assay. The cell pellet 
(approx. 3*105 cells) directly after harvesting (without fixation by alcohol) was re-
suspended in Annexin binding buffer (Biolegend, 422201). Cells were initially stained 
with the Annexin-V-FITC according to the manufacturer instructions and then stained 
with 20 µg/mL of PI. The stained samples were incubated for 20 minutes in the dark 
at room temperature. The data collection was done using an LSRFortessa cell 
analyser (BD Biosciences) using an excitation wavelength of 488nm for Annexin-V-
FITC and an excitation wavelength of 561nm for PI, and collected with a 530/30nm 
and a 610/20nm filter, respectively. At least 30,000 events were recorded for each 
sample and were then analysed using FlowJo software (Tree Star Inc).  
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3.3.9. Gene expression 
Gene expression was carried out exclusively by Chonlatep Usaku (PhD 
candidate). The materials and method is shown herein for reference purposes, as 
some of the data is shown and used in the discussion in chapter 5. 
RNeasy® Mini kit (Qiagen, 74104) was used to extract total RNA from the cell 
pellets as per the manufacturer instruction. The purity of the extracted RNA was 
assessed using Biophotometer (Eppendorf AG, Germany). The criterion of the ratio 
of the 260nm absorbance to the 280nm absorbance value being greater than 1.9 
was used to determine the RNA purity. Total RNA was immediately used as a 
template to synthesise complementary DNA (cDNA) using Reverse Transcription 
System (Promega Ltd, A3500) as per the manufacturer instruction. The cDNA was 
synthesised using random primers as building blocks and the synthesis reaction was 
performed on the GS1 thermo cycle (G-Storm, UK) with a temperature profile 
starting at room temperature for 10 minutes, then at 42 °C for 40 minutes and finally 
storing at 4 °C. cDNA was then used as a template for the real-time PCR using 
StepOnePlus™ Real-Time PCR machine (Applied Biosystems, USA) with 
SensiFAST™ Hi-ROX SYBR (Bioline, BIO-92005). Dissociation curves were also 
conducted to check if any non-specific amplification occurred during the PCR 
reaction. By using ∆∆Ct approach, the gene expressions of interest were shown in 
the form of the relative fold changes which were normalised to gapdh (housekeeping 
gene) and with respect to the sample at the beginning of the culture (day 0). Key 
transcriptional markers involved in both apoptosis and the cell cycle, were selected 
(Browne and Al-Rubeai, 2011). 
3.3.10. Statistical analysis 
Values represent the mean ± standard deviation (SD) and were based on 
triplicate experiments (unless otherwise stated). Statistical analysis of the results 
was performed with SigmaStat (Systat Software Inc.) using an analysis of variance 
(ANOVA) test to study the effect of treatments with a level of significance of p<0.05 
with data drawn from a normally distributed population. If the data were drawn from a 
non-normally distributed population or with unequal variances, the Kruskal-Wallis 
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ANOVA on ranks was performed using the Student-Newman-Keuls method in order 
to make multiple comparison with a significance of p<0.05. 
3.3.11. Model analysis and parameter estimation 
Global sensitivity analysis 
All models were implemented in gPROMS® modelling software and all 
computational tasks were performed using a desktop computer with an Intel® 
Core™ i7 CPU. As mentioned, biological models are usually non-linear and include 
several parameters of varying orders of magnitude. Therefore, GSA was applied as it 
is the preferred sensitivity analysis method for this type of systems. Output variables 
of interest were evaluated such as viable cell concentration, mAb titre, and the cell 
cycle fractions. The GUI-HDMR software tool was used for the GSA. The software 
combines the RS-HDMR method in a graphical user interface in MATLAB (Ziehn and 
Tomlin, 2009). The selection was based on the software availability, the low 
computational efforts of the method, and the computational burden of the PBMs.  
The sampling points were generated using the sobolset function in MATLAB. The 
uncertainty associated to the model parameters was ±50% from the nominal values, 
which are taken from literature or experimental data when available and when are 
not available an approximated order-of-magnitude value is assigned (Sidoli et al., 
2006). Each scenario was evaluated using the go:MATLAB tool of the gPROMS® 
modelling software. The gO:MATLAB allows an entire gPROMS model to be called 
as a single function from inside MATLAB. The sensitivity indexes (SIs) were 
calculated at characteristic time points (e.g. early exponential, exponential, decline 
phases) using the GUI-HDMR software by supplying the rescaled (between 0-1) 
input values (parameters) and the corresponding output values. The SIs are the 
result of the GSA and varies between 0 and 1, with 0 being not significant.  
Parameter estimation and model validation 
To evaluate the results SIs a threshold of 0.1 was selected, representing an 
experimental error of 10% (Sidoli et al., 2005). The SIs above the defined threshold, 
were identified as significant parameters and were re-estimated based on the 
experimental available data (as indicated on chapter 6 & 7). The non-significant 
parameters were fixed at their nominal value. All model and parameter estimation 
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calculations were implemented in gPROMS® (Process_Systems_Enterprise, 1997-
2012). Parameter estimation in gPROMS is based on the Maximum Likelihood 
formulation, which provides simultaneous estimation of parameters in both the 
physical model of the process and the variance model of the measuring instruments. 
The model predictions were compared to the experimental data after re-
estimating the significant parameters. Similarly, the models were validated against 
independent experimental data not used in the previous model development steps. 
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CHAPTER 4 
4. Cyclin Blueprint of the GS-NS0 Cell Line 
In chapters 4 & 5, the cell cycle blueprint for the GS-NS0 cell line is presented. In 
particular in chapter 4, a set of experimental assays - chemical arrests and 
proliferation assays - are used to elucidate the cyclin profiles, timings, and 
thresholds. The expression of three cyclins (D1, E1, and B1) was studied by flow 
cytometry in batch cultures of GS-NS0. The different experimental assays 
consistently confirmed the observed cyclin blueprint. These results constitute the 
pillar for the cyclin distributed model presented in chapter 6, as well as lead to the 
experimental study carried in chapter 5. 
4.1. Introduction 
The cell cycle is at the centre of cellular growth and death as well as productivity, 
which vary during the different cell cycle phases. As presented it is divided in 
sequentially distinctive phases: G1 (first gap), S (synthesis), G2 (second gap) and M 
(mitosis). Moreover, when the conditions, either internally or externally, are not 
favourable for DNA synthesis, the cells enter a quiescent state “G0” (Pardee, 1989). 
The transition between the cell cycle phases is highly regulated and it is closely 
linked with the cell programmed death (Fussenegger and Bailey, 1998). Two key 
classes of regulatory molecules, cyclins and cyclin-dependent kinases (CDKs), have 
been identified to regulate the transition process between cell cycle phases 
(Darzynkiewicz et al., 1996). Cyclins are regulatory units and have no catalytic 
activity, while CDKs are catalytic subunits and inactive in the absence of their cyclin 
partner with which they form a heterodimer. 
The development of biologically relevant and mechanistically accurate 
mathematical models has been hindered by experimental and computational 
challenges. However, single cell analysis techniques such as flow cytometry provide 
quantitative cellular information (Darzynkiewicz et al., 2001) that can help to build 
biologically relevant models. In particular, bivariate analysis of cyclin expression 
alongside DNA content can prove to be a suitable biomarker for the cell cycle 
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transitions. As reported,  progression between the G1-S checkpoint is regulated by 
two cyclins, cyclins D and E (Turchi et al., 2000). Similarly, cyclin B1 is reported to 
regulate the cell’s entrance into mitosis (Gong et al., 1993). Although a number of 
studies have dealt with cyclin regulation in various human cell lines (Darzynkiewicz 
et al., 1996; Frisa and Jacobberger, 2009; Gong et al., 1993), few have addressed 
this for industrially-relevant cell lines. Studies on industrially-relevant cell lines have 
mainly focused on the underlying mechanisms of the regulatory pathways (Ponzio et 
al., 1998; Turchi et al., 2000). Therefore, the cyclin phase-dependent expression 
profiles and thresholds for industrially-relevant cell lines are currently lacking, which 
can aid the development of biologically relevant cell cycle models. 
4.2. Objectives 
The aim of this chapter is to develop the cell cycle blueprint for the GS-NS0 cell 
line. The following scientific objectives were set: 
 Design and perform GS-NS0 culture experiments that would allow elucidating 
the cell cycle blueprint. 
 Identify the cyclin expression profiles, timings, and thresholds for cell cycle 
phase transition. 
 Quantify the cyclin profiles to make them suitable for a mathematical model 
development. 
 Estimate the cell cycle timings for the GS-NS0 cell line. 
4.3. Methodology 
A series of batch culture experiments covering both disturbed and undisturbed 
growth of the GS-NS0 cell line were carried out to study the cyclin expression by flow 
cytometry. The first set of experiments involved the disturbed growth by arresting the 
cells using two different DNA synthesis inhibitors (thymidine and DMSO). 
Simultaneous control runs, which were not treated with the chemical agents, were 
established. The undisturbed study consisted of a proliferation assay tracking a 
specific cell population that was active at DNA synthesis. All the specifics of the 
materials and methods were reported in chapter 3. 
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4.3.1. Studied cyclins 
Three cyclins were investigated: two G1 class cyclins (D1 and E1), and one G2 
cyclin (B1). The reason for studying two G1 class cyclin is that Cyclin D expression is 
reported to remain invariable or at low level in normal proliferating cells (Gong et al., 
1994; Gong et al., 1995), therefore a second G1 class cyclin that regulates the G1-S 
transition was also studied. Cyclin D1 was not studied in the proliferation assay. 
4.3.2. Thymidine arrest 
The use of different chemical agents DNA synthesis inhibitors (i.e. thymidine and 
DMSO) is aimed to arrest and synchronise a cohort or fraction of the cell population. 
After the cell arrest, the cells are re-suspended in fresh medium and “released from 
the arrest”. The synchronised cohort was tracked following the criteria of aligned 
DNA content (Section 3.3.1.). The selection of the two inhibitors was based on their 
relevance (commonly used in previous studies) and the differences in the arrest 
mechanism (Kumar et al., 2007; Sunley and Butler, 2010). 
Thymidine arrest mechanism involves the nonselective inhibition of potassium ion 
channels proteins (Ouadid-Ahidouch and Ahidouch, 2008) and indirectly arrests the 
cells in two phases G1 and S. The cell cycle arrest using thymidine involved a double 
block (Harper, 2005). A control group including all the centrifugation and washing 
steps without exposure to thymidine was established. After the thymidine exposure, 
the cells were washed and re-suspended in fresh culture medium and batch 
cultured. 
4.3.3. DMSO arrest 
DMSO is a frequently used chemical agent in bioprocessing given its efficient and 
reversible arrest in the G1 phase (Allen et al., 2008; Fiore and Degrassi, 1999). The 
arrest is attributed to an imbalance in the cell cycle regulation machinery caused by 
the DMSO (Fiore et al., 2002; Ponzio et al., 1998). Thus, DMSO provides a different 
arrest mechanism when compared to thymidine. A single block using DMSO was 
added to mid-exponential growing cells. A control group, including all the 
centrifugation and washing steps without exposure to DMSO was established. After 
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the exposure, the cells were washed and re-suspended in fresh culture medium and 
batch cultured. 
4.3.4. Proliferation assay 
Cell proliferation assays provide a direct way to study cell proliferation by tracking 
a specific initial population that was active at DNA synthesis. Moreover, the short 
duration and low concentration of the EdU proliferation assay pose a minor 
disturbance to the cell culture (Cappella et al., 2008). After the EdU exposure, the 
cells were washed and re-suspended in fresh medium and batch cultured. A control 
group was established, including all the centrifugation and washing steps without 
exposure to EdU. 
4.3.5. Cyclin quantification 
The flow cytometry data was analysed as described in the materials and methods 
(Section 3.3.7.). Briefly, the cell population is gated for doublet discrimination, 
apoptotic cells, debris, and aggregates. The DNA was deconvoluted using the 
software platform to identify three cell cycle phases (G1/G0, S, G2/M). The cyclin 
expression is extracted from the bivariate plots (cyclin fluorescence vs DNA). Both a 
non-specific binding region (isotype-stained samples) and a positive expression 
region (above isotype expression) are defined. These regions are applied to each 
deconvoluted cell cycle phases. The cyclin measured fluorescence is compared to 
the corresponding isotype control (fluorescence) for each cell cycle phase. Finally, 
the data from the previous step were normalised assuming minimal cyclin expression 
at a corresponding cell cycle phase, which enables the cyclin quantification by 
comparison. Cyclin D1 expression was assumed to be minimal in the S phase, cyclin 
E1 expression in G2/M (Gong et al., 1994) and cyclin B1 in G1/G0 (Gong et al., 1993). 
Then, the dynamic cyclin expression can be re-constructed from the normalised 
cyclin expression and the frequent experimental sampling points. 
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4.4. Results & Discussion 
4.4.1. Cell arrest 
The differences between the thymidine double block and DMSO single block 
arrest were evident at different levels. First, differences in the cell cycle distributions 
(Figure 4.1A) were observed when compared to the control runs. The thymidine 
arrested the cells both in the G1 (50% of the population, p<0.05) and early S phase 
(Figure 4.1C, t=0h). The DMSO exposure resulted in a significant fraction (approx. 
75%, p<0.05) of cells arrested in G1 (Figure 4.1B) when compared to the control 
cultures (and thymidine). DMSO proved to be more efficient as a higher fraction of 
cells was arrested in the G1 phase. However, the arrest fraction is dependent on the 
DMSO concentration, as well as exposure time (Fiore et al., 2002; Ling et al., 2003; 
Liu et al., 2001; Wang et al., 2004). Moreover, the effectiveness to group the cells in 
the G1 phase using thymidine depends on the timings of the double block (Harper, 
2005).  
Secondly, the time taken for the cells to resume proliferation (after removing the 
chemical agents) was different. Thymidine arrest appeared to be less severe and 
easily reversed, as a cohort of cells resumed proliferation after 2h (Figure 4.1C, E). 
The partially synchronised population was investigated for 10h until it was no longer 
possible to distinguish it, as the culture re-established an asynchronous growth. After 
the DMSO arrest release, the cells resumed proliferation after 12h (Figure 4.1D, E). 
The synchronised population was studied between 12 and 24 h following the release 
until it was no longer possible to distinguish it. Initial estimates of the cell cycle 
timings are inferred from the synchronised moving populations. Specifically, the 
thymidine synchronised population readily exits G1 towards the S phase (in the first 
2h), and then leaves completely the S phase after 4-6h. Similarly, the G2/M phases 
is traversed in 4h (Figure 4.1E). The DMSO synchronised population resumed 
proliferation after 12h and completes the G1 phase in approximately 4-6h, 
accompanied with an increase in the S phase population. However, these initial 
timing estimates need further validation due to the disruptive nature of the arrest 
experiments. The differences in the time to resume proliferation can be attributed to 
the different arrest mechanisms (Figure 4.1E).  
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Figure 4.1. Comparison thymidine arrest versus DMSO arrest. A) Thymidine arrest and control cell cycle 
distributions; B) DMSO arrest and control cell cycle distributions; C) DNA histograms following the thymidine cell 
cycle arrest release; D) DNA histograms following the DMSO cell cycle arrest release; E) Cell cycle distribution 
after arrest release. *Statistically significant (p<0.05). 
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The thymidine arrest mechanism has been reported (Harper, 2005; Ouadid-
Ahidouch and Ahidouch, 2008; Sunley and Butler, 2010) to be associated with an 
amino acid imbalance due to the excess of thymidine, as well as the non-selective 
inhibition of the potassium ion channel proteins (stimulating Ca2+ influx, as well as 
CDK and cyclin oscillation). Thus, after thymidine removal, the imbalance and 
blockage seemed to be promptly reversed and proliferation is resumed soon after. In 
contrast, the DMSO arrest seemed to have a more pronounced effects on the cell 
cycle machinery, which is supported by previous reports (Ponzio et al., 1998; Wang 
et al., 2004). Particularly, DMSO inhibits the synthesis of cyclin D2, introducing an 
imbalance in the levels of p27[KIP1] and p21[CIP1]. Both CDIs (p27 and p21) act in 
concert to inhibit the cyclin E1/CDK2 complex, selectively arresting in the G1 phase. 
This was supported both qualitatively and quantitatively by comparing the cyclin 
bivariate fluorescence plots with respect to the DNA content of the arrest and control 
groups. In the thymidine case, no major alterations are observed in the cyclin 
fluorescence side histograms (Figure 4.2A-C). Some differences are observed in the 
cyclin B1 side histogram, although it can be attributed to the variation of the cell 
cycle distributions (Figure 4.2C). In contrast, the DMSO cyclin fluorescence side 
histograms showed noticeable qualitative alterations (Figure 4.3A-C). Such 
differences were quantitatively confirmed to be statistically significant for the lower 
cyclin E1 and D1 expression following DMSO release (Figure 4.3A-B). These 
variations support the longer time to restart proliferation for the arrested population in 
G1. Nonetheless, once proliferation was resumed the time to establish an 
asynchronous growth was comparable (10-12h) for both arrest protocols. 
Despite the observed differences, single cell attributes can be inferred by 
monitoring the partially synchronised moving populations after the arrest release. 
Particularly, initial estimates of the cell cycle can be inferred, as well as the dynamic 
evolution of the cyclin profiles (Section 4.4.3.). 
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A) 
 
 
B) 
 
 
C) 
 
 
Figure 4.2. Bivariate cyclin fluorescence plots with respect to DNA at time=0h after thymidine arrest: Top 
adjunct histogram shows DNA distribution; right side adjunct histogram shows cyclin fluorescence distribution; 
and embedded bar chart presents cyclin fluorescence quantification for each cell cycle phase (n=3, error bars = 
standard deviation) . A) Cyclin D1; B) Cyclin E1; C) Cyclin B1. Colour notation: purple for Cyclin D1, green for 
Cyclin E1, blue for Cyclin B1, black for control groups. Gates reflect the isotype region versus the positive defined 
region for each cyclin. *Statistically significant (p<0.05). 
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A) 
 
 
B) 
 
 
C) 
 
 
Figure 4.3. Bivariate cyclin fluorescence plots with respect to DNA at time=0h after DMSO arrest: Top 
adjunct histogram shows DNA distribution; right side adjunct histogram shows cyclin fluorescence distribution; 
and embedded bar chart presents cyclin fluorescence quantification for each cell cycle phase (n=3, error bars = 
standard deviation). A) Cyclin D1; B) Cyclin E1; C) Cyclin B1. Colour notation: purple for Cyclin D1, green for 
Cyclin E1, blue for Cyclin B1, black for control groups. Gates reflect the isotype region versus the positive defined 
region for each cyclin. *Statistically significant (p<0.05). 
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4.4.2. Proliferation assay 
A specific population active at DNA synthesis was identified by labelling the DNA 
base analogue (i.e. EdU) introduced into its DNA. Further, two populations can be 
distinguished based on the EdU reaction: a positive population that was active at 
DNA synthesis, and a negative population that did not incorporate the EdU into its 
DNA (Figure 4.4A). The average transit times based on the DNA content (i.e. G0/G1, 
S and G2/M phases) are estimated by tracking the EdU positive and negative cells 
(Figure 4.4B-C).  
From the EdU positive population (Figure 4.4B) the G2/M time is estimated. The 
population entered between 0-2h of culture the G2/M phase (as indicated by the 
increase in the fraction). Likewise, a significant increase in the G1/G0 phase is 
observed at 4h, indicating that the initial EdU positive population transit through the 
G2/M phase in approximately 4h. Further, an increase in the S phase fraction (which 
was minimal between 8-10h) was observed at 12h. Thus, it can be inferred that the 
population that entered G1/G0 at 4h, completed the transition at 12h, for an average 
8h traverse of the G1/G0 phase. The S phase estimate is based on the EdU negative 
population (Figure 4.4C). The negative G1/G0 population exit the phase at 
approximately 2h, with the simultaneous increase in the S phase. The S phase cell 
fraction peaks at 8h, with the concurrent increase in the G2/M phase. Thus, a 
traversing time for the S phase of approximately 6h can be estimated. A total 
average cycle or doubling time of 18h is calculated under the given experimental 
conditions for the GS-NS0 cell line. This value is in agreement with the previous 
reported maximum growth rate of 0.04h-1 that corresponds to a doubling time of 
17.3h (Kiparissides, 2012). The estimated duration of cell cycle phases from the 
proliferation assay confirmed the previously observed timings after the arrest 
release. As in the arrest experiments, single cell attributes (i.e. dynamic cyclin 
profiles) can be estimated on the identified specific moving populations. 
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A) 
 
Figure 4.4. Cell cycle distribution proliferation assay. A) EdU versus DNA time bivariate plots; B) EdU Positive Population; C) EdU Negative Population; (n=3, error 
bars=standard deviation). 
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Figure 4.4. (Continued). Cell cycle distribution proliferation assay. A) EdU versus DNA time bivariate plots; 
B) EdU Positive Population; C) EdU Negative Population; (n=3, error bars=standard deviation). 
4.4.3. Dynamic cyclin profiles 
The control experiments established the baseline of the cell’s behaviour. 
Therefore, average cyclin expression levels of the normal cell behaviour 
(representative of the control runs) are shown in Figure 4.5. Overall a good 
agreement among the different control experiments was observed. In particular, 
cyclin E1 and cyclin B1 showed a statistically significant difference in the cyclin 
expression between the phases. Contrary, cyclin D1 did not show statistical 
variation. 
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Figure 4.5. Average cyclin expression levels for the control experiments for the first 24h. Notation: vertical 
dashed pattern bars represent the thymidine control group, solid bars represent the DMSO control group, 
diagonal pattern bars represent EdU control. Cyclin E1 (green), Cyclin D1 (purple), and Cyclin B1 (blue). 
*Statistically significant (p<0.05). 
The identified statistical difference of cyclin E1 and cyclin B1 was further 
investigated in the control runs of the arrest experiments over the first 4 days. The 
cyclin profiles were split through the S phase (in four regions, S1 to S4) using the 
DNA content as criteria (Figure 4.6). Cyclin E1 expression (Figure 4.6A) showed a 
significant difference (p<0.05) between G1/G0 and the S phase starting from the S2 
region onwards (S3-S4). This subdivision and statistical analysis aid the 
establishment of the cyclin E1 threshold, which can be narrowed to the transition 
from G1/G0 to the S1 phase subdivision at the presented levels. Cyclin B1 expression 
(Figure 4.6B) was found significantly different (p<0.05) from the S phase regions (S2 
to S4) to the G2/M expression. The cyclin B1 profile increased along the S phase and 
peaked at G2/M, which suggests the fast build-up and threshold of the cyclin. 
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Figure 4.6. Average cyclin expression levels for the arrest control experiments over 4 days of batch culture. 
A) Cyclin E1 expression; B) Cyclin B1 expression. Notation: vertical dashed bars represent the thymidine control 
group, solid bars represent the DMSO control group, diagonal patterned bars represent the EdU control group, 
(n=3, error bars=standard deviation). *Statistically significant (p<0.05). 
The presented profiles do not account for the dynamics of the system. However, 
the study of the partially synchronised populations (after the arrest release) and the 
EdU populations (from the proliferation assay) can aid to elucidate the dynamics of 
the cyclin blueprint. Thus, the normalised cyclin expression for each time point of the 
different identified moving population traversing a particular cell cycle phase (as 
observed in the cell cycle distribution) was plotted. 
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Cyclin E1 
The cyclin E1 profiles are shown both for the synchronised moving population 
after the arrest experiments (Figure 4.7A-B) and for the identified populations of the 
proliferation assay (Figure 4.7C-D). The profiles showed a consistent pattern of 
expression. Briefly, cyclin E1 was normalised to be minimum in G2/M phase (Gong et 
al., 1994). Cells that would transit the G1 phase would show a positive cyclin 
expression usually of at least 8% (Figure 4.7A). Cyclin E1 build-up (taking 
approximately 6h) was observed in populations that were clearly identified as 
entering and progressing through the G1 phase (Figure 4.7B-D).The previously 
suggested threshold was confirmed to be consistently at least 15%. Similarly, the 
cyclin E1 degradation after the G1-S transition was observed to be fast, taking less 
than 2h to levels below 6%. An increasing number of cyclin E1 positive cells (cells 
expressing cyclin E1 above the isotype control) is associated with the build-up of the 
cyclin levels. Consistently, the percentage of cyclin E1 positive cells were maximum 
(above 90%) near the G1-S transition. 
Cyclin B1 
Cyclin B1 showed a consistent pattern of expression among the different 
experiments (Figure 4.8). The cyclin B1 expression was normalised to the G1 phase 
based on the assumption that its expression is minimum at this phase (Pozarowski 
and Darzynkiewicz, 2004). Cyclin B1 increased from minimal at G1, to between 10-
20% while traversing the S phase, towards a maximum in the G2/M phase. Once the 
populations entered G2/M phase the expression grew rapidly, in approximately 2h to 
a maximum and threshold of 40-50%. Finally, after the G2/M to G1 transition the 
cyclin is rapidly degraded. Cyclin B1’s expression is associated with an increase in 
the percentage of cyclin B1 positive cells (cells expressing cyclin B1 above the 
isotype control). Consistently, the lowest percentage (below 50%) of positive cyclin 
B1 cells was observed in G1/G0 phase. In the S phase the percentage rapidly 
increased towards the transition S to G2/M, up to 80-90%. 
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Figure 4.7. Cyclin E1 expression profiles. A) after thymidine arrest release; B) after DMSO arrest release; 
C) EdU positive cells; D) EdU negative cells. Notation: bars represent % cyclin relative expression normalised 
to cell cycle phase (left axis) and the solid line represents % cells expressing cyclin above isotype control (right 
axis). 
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Figure 4.7. (Continued). Cyclin E1 expression profiles. A) after thymidine arrest release; B) after DMSO 
arrest release; C) EdU positive cells; D) EdU negative cells. Notation: bars represent % cyclin relative expression 
normalised to cell cycle phase (left axis) and the solid line represents % cells expressing cyclin above isotype 
control (right axis). 
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Figure 4.8. Cyclin B1 expression profiles. A) after thymidine arrest release; B) after DMSO arrest release; 
C) EdU positive cells; D) EdU negative cells. Notation: bars represent % cyclin relative expression normalised 
to cell cycle phase (left axis) and the solid line represents % cells expressing cyclin above isotype control (right 
axis). 
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Figure 4.8. (Continued). Cyclin B1 expression profiles. A) after thymidine arrest release; B) after DMSO 
arrest release; C) EdU positive cells; D) EdU negative cells. Notation: bars represent % cyclin relative expression 
normalised to cell cycle phase (left axis) and the solid line represents % cells expressing cyclin above isotype 
control (right axis). 
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Cyclin D1 
Cyclin D1 showed a less conserved profile (Figure 4.9), which did not vary 
significantly between the cell cycle phases. The cyclin D1 expression was analysed 
by normalising to the S phase. Despite considering other normalisation alternatives 
(i.e. G1 or G2 phase), no clear profile was observed. Overall, cyclin D1’s expression 
profile varied between 4-8% when the moving population traversed either G1 or G2/M 
phases. Following the thymidine release, a high percentage of cyclin D1 positive 
cells (above 90%) was observed (Figure 4.9A). However, after the DMSO release 
when cyclin D1 expression is low, a high percentage of cyclin D1 positive cells was 
observed and vice versa. Due to observed differences, the cyclin D1 profile cannot 
be fully established. The observed fairly invariable cyclin D1 profile is in agreement 
with previous studies (Gong et al., 1995; Stacey and Hitomi, 2008). In addition, cyclin 
D have been reported to provide a link between the external environment and the 
actual cell cycle machinery (Sherr, 1993). The observed patterns reported herein 
seemed to indicate the proliferative state of the population (either with the 
percentage of cyclin D1 expressed or a high percentage of cells expressing cyclin 
D1).  
Further analysis of the cyclin expression was carried considering the availability 
of glutamate, which is key for the GS cell line and it was usually exhausted between 
day 2 and 3 under the culture conditions (Section 4.4.4.). The analysis revealed that 
all the cyclins (D1, E1, and B1) showed a significantly lower expression (p<0.05) 
after glutamate was exhausted from the medium (Figure 4.10). These results 
suggest the existing link between the culture conditions and cell cycle machinery. 
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Figure 4.9. Cyclin D1 expression profiles. A) after thymidine arrest release; B) after DMSO arrest release. 
Notation: bars represent % cyclin relative expression normalised to cell cycle phase (left axis) and the solid line 
represents % cells expressing cyclin above isotype control (right axis). 
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Figure 4.10. Average cyclin expression before and after glutamate exhaustion. A) after thymidine arrest 
release; B) after DMSO arrest release; C) Proliferation assay; (error bars=standard deviation). *Statistically 
significant (p<0.05). 
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4.4.4. Batch cell culture profiles 
The batch culture profiles are presented in this section. Cell growth was similar 
across all batch cultures (Figure 4.13A). No statistical differences were identified in 
the cell density between the corresponding control and proliferation assay or after 
arrest release culture. The thymidine control and after arrest culture showed a 
significant higher (p<0.05) cell density at 96h. This could be attributed to the handling 
of the cells prior to start the batch cultures, as the thymidine experiment required a 
double block. Therefore, the cells treated with thymidine (and control) were 
centrifuged two times more than any of the other cultures. However, this did not have 
an effect on the mAb titre between all the control groups (Figure 4.13B). The DMSO 
treated culture did show a significantly (p<0.05) lower mAb titre after 72h of culture. 
Although DMSO has been used to increase productivity in hybridoma cells (Wang et 
al., 2004), there are no reports on the DMSO effects after arrest release.  
The viability was consistently around 90% in all experiments for the first 96h of 
culture (Figure 4.13A). After 96h the viability rapidly decreased. The decrease in 
viability is associated with the exhaustion of glutamate (key amino acid for the cell 
line), which gets exhausted between 48-72h of culture (Figure 4.13C). After 72h, the 
glutamate concentration is below the detection limit (i.e. 0.2mM) and remains below 
detection in most cases. In few experiments, glutamate presence is detected at 
144h. The late detection of glutamate could be plausibly associated with cell lysis, 
although the possibility that it is synthesised from other sources cannot be discarded.  
The cell marker Ki-67 was used to determine the proliferative state of the cell 
population and discriminate between the G0 and G1 fractions in the proliferation 
assay. A high proliferative state was observed and it is highly correlated with the cell 
viability (Figure 4.13D). The decline of the cell viability was accompanied by a drop 
in the positive percentage of Ki-67 cells, indicating that some of the cells are entering 
the non-proliferative state (G0). The commitment to apoptosis in the G0 phase cannot 
be confirmed, as it was not quantified in these experiments. 
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Figure 4.11. Batch cell culture profiles. A) Cell growth and viability; B) mAb titre; C) Glutamate 
concentration; D) Proliferation assay - proliferation marker Ki-67 and viability; E) Glucose and lactate 
concentration after thymidine arrest; (n=3, error bars=standard deviation). 
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Figure 4.11. (Continued). Batch cell culture profiles. A) Cell growth and viability; B) mAb titre; C) Glutamate 
concentration; D) Proliferation assay - proliferation marker Ki-67 and viability; E) Glucose and lactate 
concentration after thymidine arrest; (n=3, error bars=standard deviation). 
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The glucose and lactate profiles are shown for the arrest experiments in Figure 
4.12A-B and for the proliferation assay in Figure 4.12C. The glucose consumption 
did not show major differences between the control and arrest release groups. 
Exposure to thymidine appeared to result in the cells being metabolically more active 
during the first 24h, as a significant lactate production (24h after release) was 
observed (Figure 4.12A). After this point, the lactate profile is comparable to the 
control. The metabolic activity seems to be a short-term effect of the arrest 
mechanism. The blockage of ion potassium channels can lead to the accumulation 
of cyclin dependent inhibitors p27 and p21 (Ghiani et al., 1999). A plausible 
overexpression of p27, which inhibits growth (Carvalhal et al., 2003) is accompanied 
by an increase in the glucose consumption and lactate production rates. Similarly, Bi 
et al. (2004) reported more metabolically active cells when arresting CHO cells at G1 
phase using p21. Although DMSO exposure has also been reported to imbalance 
p21 and p27 (Ponzio et al., 1998), this did not result on an increased lactate 
production at 24h. On the contrary, DMSO treated cells did not show lactate 
production (below detection limit of 0.2g/L) the first 24 hours (Figure 4.12B). 
Plausibly the reason for not observing an increased lactate is that: 1) the p21/p27 
imbalances were reported after exposing the cells at 3 times higher DMSO 
concentration than that used herein; and 2) the released cells did show an 
approximately 14h lag phase to resume proliferation. After 48h, the DMSO culture 
showed comparable lactate production levels to the control. The glucose and lactate 
profiles of the proliferation assay did not show statistical differences (Figure 4.12C) 
compared to the control group. This is in agreement with the less disruptive nature of 
the proliferation assay. 
Finally, the cell cycle distributions are shown (Figure 4.13A-C). The trends are 
comparable between the corresponding control and proliferation assay or after arrest 
culture. In particular, an asynchronous growth was re-established between 24-48h of 
culture in the after arrest release cases. 
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Figure 4.12. Batch cell culture profiles. A) Glucose and lactate concentration after thymidine arrest; B) 
Glucose and lactate concentration after DMSO arrest; C) Glucose and lactate concentration proliferation assay; 
(n=3, error bars=standard deviation). 
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Figure 4.13. Batch cell culture profiles. A) G0/G1 phase distribution; B) S phase distribution; C) G2//M phase 
distribution; (n=3, error bars=standard deviation). 
 
89 
 
4.5. Conclusions 
In this chapter, the cell cycle blueprint for the GS-NS0 cell line was elucidated. 
The blueprint encompasses the cell cycle timings, the cyclin pattern and thresholds, 
as well as the proliferative state (non-G0 phase cells).  
Two distinctive approaches were used as an experimental tool. In first place, 
chemical cell arrest to synchronise the cell population was used. However, the 
effectiveness of chemical synchronisation, as well as some drawbacks of using DNA 
inhibitors for synchronisation have been reported (Cooper, 2003). Thus, it should be 
emphasised that by the synchronisation herein refers only to the DNA alignment of 
the cells. Even though the DNA alignment does not guarantee that the cells will 
share the same state, it does facilitate the reconstruction of the cyclin profiles and 
cell cycle progression times. In addition, cells that have restarted proliferation 
together and passed a cell control mechanism will most likely share a similar state. 
Moreover, the use of two chemical agents provides a useful tool to study the system 
under different arrest mechanisms, as well as increasing the confidence in the 
results. Nonetheless, control experiments are used throughout for validation 
purposes of normal cell behaviour. A second approach using a proliferation assay 
was carried out. This approach differentiates the cells into two populations and 
enables to further study the system. Similarly, a control serves for validation 
purposes. Overall, the results are consistent between the approaches (arrest and 
proliferation assay), complement each other, and confirmed the observed cyclin 
blueprint. 
Clear timings and thresholds were obtained for cyclin E1 and B1, while cyclin D1 
appeared to be linked to the proliferative state of the GS-NS0 cell line. The effect of 
nutrient exhaustion was identified on the cyclin expression, and provides a first link 
between the culture environment and the cell cycle machinery. The observed 
glutamate effect led us to explore further specific culture conditions (i.e. temperature 
variations, substrate availability). In particular, effects on the cyclin expression, cell 
cycle, and the link with apoptosis are presented in chapter 5. The elucidated 
blueprint is not only cell line-specific but is expected to be dependent on culture 
conditions (e.g. temperature, medium formulation, serum, growth factors, etc.). 
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Similarly, different cell lines and culture conditions may need different normalisation 
compared to the ones presented herein since cyclin expression patterns may vary.  
The conserved profiles for cyclin E1 and B1 render them as excellent candidates 
to be distributed variables in cell cycle models given the clear observed timings and 
thresholds. Moreover, the blueprint provides a unique tool for describing the cell 
cycle using a relevant biological marker, avoiding weakly supported markers (e.g. 
mass, age) as presented in chapter 6.  
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CHAPTER 5 
5. Effect of Culture Conditions on the Cell Cycle 
Chapter 5 includes a set of experiments that aimed to identify the effect of culture 
conditions both on the cell cycle and apoptosis. Specifically, the effect of 
temperature shifts, as well as medium shifts (using spent medium) were screened in 
culture. The expressions of cyclins and apoptotic markers were studied by flow 
cytometry in batch cultures of GS-NS0. The results stress the close link and balance 
between the cell cycle machinery and programmed cell death. 
5.1. Introduction 
Process parameters can affect the growth of mammalian cells and their antibody 
production. These include dissolved oxygen concentration, nutrient concentrations, 
pH, osmolality, shear stress, toxic metabolite accumulation, and temperature, among 
others. However, the reported effects are variable between cell lines, expression 
systems, and expressed recombinant product (Kumar et al., 2007; Sunley and 
Butler, 2010). Therefore, the improvement of productivity is based on the 
proliferation control mainly by using optimised culture media (Wurm, 2004) or 
reduced temperature cultivation. Particularly, proliferation control aims to find a 
balance between the viable biomass, viability, and culture length, as all these impact 
directly the productivity (Kumar et al., 2007). However, the underlying mechanisms 
of these approaches are not fully understood and finding a balance has proved to be 
challenging. 
The use of optimised culture media serves as a tool to regulate the positive 
signals (e.g. growth factors) that promote the cell cycle progression, while the 
withdrawal of growth factors correlates with cell arrest and induces apoptosis 
(Fussenegger and Bailey, 1998). Similarly, cell cycle control and improvement of 
productivity by temperature shifts have been reported to be variable, although 
reduced growth is usually observed under mild hypothermia. However, many of the 
reported effects lack the study on both the cell cycle and apoptosis.  
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The difficulties in optimising or improving the cultures are related to the intimate 
link between the cell cycle proliferation and programmed death. These two cell 
events overlap at multiple specific points, which make the control a difficult task. For 
instance the entrance to apoptosis seems to take place at late G1 (entry to S phase), 
while arrest prior to that stage delays or blocks apoptosis (Fussenegger and Bailey, 
1998). Moreover, cyclins, CDKs and cyclin-CDK complexes – particularly G1-S and 
G2-M regulators (Meikrantz and Schlegel, 1996) - have been also reported to be 
required for apoptosis in a number of differentiated cell types (Rubin et al., 1994). 
Therefore, the study of temperature and nutrient variations and its effects on the cell 
cycle and apoptosis are of interest to expand the elucidated blueprint presented in 
chapter 4. 
5.2. Objectives 
The aim of this chapter is to study the effect of temperature and medium 
composition on the cell cycle and apoptosis for the GS-NS0 cell line. The following 
scientific objectives were set: 
 Design and perform GS-NS0 culture experiments that would allow evaluating 
the temperature effect on cyclin D1 expression and apoptosis. 
 Design and perform GS-NS0 culture experiments that would allow evaluating 
the nutrient variations short-term effect on cyclins expression (D1, E1, and B1) 
and apoptosis. 
 Identify relevant links between the cell cycle and apoptosis for future model 
development. 
5.3. Methodology 
A series of batch culture experiments varying the temperature of GS-NS0 cells in 
mid-exponential batch culture were carried out. Cyclin D1 expression and apoptosis 
induction were studied by flow cytometry. In addition, a short-duration (24h) study on 
the rapid effect of medium shift on the cell cycle and apoptosis was carried out. All 
the specifics of the materials and methods were reported in chapter 3. 
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5.3.1. Temperature shifts 
Batch cultures of GS-NS0 carried out in triplicates covered hypothermia (35 °C), 
hyperthermia (39 °C), and baseline (37 °C) conditions in 1L Erlenmeyer flasks. The 
medium composition was reported in chapter 3 using dialyzed FBS and cells seeded 
at 2.5*105 cells/mL. The cultures were started at 37 °C for 30h and then the 
incubator temperature was shifted to either 35 °C or 39 °C. The outputs investigated 
were the cell growth, metabolic profiles, cell cycle (distribution and cyclin D1), 
apoptosis markers, and antibody productivity. Cyclin D1 was selected based on the 
premise that it provides a link with the culture environment (Sherr, 1993). The 
experiments were carried out with the collaboration of Chonlatep Usaku (PhD 
candidate) and Anne Gauthier during her MSc project in our lab (Gauthier, 2013). 
5.3.2. Medium shifts 
The medium shift experiments consisted on the quick transfer of GS-NS0 cells in 
mid-exponential growth (prior to glutamate exhaustion) to three different medium 
compositions of fresh and conditioned medium (cell-free spent medium). The 
medium compositions consisted on a 100% fresh medium, 50/50% (v/v) 
fresh/conditioned medium and 0% fresh medium (i.e. 100% conditioned medium). 
The cells in mid-exponential growth were centrifuged for 5min at 800rpm. The 
medium was aspirated and the cells were re-suspended in 50mL working volume of 
one of the levels (carried in triplicates) at a cell density of 5*105 cells/mL. 
Samples were taken every 6h for 12h, and then at 24h. The aim was to monitor 
the response to the medium compositions changes in a short-period. The outputs 
investigated included the cell growth, metabolic profiles, cell cycle (distribution, Ki-67 
proliferation marker, and cyclins), apoptosis markers (and genes), and antibody 
productivity. The experiments were carried out with the collaboration of Chonlatep 
Usaku (PhD candidate).  
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5.4. Results & Discussion 
5.4.1. Temperature shifts 
Cell growth, viability, and apoptosis 
The temperature shift showed a direct effect on the achieved cell densities 
(Figure 5.1A). Whereas the 39 °C shift showed a similar growth to the baseline (37 
°C), the 35 °C shift batch showed a significant lower peak cell density. Particularly 
after the temperature shift (30h), cell growth seemed slower and the cell density did 
not vary significantly at 35 °C. Similarly, the 39 °C batch did not show significant 
changes soon after the temperature shift. However, a faster cell density decline was 
observed at late stages (96h onwards) of the 39 °C culture when compared to the 37 
°C culture. The cell viability of both temperature shifted cultures showed a sharper 
decrease in viability after 48h, which was significant when compared to the 37 °C 
batch. Despite the fact that the 35 °C shift batch culture started with a lower viability, 
it seemed to recover during the first 24h. A similar effect was also observed in the 
fraction of early stage apoptotic (ESA) cells (Figure 5.1B), as the ESA fraction of the 
35 °C shifted culture significantly decreased during the first 24h. After the 
temperature shifts, there was no immediate (48h) significant change in the ESA 
fraction in both cases (35 °C and 39 °C). Whereas both the 37 °C and 39 °C cultures 
showed a significant increase in the ESA fraction (compared to 48h) after glutamate 
was exhausted (48h), the 35 °C culture showed no significant change until 96h in the 
ESA fraction (compared to 48h). This suggests that the 35 °C culture displayed a 
delay in the induction of apoptosis compared to the other cultures. After 96h, the 
ESA fraction of the 35 °C culture was comparable to the 37 °C culture. The 39 °C 
culture showed no further changes in the ESA fraction after the glutamate 
exhaustion despite the observed continuous drop in viability. Such effect can be due 
to either a fast transition from the ESA fraction to the LSA fraction or a high lysis rate 
due to the high temperature. An experimental error in the cell counts did not seem 
supported given the satisfactory correlation between the manually counted cell 
viability and the apoptosis analysis via flow cytometry (Figure 5.1C). 
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Figure 5.1. Batch temperature cell growth and apoptosis. A) Cell growth and viability; B) % Early Stage 
Apoptotic cells; C) % Late Stage Apoptotic cells versus % Death cells. Notation: vertical dotted line indicates time 
of the temperature shift, (n=3, error bars=standard deviation). 
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The observed results for the mild hypothermia are in agreement with previous 
reports. Both a lower cell density (Chong et al., 2008; Kaufmann et al., 1999; Moore 
et al., 1997) and an apparent delay on the onset of apoptosis have been reported 
(Furukawa and Ohsuye, 1998; Reuveny et al., 1987; Swiderek and Al-Rubeai, 2007). 
In contrast, for mild hyperthermia (39 °C) lower densities or no growth have been 
reported (Bloemkolk et al., 1992; Furukawa and Ohsuye, 1998). However, herein a 
sharper viability decrease at late stages of the 39 °C culture was observed, as 
previously reported (Barnabe and Butler, 1994; Furukawa and Ohsuye, 1998). 
Metabolic profiles and mAb productivity 
The glutamate consumption was comparable across all the temperature 
conditions. Glutamate was consumed at a similar rate during the first 30h, as the 
culture conditions are identical, and glutamate is exhausted (below detection) after 
48h (Figure 5.2A).  The glucose profile is similar for all runs and the lactate profile 
showed some differences (Appendix I.). However, in order to make a direct 
comparison due to the differences in cell density, the consumption and production 
rates were estimated based on the linear regression between the 
substrate/metabolite concentration and the integral viable cell (IVC). The glucose 
specific consumption rate (Figure 5.2B) showed an increasing trend in glucose 
consumption with the increase of temperature, as indicated by the slopes of the 
regression. Similarly, the lactate specific production rate (Figure 5.2C) showed an 
increasing trend as a function of the temperature. Thus, the yield of lactate on 
glucose seemed to be the lowest for the 35 °C culture (approx. 1.22 mol lactate/mol 
glucose) compared to the 37 °C and 39 °C cultures (approx. 1.63 and 1.59 mol 
lactate/mol glucose, respectively). These results are in agreement with previous 
studies reporting an enhanced metabolism at higher temperatures (Barnabe and 
Butler, 1994) and a reduced metabolism at lower temperature (Furukawa and 
Ohsuye, 1998; Reuveny et al., 1987). 
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Figure 5.2. Batch temperature shift metabolic and antibody profiles. A) Glutamate concentration and mAb 
titre; B) Glucose specific consumption rate; C) Lactate specific production rate; D) Antibody specific production 
rate. Notation: vertical dotted line indicates time of the temperature shift, (n=3, error bars=standard deviation). 
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Figure 5.2. (Continued). Batch temperature shift metabolic and antibody profiles. A) Glutamate 
concentration and mAb titre; B) Glucose specific consumption rate; C) Lactate specific production rate; D) 
Antibody specific production rate. Notation: vertical dotted line indicates time of the temperature shift, (n=3, error 
bars=standard deviation). 
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Figure 5.3. Batch temperature cell cycle and cyclin D1 profiles. A) %G1/G0 phase; B) %G2/M phase; C) 
Cyclin D1 profile for G1/G0 phase. Notation: vertical dotted line indicates time of the temperature shift, (n=3, error 
bars=standard deviation). 
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The antibody titre showed a comparable trend for the first 48h, after that point a 
higher titre was observed for the 39 °C culture (Figure 5.2A). A significant higher 
mAb titre was observed for the 39 °C culture between 72-96h compared to the other 
cultures. However, at 120h due to the mAb titre variability on the 37 °C culture, the 
39 °C culture mAb titre was only statistically significantly different compared to the 35 
°C. The specific mAb productivity was calculated for all cultures (Figure 5.2D). The 
mAb rates between the 35 °C and 37 °C cultures are comparable, whereas the 39 
°C culture did show a higher rate. However, some of the most significant increments 
in the mAb titre occurred during the death phase and it could be attributed to the 
lysis of cells. Thus, productivity was divided in culture phases (0-1 day, 1-3 day, 3-5 
day) and a higher rate was observed in all cases during the 3-5 days (Appendix I.). 
Particularly, the temperature shifted cultures showed a higher mAb rate (between 
day 3-5) than the 37 °C, around 1.3 and 1.5-fold higher for the 35 °C and 39 °C 
cultures, respectively.  
Cell cycle and cyclin D1 expression 
The G1/G0 lumped phase was the highest cell cycle fraction across the 
experiments (Figure 5.3A). The profiles were similar and follow the same trend up to 
the temperature shift point. An immediately evident effect on the cell cycle 
distribution from the temperature shift was not observed. In contrast, a temporary 
G2/M increase was observed between 48-72h (Figure 5.3B), prior to the increase in 
the G1/G0 cell fraction at 72h of the 35 °C culture. Shi et al. (2005) reported a 
temperature arrest at G2/M when lowering the temperature, as well as previous 
reports have observed an accumulation in this phase at low temperature (Moore et 
al., 1997; Swiderek and Al-Rubeai, 2007; Trummer et al., 2006). However, there is 
no other evidence to support that this is part of a cell arrest either at the G2/M or 
G1/G0 lumped phases. Nonetheless, the increase in the G1/G0 fraction was observed 
prior to the increment of the ESA fraction (at 96h) for the 35 °C culture. Similarly, 
prior to the increase in the ESA fraction (at 72h) for the 37 °C and 39 °C cultures, an 
accumulation in the G1/G0 phase was observed on both culture conditions. These 
trends seem to confirm the report that cells must progress to late G1 for apoptosis to 
occur (Fussenegger and Bailey, 1998).  
101 
 
The cyclin D1 expression for the G1/G0 lumped phase showed a similar profile as 
reported in chapter 4, despite the temperature shifts (Figure 5.3C). Mild 
hyperthermia has been reported to induce cyclin D1 expression (Han et al., 2002), 
however herein it was not observed. In contrast, the previously observed correlation 
between substrate availability (i.e. glutamate) and the cyclin D1 expression was 
confirmed. The cyclin D1 expression started at a low level (due to subculture process 
every 3 days, which is in the limits of glutamate exhaustion) and it increased in the 
presence of fresh medium. Once again, soon after the glutamate was exhausted 
(after 48h), the cyclin D1 expression decreased. The significantly lower cyclin D1 
expression at the start of the 35 °C temperature shift culture seemed to correlate 
with the lower starting viability and higher ESA fraction, as previously discussed. 
Although the cyclin D1 induction due to the hyperthermia conditions cannot be 
completely discarded, it seems that the substrate availability is the dominant event.  
5.4.2. Medium shifts 
Cell growth, viability, and apoptosis 
The medium shift experiments showed differences on the cell growth. After 12h 
and 24h, a significant difference was observed between the medium compositions 
containing fresh medium (50% and 100%) compared to the conditioned medium (0% 
fresh medium, Figure 5.4A). Although a higher average cell density was observed for 
the 50% blend at 24h compared to the 100% fresh medium, the difference was not 
statistically significant (p>0.05). The cell viability also showed significant differences 
between the 0% fresh medium and the other two medium compositions, both after 
12h and 24h (Figure 5.4A). Despite all the cultures starting with the same viability, 
after 24h an approximately 10% decrease in viability was observed in the 0% fresh 
medium. 
In contrast, no significant differences were observed in the percentage of cells 
expressing the proliferation marker Ki-67 (Figure 5.4B). Although after 6h of culture 
the 0% fresh medium showed on average a lower fraction of cells expressing Ki-67, 
it was not found to be statistically significant due to the broad variance in the 
measurement. However, statistical differences in the percentage of ESA were 
observed. The 0% fresh medium showed a statistically higher percentage of ESA 
cells (at 0, 12, and 24h) compared to the other groups (Figure 5.4B). Further, the 0% 
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fresh medium showed a statistically significant increase in the percentage of ESA 
cells between 0h and 24h, whereas the other medium compositions did not. 
 
 
 
Figure 5.4. Medium shift experiment cell growth and apoptosis. A) Cell growth and viability; B) % Ki-67 
positive cells and % Early Stage Apoptotic cells. Notation: Fresh medium (FM), % viability and % Ki-67 positive 
without connecting lines, viable cells (Xv) and % Early apoptotic with connecting lines, (n=3, error bars=standard 
deviation). 
Metabolic profiles and mAb productivity 
The glucose and lactate concentration profiles showed differences among the 
medium compositions (Figure 5.5A). The glucose profiles of the 100% fresh medium 
and 50% blend showed a significant glucose concentration decrease between 0h 
and 24h. Similarly, these two medium compositions showed a significant increase in 
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the lactate concentration between the same time points. The increase in the lactate 
concentration was steeper in the 100% fresh medium compared to the 50% blend. 
This could be attributed to the feedback inhibition of lactate on the lactate on glucose 
yield (Ozturk et al., 1992). In contrast, glucose consumption in the 0% fresh medium 
was not evident; whereas a significant lactate decrease was observed between 0h 
and 24h. Such profiles seemed to indicate a shift in the cell metabolism, going from 
lactate production (commonly observed) to lactate consumption. This effect has 
been previously reported in fed-batch cultures (deZengotita et al., 2000; Zhou et al., 
1996).  
 
 
 
Figure 5.5. Medium shift experiment metabolic and antibody profiles. A) Glucose and lactate concentration; 
B) Glutamate concentration and mAb titre. Notation: Fresh medium (FM), substrate (glucose, glutamate) without 
connecting lines, lactate and mAb with connecting lines, (n=3, error bars=standard deviation). 
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Glutamate was consumed when present (i.e. 100% and 50% fresh medium) and 
it was at the limit of detection for the 50% blend after 24h (Figure 5.5B). The mAb 
titre (shown normalised to time 0h for comparison purposes) was comparable 
between the 0% fresh medium and 50% blend, despite the observed differences in 
cell growth. In contrast, the mAb titre in the 100% fresh medium was significantly 
lower when compared to the 50% blend at 24h, despite showing a similar cell 
growth. The higher mAb titre in the 50% blend and 0% fresh medium seems to be 
related to the use of conditioned medium. These two medium compositions (0% and 
50%) have in common the conditioned medium, which contains lactate and most 
likely other factors released by the cells during growth. Although it has been reported 
that higher osmolality can increase the antibody titre (Wu et al., 2004), it is expected 
(not measured) that the osmolality differences between the three medium 
compositions are not enough to cause the high titre in 0% fresh medium and 50% 
blend. However, the contribution of cell lysis to the mAb titre on the 0% fresh 
medium needs to be also considered. Nonetheless, the mAb differences reflect that 
the cells experience an adaptation process even if the new conditions were 
favourable such as the 100% fresh medium.  
Cell cycle and cyclins expression 
The cyclin expression profiles were reported in relative terms to the expression at 
time 0h. This representation allowed a direct comparison between the cultures, as 
well as to quantify the differences in time within each culture. The 100% fresh 
medium showed a fast increase in the cyclin D1 levels and cyclin E1 levels soon 
after the medium shift (Figure 5.6A). However, the cyclin B1 did not show a 
statistically higher level until 12h. The expression of the three cyclins was in general 
above the initial expression level, which is in agreement with the shift to a 100% 
fresh medium (that provided favourable conditions for proliferation). The 50% 
medium blend showed a similar expression profile (Figure 5.6B). Both cyclin D1 and 
E1 were expressed above the initial levels after 6h of culture. However, at 24h a 
decrease in the cyclin D1 levels was observed. The decrease was in agreement with 
the previous observed trends of cyclin expression with the exhaustion of glutamate, 
which in the 50% blend was in the limits of detection at 24h. Cyclin B1 showed 
throughout a significantly higher expression compared to the initial level. However, 
cyclin B1 showed a decrease at 24h compared to the levels at 12h that correlates 
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with the lower glutamate levels. Finally, the 0% fresh medium showed a significant 
increase in the cyclin E1 and D1 levels from 0 to 12h (Figure 5.6C). Particularly at 
12h, the levels of both cyclin D1 and E1 were the highest among all cultures. 
However, at 24h both cyclins’ expression seemed to decrease and cyclin E1 is even 
at a significantly lower level than at 0h. Cyclin B1 expression decreased throughout 
and it was significantly lower at 24h when compared to 0h. The lower cyclin B1 
expression correlates with the higher G2/M fraction observed (Figure 5.6F). In 
addition, the G1/G0 and S (Figure 5.6D-E) cell fractions of the 0% fresh medium 
showed a different trend compared to the medium compositions containing fresh 
medium (50% and 100%). The 0% fresh medium cell cycle fractions seemed to show 
qualitatively a less oscillatory trend, in agreement with the apparent absence of cell 
growth reported at the cell density. 
 
Cyclin D1 expression has been reported to depend on the quantity of growth 
factors available (Fussenegger and Bailey, 1998), which is in agreement with the 
observed trends in the 50% blend and 100% fresh medium. However, the increase 
of both cyclin D1 and E1 in the 0% fresh medium could be attributed either to the 
presence of not quantified factors (as the medium formulation contains serum) in the 
conditioned medium, or cyclin D1/E1 involvement in other cell events. Particularly, 
between 12h and 24h a decrease in the 0% fresh medium viability was observed, as 
well as an increase in the percentage of ESA cells. It has been previously reported 
(Rubin et al., 1994) that cyclins-CDKs complexes - such as cyclin D1 - can be 
required for apoptosis. In addition, the overexpression of cyclin D1 is sufficient to 
induce apoptosis in neuronally differentiated cells (Kranenburg et al., 1996).  
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Figure 5.6. Medium shift experiment cyclin profiles. A) Cyclin profiles in the 100% fresh medium; B) Cyclin 
profiles in the 50% fresh medium; C) Cyclin profiles in the 0% fresh medium; D) %G1/G0 phase; E) %S phase; 
F) %G2/M phase. Notation: Fresh medium (FM), (n=3, error bars=standard deviation). 
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Figure 5.6. (Continued). Medium shift experiment cyclin profiles. A) Cyclin profiles in the 100% fresh 
medium; B) Cyclin profiles in the 50% fresh medium; C) Cyclin profiles in the 0% fresh medium; D) %G1/G0 
phase; E) %S phase; F) %G2/M phase. Notation: Fresh medium (FM), (n=3, error bars=standard deviation). 
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As mentioned, there is a close link between the cell cycle progression and the 
programmed cell death. A simplified schematic representation of the two cell events 
is presented (Figure 5.7). In particular, there is a fine balance between cyclins, CDKs 
(and their complexes), CDIs (e.g. p21), and p53 (transcription factor that functions as 
a tumour suppressor inducing apoptosis) in the regulation of both processes. 
 
 
Figure 5.7. Schematic representation of the cell cycle and apoptosis. 
Gene expression was measured as part of the collaboration work conducted with 
Chonlatep Usaku (PhD candidate). Among the quantified genes, two are of interest 
to the link between the cell cycle and apoptosis, p21 and trp53bp2. The relevance of 
these two genes is due to their reported roles. First, p21 is a CDI that regulates the 
cell cycle (Gartel and Tyner, 2002; Niculescu et al., 1998). Specifically, p21 has been 
reported to inhibit CDKs for the G1-S transition and its complexes, as well as other 
cyclin-CDK complexes (Fussenegger and Bailey, 1998; Meikrantz and Schlegel, 
1995; Xiong et al., 1993). Second, trp53bp2 encodes 53BP2, which interacts with 
p53 to mediate apoptosis via the mitochondrial pathway (Kobayashi et al., 2005; 
Samuels-Lev et al., 2001). Both p53 and p21 have been reported to inactivate cyclin 
B complexes (Dulic et al., 1998; Innocente et al., 1999). Therefore, plots of the 
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relative expression of cyclins versus the relative gene expression (p21, trp53bp2) 
were used to evaluate the existence of a relation or association.  
Based on the presented results some links between the cyclin expression and 
p21/trp53bp2 gene expression were identified. The cyclins (D1, E1, and B1) 
expression versus the p21 gene expression did show correlation patterns. In 
particular, it was observed (Figure 5.8A-C) that if p21 was expressed below the 
reference level (0h) then there was a positive cyclin expression above the reference 
(0h). However, if p21 was expressed above the reference, the cyclin expression was 
decreased (Figure 5.8C). Two points in the cyclin D1 and E1 (Figure 5.8A-B) 
expression seemed not to follow the above mentioned pattern. These points 
corresponded to the 6h of the 0% fresh medium culture, where it was previously 
discussed a decrease in the Ki-67 positive cell fraction (although not statistically 
significant). Therefore, it can be inferred that p21 expression is partially responsible 
for the cell arrest (Bi et al., 2004; Khoo and Al-Rubeai, 2009) and the observed 
cyclins (D1 and E1) imbalances.  
The trp53bp2 gene expression did not show a clear link with the expression of 
cyclin D1 and E1 (Figure 5.8D-E). Both cyclins seemed to be expressed above the 
reference, regardless of the trp53bp2 gene expression. In the cyclin B1 case (Figure 
5.8F) a weak association was identified. Whenever the trp53bp2 gene was 
expressed above the reference (particularly above 1.5-fold), there was no cyclin B1 
expression. The highest trp53bp2 expression was observed for the 0% fresh medium 
at 6h and 24h. It could be inferred that the cells are driven at these points towards 
apoptosis given the existing links between trp53bp2 and p53 (Yang et al., 1999). The 
herein identified links are subject to the experimental conditions and further 
experimentation is required to fully confirm these associations. The presence of 
serum in our medium formulation gives an undefined character to it, which 
complicates the analysis. However, the observed results stressed the importance 
and need to link the cell cycle and apoptosis.  
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Figure 5.8. Medium shift experiment cyclin versus gene expression. A) Cyclin D1 vs p21 expression; B) 
Cyclin E1 vs p21 expression; C) Cyclin B1 vs p21 expression; D) Cyclin D1 vs trp53bp2 expression; E) Cyclin 
E1 vs trp53bp2 expression; F) Cyclin B1 vs trp53bp2 expression. Notation: Fresh medium (FM), (n=3, error 
bars=standard deviation). 
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Figure 5.8. (Continued). Medium shift experiment cyclin versus gene expression. A) Cyclin D1 vs p21 
expression; B) Cyclin E1 vs p21 expression; C) Cyclin B1 vs p21 expression; D) Cyclin D1 vs trp53bp2 
expression; E) Cyclin E1 vs trp53bp2 expression; F) Cyclin B1 vs trp53bp2 expression. Notation: Fresh medium 
(FM), (n=3, error bars=standard deviation). 
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5.5. Conclusions 
The aim of this chapter was to study the effect of temperature and medium 
composition on the cell cycle and apoptosis for the GS-NS0 cell line. The 
temperature shift experiments allowed screening the effect of this control variable on 
the cell culture. Particularly, at mild hypothermia (35 °C) a slower growth, a delay in 
the onset of apoptosis, a reduced metabolism, and similar mAb productivity 
compared to the 37 °C case were observed. Whereas at hyperthermia (39 °C) a 
similar cell growth, a faster cell death, an enhanced metabolism, and an apparent 
increased productivity compared to the 37 °C experiment were observed. Cyclin D1 
induction due to hyperthermia conditions was not observed, although cyclin D1 
expression was confirmed to be partially-associated to the substrate availability 
(glutamate). At the cell cycle distribution, a weak increase of the G1/G0 cell fraction 
was observed, prior to the onset of apoptosis under hypothermic conditions. 
The medium shift experiment provided an overview of the effect of medium 
changes directly on a high viable growing mid-exponential population. In the 
absence of fresh medium (0%), growth suppression, low levels of cyclin B1 
expression, and a decrease in viability was observed in a period of 24h. Apoptosis 
was confirmed to be induced after the shift to 0% fresh medium, both at the gene 
level and by morphological changes (%ESA). Moreover, the metabolic shift from 
lactate production to consumption was observed, and it correlates with the absence 
of glutamate. The experiments containing fresh medium (50% and 100%) showed a 
comparable cell growth, a high viability and the expression of all the cyclins (D1, E1, 
and B1). Cyclin D1 and E1 seemed to be temporarily overexpressed in the 0% fresh 
medium. The overexpression was correlated to the induction of apoptosis at the 
gene level. Similarly, the results showed the fine balance between the cell cycle and 
apoptosis. Some patterns between the gene expression (p21 and trp53bp2) and the 
expression of the cyclins (D1, E1, and B1) were identified. These results confirmed 
the intricate and intimate link between the cell cycle machinery and the programmed 
cell death. Moreover, the observed patterns, although dependent to the culture 
conditions, render these entities (cyclins, p21 and trp53bp2) as excellent candidates 
for the coupling between the cell cycle and apoptosis mathematical models. 
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CHAPTER 6 
6. Development of a Cyclin Distributed Cell Cycle Model of 
GS-NS0 Cell Line 
The cell cycle blueprint elucidated in chapter 4 & 5 provides a unique tool for 
describing the cell cycle using biologically relevant markers for each of the cell cycle 
phases. In chapter 4, key cell cycle metrics (cell cycle timings, cell cycle distribution, 
and cyclin expressions) were experimentally quantified by flow cytometry. These 
results are herein integrated in a novel experimental-modelling approach to 
formulate a cyclin and DNA distributed model for the industrially relevant cell line 
GS-NS0. In addition, the model structure was studied by global sensitivity analysis 
(GSA) following the model development framework. The parameters identified with a 
significant effect on the model outputs were further re-estimated from a set of batch 
experiments. After, the model accuracy and predictive power was tested and 
compared to experimental data. Most importantly, the presented approach can easily 
be extended to include further biological detail, as well as to other cell cycle relevant 
systems such as clinical problems (tumours, cancer treatments, etc.). 
6.1. Introduction 
A key underlying source of heterogeneity in mammalian cell culture systems is 
the cell cycle segregation (Karra et al., 2010; Pilbrough et al., 2009). The cell cycle is 
at the centre of cellular growth, death, and mAbs productivity that varies during the 
different cell cycle phases. Both productivity (Alrubeai et al., 1992) and glycosylation 
(Fussenegger and Bailey, 1998) have been reported to be influenced by the cell 
cycle state. Thus, the development of these industrially relevant systems can be 
improved through a better understanding of the cell cycle and its association with the 
productivity (Dutton et al., 2006).  
As reviewed in chapter 2, the development of relevant segregated cell cycle 
models has proved to be challenging, particularly due to difficulties in providing 
quantitative experimental validation. PBMs represent the most accurate description 
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of the cell culture heterogeneity; alas the age/mass/volume formulations lack 
biological relevance (non-mechanistic and/or hardly quantifiable) for the cell cycle 
transition in mammalian cell cultures. Moreover, the absence of biological 
mechanism in the model descriptors limits its applicability and extension to include 
further biological detail. For example, the intimate link of the cell cycle and the cell 
programmed death would require relevant cell markers in order to meaningfully 
couple the two events (chapter 5). Furthermore, computationally intensive nature of 
PBM needs to be considered towards model-based applications. The development 
of biological mathematical models can aid the study of these complex systems and 
contribute to understand its features (Bailey, 1998). Thus, biologically relevant 
computational models can offer insight in the biological process and support a 
systematic process development.  
6.2. Objectives 
The aim of this chapter is to formulate a biologically-relevant distributed cell cycle 
model for the industrial cell line GS-NS0 that captures cell population heterogeneity, 
whilst being computationally fast to be used for model-based applications. The 
following scientific objectives were set: 
 Formulate a biologically-relevant distributed cell cycle model for the industrial 
cell line GS-NS0 using first principles with fast computational solution times. 
 Study the model structure using GSA (Section 3.3.11.) and identify the most 
significant model parameters. 
 Re-estimate the subset of significant parameters. 
 Compare the simulation results to experimental data to test the accuracy and 
predictive power of the model. 
6.3. Methodology 
The methodology adopted for the model development followed the framework for 
biological systems illustrated in Figure 2.7. Experimental and modelling aspects were 
integrated in the model development. Most of the experimental results presented in 
this chapter, were derived from chapter 4 (Section 4.4.4.). Specifically the control 
and arrest release experiments, which are compared to the model simulations.  
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The model implementation and all simulations were carried out in gPROMS®. 
The details of the employed GSA software tool and parameter estimation procedure 
can be found in Section 3.3.11. The control runs for the arrest release experiments 
presented in chapter 4 were used for the parameter re-estimation, whereas the after 
arrest release experiments (after thymidine and DMSO arrest release) were used to 
test the model against disturbed growth scenarios. 
The undisturbed cell growth experiment with higher starting cell density used for 
model validation was conducted as described (Section 3.1.3.) and the employed 
analytical techniques can be found in Section 3.3. 
6.4. Model Development & Experimental Validation 
Based on the literature review and the experimental cell cycle blueprint (chapter 
4), a multivariable and multistage PBM is proposed. The model is cyclin distributed 
for the lumped phases - G1/G0 in Equation (6.1) and G2/M in Equation (6.3) - and it is 
DNA distributed for the S phase as presented in Equation (6.2). The lumped G1/G0 
phase is justified due to the observed high percentage of cells positively expressing 
the Ki-67 proliferation marker (chapter 4 & 5). Although the fraction of proliferating 
cells decreased throughout the culture, it was identified to be correlated with the 
viability and plausibly with the onset of apoptosis. Thus, as an initial approximation, 
the lumped phases provide enough detail. Similarly, the G2/M lumped phase is 
justified on the basis of the M phase short duration in mammalian cell cultures (i.e. 
usually less than 1h).  
The truthful biological representation of the system should consider the bivariate 
distribution of the S phase with internal coordinates DNA and cyclin B1 (as 
experimentally observed). However, under specific conditions for the rate functions, 
a mathematical dimensionality reduction of the S equation can be achieved as 
detailed in Appendix II. The approximation is justified as cyclin B1 is not biologically 
relevant for the S to G2 phase transition (Darzynkiewicz et al., 1996), and the 
modelled cells will enter the G2/M phase with an approximated cyclin B1 content 
equal to the one observed experimentally between these two phases (S-G2/M) in 
chapter 4. 
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G1/G0 phase: (6.1) 
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S phase: (6.2) 
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G2/M phase: (6.3) 
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The number distribution (Ni=G1,S,G2) correspond to the number of cells distributed 
on a variable for each phase. The selected distributed variables for each phase are 
experimentally derived from the cell cycle blueprint presented in chapter 4. The 
model utilises cyclin E1 (cycE, key for the transition from G0/G1 to S phase), DNA 
(key for the transition between S phase and G2/M) and cyclin B1 (cycB, key for the 
transition between G2/M phases to G0/G1). Cyclin B1 regulates the G2-M transition, 
although herein is used for the lumped G2/M to lumped G0/G1 phase transition due to 
the G2/M lumped approximation.  
The growth functions (ri) are responsible for the transition of the cells within each 
cell cycle phase. The cyclin growth functions (ri=G1,G2) in Equation (6.4) denote cyclin 
(E1 or B1) build-up on the corresponding phase (G0/G1 or G2/M). These functions are 
responsible for the transition of the cells within each cyclin domain. Similarly, the 
DNA growth function (ri=S) in Equation (6.5) denotes the DNA build-up or synthesis in 
the S phase and is responsible for the transit of the cells within that phase. The 
growth functions (ri) are coupled to the substrate/metabolite concentrations in the 
culture medium. Specifically, glutamate dependence was introduced for all the 
growth functions based on the energy-yielding importance of glutamine (Dorka et al., 
2009; Naderi et al., 2011; Zhou et al., 2007), which is derived from glutamate in the 
GS system (Barnes et al., 2000). In the GS-NS0 cell line, over 90% of the glutamate 
has been identified to flow into the TCA cycle (Zhao et al., 2009) for further 
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metabolism (biomass synthesis and antibody production). Furthermore, the cyclin 
growth functions (ri=G1,G2) were formulated as lactate-dependent based on the reports 
that lactate concentration inhibits cell growth (Mulukutla et al., 2012; Ozturk et al., 
1992). The lactate dependence was not introduced in the S phase (ri=S) given the 
common acceptance that the duration of this phase shows minor variability (Heath, 
2001) and that the main control checkpoints are in the gap phases. 
 1, 2 lim lim,i G G Glu Lacr cyc S Cycgrow f f     (6.4) 
  lim,S Glur DNA S DNAgrow f   (6.5) 
The glutamate (flimGlu), glucose (flimGlc) and lactate (flimLac) dependences utilise 
Monod kinetics (Kiparissides et al., 2010b; Kontoravdi et al., 2005), Equation (6.6). 
The Glu, Glc, and Lac terms represent the extracellular glutamate, glucose, and 
lactate concentrations, respectively. The Ki=Glu,Glc,Lac parameters represent the 
Monod constant, while the exponential factors (n, m, and p) capture the sensitivity 
towards the respective substrate/metabolite. 
lim lim lim; ;
pn m
Lac
Glu Glc Lacn n m m p p
Glu Glc Lac
KGlu Glc
f f f
Glu K Glc K K Lac
  
  
 
(6.6) 
The cyclin transition functions (i) are defined as the probability of transition 
between the phases. The transition functions between G0/G1 and S phases (i=G1), 
as well as between G2/M and G0/G1 phases (i=G2) are formulated as a step function, 
Equation (6.7). The functions take a value of zero below the respective cyclin 
threshold for the phases G1 (cyclin E1) and G2 (cyclin B1), and become positive 
above the threshold while being glucose dependent (flimGlc), Equation (6.6). Although 
glucose has not been identified as growth limiting, it does prolong the stationary 
phase and delay the decline phase (Sellick et al., 2011). 
 1, 2
lim
0 ,
,
,
i G G
i Glc
below threshold
cyc S
prob f above threshold


  

 
(6.7) 
The cell cycle transition proceeds as follows. The cells transit from G1/G0 (G1) to 
the S phase - by means of the Dirac delta function δ(DNA-1) - with an initial DNA 
content. After the cells doubled their DNA content, transit occurs immediately from 
the S to the G2/M phase, i.e. S(DNA=2)=1. Then, the cells enter G2/M phase by 
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means of the Dirac delta function δ(cycB-cycBS-G2/M) - with a cyclin B1 content equal 
to the one observed experimentally between these two phases (as discussed). The 
cycle is completed by giving birth to two daughter cells (G2) and enter the G1 phase 
- by means of the Dirac delta function δ(cycE) - with a minimum cyclin E1 content. 
The phase populations are calculated over each domain as in Equation (6.8), 
whereas the total population is the sum over all the three distributed domains, see 
Equation (6.9). 
_ max
1, , 2
_ min
( )  
phase
i G S G i i i
phase
phase N x dx  where xG1=cycE, xS=DNA, xG2=cycB 
(6.8) 
1 2G S Gtotal phase phase phase    (6.9) 
The cell cycle distribution can be estimated as in Equation (6.10), while the viable 
cell density (XV) is expressed by dividing over the reactor working volume (V), see 
Equation (6.11). The model is presented in batch operation mode and under the 
standard assumption of ideal mixing within the flasks. 
1, , 2
i
i G S G
phase
f
total
   
(6.10) 
V
total
X
V
  
(6.11) 
The dead cell population (XD) accounts for the specific death rate (kd) of the 
viable cells and the lysis specific rate (klys) of the dead cells, Equation (6.12). The 
specific death rate – Equation (6.13) - is linked to the extracellular glutamate 
concentrations due to glutamate’s essential role in the GS system (Barnes et al., 
2000) and exhaustion from the culture medium in batch mode. The sensitivity of the 
cell death to glutamate is given by the affinity death parameter (kdGlu) and the 
exponential factor (q). 
 D
d V lys D
d X V
k X V k X V
dt
 
 
(6.12) 
max
q
dGlu
d d
dGlu
k
k k
k Glu
 
  
 
 
(6.13) 
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The PBM is coupled to an unstructured metabolic model in order to fully 
represent the system. The unstructured metabolic model supports fast computational 
times, as well as a good description without introducing too many parameters (Ho et 
al., 2006). The dynamics of the substrate/metabolite changes are linked to the cell 
growth rate. The growth rate (μ) utilised in the metabolic model is calculated based 
on the cyclin and DNA growth functions, Equation (6.14). 
 
1, 2
1, 2 1 2
ln 2_ 1
; ;i G G S
i G G S G S G
cyclin threshold
t t
r r t t t


  
 
 
(6.14) 
The basic metabolism is accounted for through the reactor mass balances. The 
biomass yield (Yi=Glu,Glc) on substrates (glutamate and glucose) defines the 
consumption rates (Qi=Glu,Glc), Equation (6.15). The material mass balance for the 
substrates is presented in Equation (6.16). 
,
,
i Glu Glc
i Glu Glc
Q
Y



  
(6.15) 
,i Glu Glc V
dS
Q X V
dt
   
(6.16) 
Lactate is modelled to be produced on a yield basis (YLac) from glucose and 
glutamate consumption as supported by previous reports (Dorka et al., 2009; Nolan 
and Lee, 2011), see Equation (6.17). In addition, lactate is considered to be 
consumed (QLac) as experimentally observed (Mulukutla et al., 2012; Templeton et 
al., 2013), which herein is considered to be triggered by glutamate’s exhaustion. 
 lim lim1
2
   LacGlc Lac Glu Glu V Lac Glu
YdLac
Q Y f Q X V Q f
dt
 
(6.17) 
Finally, the antibody production (mAb) is specific for each cell cycle phase 
(Qi=G1,S,G2) as stated in Equation (6.18). 
 1 1 2 2G G S S G G V
dmAb
Q f Q f Q f X V
dt
    
(6.18) 
The presented PBM coupled with an unstructured metabolic model consists of a 
system of hyperbolic partial integrodifferential equations. The system is discretised in 
the cell content space using conservative first order finite differences (Kostoglou and 
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Karabelas, 1995), which transforms it into ordinary differential equations with respect 
to time. The model was implemented in gPROMS® modelling software and all 
simulations were performed using a desktop computer with an Intel® Core™ i7 CPU. 
6.5. Model Analysis & Re-estimation of Significant Model 
Parameters 
The next step in the model development was to evaluate the model structure 
using GSA (Section 3.3.11.). As outlined in chapter 2 and in the biological model 
development framework (Section 2.5), GSA systematically evaluates output 
variability. GSA is a key step in the model analysis due to the nonlinearity nature of 
the system. However, prior to GSA, where a substantial number of scenarios are 
evaluated, a cell conservation test was carried out.  
The aim of the cell conservation test was to ensure that the selected 
discretisation space (i.e. maximum number of bins or intervals) would minimise the 
cell losses. Thus, the number of bins for the cyclin E1 and B1 domains was 
increased in order to ensure that over 99% of the cells remained in the system after 
120h of simulation. The DNA space can be fixed (i.e. 20 bins) as the transition from 
S to G2/M is deterministic and does not affect the cell conservation. For this purpose, 
the full range of 24 parameters is varied ±50% (Sidoli et al., 2006) from their nominal 
value and the cell conservation is evaluated. In addition, the birth term is fixed to 1 
(to avoid generation), the death rate is fixed to zero (kdmax=0, to neglect cell death) 
and the interaction with the nutrients is neglected (flimGlu/Glc/Lac=1, to maintain 
maximum rates). A uniform distribution is applied for all domains (cyclin E1 between 
0-95%, DNA between 1-2, and cyclin B1 between 0-95%). Such formulation 
evaluates the worst case scenario for cell conservation in the system. The number of 
bins was increased to 200, both for cyclin E1 and cyclin B1, which ensured 99% 
retention of cells in the system after 120h (Appendix III.).  
GSA followed the cell conservation test, after restoring the birth term, death rate 
and limiting functions. In order to evaluate the relative influence of the uncertainty of 
the parameters in the outputs, a large number of sampling points is typically 
required. A total of five outputs were evaluated (Xv, fG1, fS, fG2, and mAb) at three 
characteristic simulation time points. The simulation time points covered the early-
121 
 
exponential stage (36h), entrance to stationary phase (72h), and the onset of death 
phase (120h). A total of 40,000 scenarios were evaluated varying the 24 parameters 
±50% from their nominal value. The nominal values were taken from experimental 
data (e.g. chapter 4) and when data were not available an approximated order-of-
magnitude values were assigned (Kiparissides, 2012; Sidoli et al., 2006). The output 
of the scenarios was used to estimate the SIs using the GUI-HDMR software as 
outlined in chapter 3. The computational solution time for a single run was fast (< 
4s), and two fold faster compared to the mass structured PBM of Karra et al. (2010). 
Similarly, the GSA was completed in less than 30h, which is also fast compared to 
previous contributions (Karra et al., 2010; Pinto et al., 2007; Sidoli et al., 2006). From 
the initial 24 varied parameters, 9 were found significant (above the threshold, 
chapter 3), see Table 6.1. These parameters are reviewed next. 
The viable cell population output (Xv) was found to be sensitive to the cyclin and 
DNA growth rates, as well as the exponential death factor (q) at early stage (i.e.36h). 
Also an increasing sensitivity (from mid stage 72h towards late stage 120h) to the 
biomass yield on glutamate (YGlu) and to the maximum death rate (kdmax) was 
observed. The cell fractions (fi=G1,S,G2) showed higher sensitivity towards the 
respective growth rates (i.e. CycEgrow, DNAgrow, CycBgrow) at all stages. 
Similarly, the cell fractions (fi=G1,S,G2) showed mild sensitivity to the growth rates 
governing the preceding cell cycle phase. However, none of the transition 
probabilities or thresholds for the cyclins were identified as significant. This should 
not be interpreted as irrelevant, as it factually reflects the structure of the model. 
Hence, a few aspects should be considered on this result. First, the model uses the 
transition probabilities to determine the dispersion around the cyclin thresholds. 
Thus, if there is a positive transition probability, the cells will transit to the next stage 
and only the dispersion around the threshold is affected. Second, the transitions are 
not independent of the threshold. However, from a pure numerical value perspective, 
once a cell reaches the threshold (regardless of its value), the cell is a candidate to 
proceed to the next stage. Therefore, the cyclin thresholds alone are not relevant, as 
it should be considered in connection with the cyclin growth rates - together 
determine the transitions. 
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Table 6.1. GSA Indexes and parameters values for the cyclin distributed cell cycle model. Outputs: XV=viable cell density, fG1=G1/G0 cell fraction, fS=S cell fraction, 
fG2=G2/M cell fraction, and mAb=antibody titre. 
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An important aspect of the GSA is that the results are subject to the proposed 
model structure and outputs considered. Thus, other model structures or outputs 
might result in other identified significant parameters. Finally, the antibody titre output 
(mAb) was sensitive to all the specific productivities (Qi=G1,S,G2) at early stage (36h), 
though QG2 was not sensitive at the other times points and QS was not sensitive at 
120h. These results suggest some association of the specific cell cycle production 
with the mAb titre. A better correlation seems to be observed towards the G1 specific 
productivity (identified throughout significant). Such correlation could be attributed to 
the longer cell cycle time experimentally observed for the G1 phase, which usually 
translates into higher G1 cell fractions when compared to the other two phases (S, 
G2/M). 
Following the biological model development framework (Section 2.5), the 
identified significant parameters were re-estimated; whereas the non-significant 
parameters were fixed to their nominal value. The control runs for the arrest release 
experiments presented in chapter 4 were used for the parameter re-estimation. 
6.6. Results & Discussion 
In this section, the model simulation results are shown and compared to the 
experimental data. The simulation results are carried with the same set of 
parameters and only varying the initial culture conditions, unless otherwise stated. 
6.6.1. Model results for the control runs 
The model simulation results for the control runs (used for parameter estimation) 
of the arrest experiments showed a good agreement with the experimental data. The 
cell growth kinetics, peak and decline, as well as the timing in viability decline of the 
culture for both control runs were captured by the model simulations (Figure 6.1A). 
Similarly, the glucose/lactate (Figure 6.1B) and glutamate/mAb (Figure 6.1C) 
simulations captured the experimental trends. The model predicted cell cycle 
distributions showed a good agreement, particularly at early stages of the culture 
(Figure 6.1D). Overall, the model predictions showed a good fit to the experimental 
data. 
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Figure 6.1. Model results for the control experiments. A) Cell growth and viability; B) Glucose and lactate 
concentration profiles; C) Glutamate and mAb concentration profiles; D) Cell cycle distribution. Notation: dots 
represent experimental data (n=3, error bars=standard deviation), lines represent the simulation results. 
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Figure 6.1. (Continued). Model results for the control experiments. A) Cell growth and viability; B) Glucose 
and lactate concentration profiles; C) Glutamate and mAb concentration profiles; D) Cell cycle distribution. 
Notation: dots represent experimental data (n=3, error bars=standard deviation), lines represent the simulation 
results. 
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Figure 6.1. (Continued). Model results for the control experiments. A) Cell growth and viability; B) Glucose 
and lactate concentration profiles; C) Glutamate and mAb concentration profiles; D) Cell cycle distribution. 
Notation: dots represent experimental data (n=3, error bars=standard deviation), lines represent the simulation 
results. 
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Figure 6.1. (Continued). Model results for the control experiments. A) Cell growth and viability; B) Glucose 
and lactate concentration profiles; C) Glutamate and mAb concentration profiles; D) Cell cycle distribution. 
Notation: dots represent experimental data (n=3, error bars=standard deviation), lines represent the simulation 
results. 
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6.6.2. Model results for the arrest release experiments 
The model was tested against the disturbed growth scenarios (after thymidine 
and DMSO arrest release). These experiments provide significantly different starting 
cell cycle scenarios (chapter 4) when compared to the control runs. For the 
thymidine arrest release case, a good model prediction was observed for the cell 
growth (Figure 6.2A), substrate consumption (Figure 6.2B-C), and mAb titre (Figure 
6.2C). The lactate predictions followed the trends (Figure 6.2B), particularly after 48h 
of culture. However, the high lactate levels at 24h were not captured by the model, 
which were attributed to an effect of the cell arrest (chapter 4). Despite this 
difference, the cell cycle distribution (Figure 6.2D) was satisfactorily predicted. The 
sharp oscillations soon after the arrest release were captured by the model 
prediction. The relevance of the model formulation using cyclins/DNA distribution is 
evident on the ability to predict the cell cycle variations. 
The DMSO arrest release case proved to be more challenging due to the 
discussed effects on the cell cycle machinery (chapter 4). The model predictions 
using the re-estimated set of parameters showed overall a good agreement in terms 
of cell growth and viability (Figure 6.3A, grey lines) with an apparent systematic 
difference between the predictions and experimental data. The systematic difference 
seems to be due to the pronounced experimental lag phase. Nonetheless, the 
glucose/lactate (Figure 6.3B, grey lines) and glutamate (Figure 6.3C, grey lines) 
predictions showed a good experimental agreement. In contrast, the mAb titre 
prediction (Figure 6.3C, grey lines) showed a poor fit, overestimating the final titre. 
The mAb prediction deviation could be partially attributed to differences in cell 
density prediction, as well as to the discussed effects of the DMSO on the 
productivity (chapter 4). However, the cell cycle predicted distribution (Figure 6.3D) 
showed that the model was not accurately capturing the cell cycling behaviour. The 
cell cycle simulation trends are correct, but there seems to be a systematic 
difference. 
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Figure 6.2. Model results for the thymidine arrest release experiment. A) Cell growth and viability; B) 
Glucose and lactate concentration profiles; C) Glutamate and mAb concentration profiles; D) Cell cycle 
distribution. Notation: dots represent experimental data (n=3, error bars=standard deviation), lines represent the 
simulation results. 
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Figure 6.2. (Continued). Model results for the thymidine arrest release experiment. A) Cell growth and 
viability; B) Glucose and lactate concentration profiles; C) Glutamate and mAb concentration profiles; D) Cell 
cycle distribution. Notation: dots represent experimental data (n=3, error bars=standard deviation), lines 
represent the simulation results. 
131 
 
 
 
        
Figure 6.3. Model results for the DMSO arrest release experiment. A) Cell growth and viability; B) Glucose and 
lactate concentration profiles; C) Glutamate and mAb concentration profiles; D) Cell cycle distribution; E) Cell 
cycle distribution delay growth. Notation: dots represent experimental data (n=3, error bars=standard deviation), 
lines represent the simulation results. Grey lines: simulation with estimated parameters (Table 6.1). Black lines: 
simulation with DMSO delay parameters (Table 6.1). 
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Figure 6.3. (Continued). Model results for the DMSO arrest release experiment. A) Cell growth and viability; 
B) Glucose and lactate concentration profiles; C) Glutamate and mAb concentration profiles; D) Cell cycle 
distribution; E) Cell cycle distribution delay growth. Notation: dots represent experimental data (n=3, error 
bars=standard deviation), lines represent the simulation results. Grey lines: simulation with estimated parameters 
(Table 6.1). Black lines: simulation with DMSO delay parameters (Table 6.1). 
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The observed differences are hypothesised to be due to the imbalances caused 
by the DMSO. DMSO action has been reported to indirectly inhibit the cyclin 
E1/CDK2 complex (Ponzio et al., 1998), and herein a cyclin E1 imbalance was 
observed experimentally (chapter 4). Thus, the hypothesis of a slower G1 phase 
completion during the first 24h due to DMSO’s effect was tested in the model. This 
was captured by slowing the Cyclin E1 growth rate (cycEgrow) during the first 24h of 
simulation. For comparison purposes to the initial simulated scenario, the yields on 
substrates (Yi=Glu,Glc) were adjusted by the same factor. The decreased factor for the 
cyclin E1 growth rate was found to be approximately 2.3-fold slower. 
The three parameters were modified for the first 24h of simulation (DMSO delay 
simulation values, Table 6.1) and set back to their initial values (nominal or 
estimated values, Table 6.1) after 24h. All other model parameters were kept at the 
reported values. The simulation results for the delay growth are shown in Figure 
6.3A-C (black lines). The cell growth and viability predictions showed an improved fit 
to the experimental data and the lag phase was captured (Figure 6.3A). Similarly, the 
mAb titre prediction was improved (Figure 6.3C). Alas, the final titre is still 
overpredicted, suggesting that the lower experimental titre is due to a DMSO 
treatment effect. The metabolism predictions were comparable to the initial scenario 
as intended (Figure 6.3B-C). The sharp cell cycle predictions captured the 
experimentally observed oscillations (Figure 6.3E). The biological relevance of the 
model allowed to uniquely postulate an in silico plausible explanation to the 
experimental observations. Previous models based on mass/volume cannot account 
for a mechanistic delay in the cell cycle transition. Although, the imbalances caused 
by the DMSO are several and complex, the model provides a platform for more 
structured studies. Thus, the introduced temporary variation of three parameters (by 
the same factor) justified the experimentally observed cell growth delay, lower peak 
density and moderately explained the lower mAb productivity.  
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6.6.3. Model results for the undisturbed cell growth experiment with higher 
starting cell density 
The predictive power of the model was tested against an undisturbed growth 
experiment with a two fold higher starting cell density. The model predictions for cell 
growth, viability (Figure 6.4A) and substrate consumption (Figure 6.4B-C) showed a 
good fit. Few deviations in the predictions when compared to the experimental data 
were observed. The cell density peak and decline timing were captured by the 
model, although the peak cell density was overpredicted. Similarly, around 96h, 
glutamate was observed experimentally in the culture (either produced or released 
by cell lysis), which the model does not account for. The lactate predicted profile 
showed the largest deviations, particularly after 48h of culture (Figure 6.4B). The 
overall lactate trends are correct, but the lactate consumption seemed to be 
pronounced after 48h, which the model moderately captured. Thus, the shift in the 
lactate metabolism needs further consideration and study. In contrast, the observed 
mAb titre was closely predicted (Figure 6.4C). The cell cycle distribution (Figure 
6.4D) predictions showed a fair fit to the experimental data. The overall trends are 
accurate but some deviations were observed during the first 12h.  
The observed model predictions discrepancies stressed the importance between 
the cell growth and the culture environment. Particularly, the lactate metabolism 
needs to be further considered. Although, the current formulation accounts for the 
lactate being produced from two sources (glucose, glutamate), other sources might 
be available in the used medium formulation such as pyruvate (Dean and Reddy, 
2013). The glutamate exhaustion seemed to be a fair descriptor for the onset of the 
lactate consumption, although this needs further validation. However, the undefined 
character of the medium (serum containing) obscures such studies. In particular, the 
use of chemically defined medium would enable the refinement of the modelled 
cyclin-extracellular substrate/metabolite concentrations links. This is a key feature as 
it was experimentally observed how the metabolic shift (or use of other carbon 
sources) has an effect in the cell cycle progression and ultimately in the cell growth. 
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Figure 6.4. Model results for undisturbed higher cell density experiment. A) Cell growth and viability; B) Glucose 
and lactate concentration profiles; C) Glutamate and mAb concentration profiles; D) Cell cycle distribution. 
Notation: dots represent experimental data (n=3, error bars=standard deviation), lines represent the simulation 
results. 
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Figure 6.4. (Continued). Model results for undisturbed higher cell density experiment. A) Cell growth and 
viability; B) Glucose and lactate concentration profiles; C) Glutamate and mAb concentration profiles; D) Cell 
cycle distribution. Notation: dots represent experimental data (n=3, error bars=standard deviation), lines 
represent the simulation results. 
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6.7. Conclusions 
A biologically and mechanistically relevant cell cycle distributed model for an 
industrial cell line was presented in this chapter. The model formulation captured the 
cyclins key role as a quantifiable marker determining the proliferating state of the 
culture. Moreover, the experimental approach presented in chapter 4 is integrated 
seamlessly into the model. As a result, the model is able to capture the complex 
heterogeneity and multi-scale nature of mammalian cell culture systems. The 
versatile model structure can easily accommodate further biological detail (e.g. 
apoptosis, energy requirements, proliferation cessation, among others), which is the 
next logical step. 
As intended, the model formulation resulted in low computational requirements 
finding a balance between model detail and solution times. The fast solutions 
enabled the model analysis completion in a short period of time. The GSA allowed 
identifying the most significant parameters and by re-estimating such, the model 
output uncertainty is reduced. These results encourage the use of the model in 
model-based applications of industrial relevance such as control and optimisation. In 
particular, it can be used as a computer-aided tool to derive optimal operating 
policies to improve product titre and product quality while satisfying tight operating 
constraints and product specifications. Product quality (i.e. glycosylation) has been 
suggested to be cell cycle dependent (Fussenegger and Bailey, 1998). Moreover, 
post-translational modifications are dependent on the culture environment (Osman et 
al., 2001; Trummer et al., 2006), as well as dependent on the proliferation control 
strategy (Andersen et al., 2000; Gawlitzek et al., 2009; Kaufmann et al., 2001). 
Therefore, the model can accommodate for environmental factors as well as 
proliferation control strategies, which can include mechanistic effects in the 
presented model formulation. The significance of this approach is not limited to 
industrial scenarios (where the cell cycle productivity, cell growth or product quality 
can be optimised) but also to clinical environments (tumours growth models, design, 
and optimisation of cancer treatments, etc.).  
The model predictions were compared to different experimental scenarios 
including both disturbed and undisturbed growth. Overall, the model showed a good 
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prediction throughout the different experiments. However, a few aspects that need 
further refinement were identified. In particular, studies on the link between the 
substrate/metabolite and the cell cycle machinery will help to further develop the 
model structure. The model development framework can be applied recursively for 
the formulation and refinement of relevant cell cycle models both at the industrial and 
clinical environments.  
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CHAPTER 7 
7. Development of an Unstructured Metabolic and 
Temperature Dependent Cell Cycle Model in Hybridoma 
Cell Cultures 
Mammalian cell fed-batch cultures are the preferred operation mode at an 
industrial scale for the production of monoclonal antibodies (mAbs). Improvements in 
the product yields have been fostered partially by the better understanding of fed-
batch bioprocessing. A commonly used strategy in industrial fed-batch processes is 
based on the temperature shift of the bioreactor in order to obtain a good balance 
between temperature induced growth limitation and cell cycle specific enhanced 
productivity. Herein, the biological model development framework is used to 
formulate an unstructured cell cycle model considering the distribution of proliferating 
(G1, S, G2/M) and arrested cells (G0) in batch and fed-batch cultures for a murine 
hybridoma cell line. The model is applied to predict temperature shifts from 37 °C to 
33 °C, while capturing the cell growth, basic cell metabolism, and cell cycle 
distribution. 
7.1. Introduction 
Over the last three decades, improvements in product yields have been reported 
in mammalian cell cultures. Those improvements are due to the use of advanced 
production cell lines (Munro et al., 2011), optimised culture media, and process 
control (Wurm, 2004). Typical process controlled parameters are temperature, pH, 
and dissolved oxygen due to their influence on the cell proliferation and productivity 
(Trummer et al., 2006). In particular, reduced temperature control is a well 
established and preferred strategy to improve productivity due to its proven reliability 
and efficiency (Kumar et al., 2007). However, the reported temperature effects are 
variable between cell lines, expression systems, and expressed recombinant product 
(Al-Fageeh et al., 2006; Sunley and Butler, 2010). 
140 
 
The implementation of a reduced temperature control strategy commonly results 
in a reduced cell growth and cell arrest. Therefore, a balance between growth 
limitation, integral viable cell density (IVCD), and cell specific productivity must be 
achieved in order to increase the final antibody titre (Dutton et al., 1998; Sunley and 
Butler, 2010). Successful examples include the increase in total antibody production 
of GS-NS0 cells accumulated in G1 and S phases at 34 °C (Swiderek and Al-Rubeai, 
2007) and CHO cells arrested at G2/M at 30 °C reporting an enhancement in the 
production (Shi et al., 2005). However other studies, despite reporting prolonged 
viability (Reuveny et al., 1987) or maximum viable cell concentration (Sureshkumar 
and Mutharasan, 1991) at low temperature, did not observe an improvement in 
productivity. Thus, the systematic study of temperature shifts in fed-batch cultures 
can aid the bioprocess development to improve product titre and product quality. 
The development and selection of the culture temperature profiles seem to be 
empirical, lacking a systematic model-based approach. Early contributions used 
mathematical models to study the cell cycle and temperature effect (Slater et al., 
1977; Watanabe and Okada, 1967). However, further developed cell cycle models 
excluded the temperature effects when considering productivity (Cazzador and 
Mariani, 1993; Kromenaker and Srienc, 1994; Linardos et al., 1992; Suzuki and Ollis, 
1989), whereas Fox et al. (2004) aimed to optimise the temperature shift time 
without accounting for the cell cycle segregation. Recently, a mass based-PBM 
describing the cell cycle coupled to an unstructured model did account for the 
temperature effect (Karra et al., 2010). Alas, the model was validated only with batch 
cultures, limiting its industrial relevance. Thus, the opportunity to study the 
temperature shift effect on fed-batch cultures accounting for the cell cycle 
segregation remains open. 
7.2. Objectives 
The aim of this chapter is to formulate a (fed)-batch temperature dependent cell 
cycle model for a mAb producing hybridoma cell line. The overall methodology maps 
the path to systematically develop industrially relevant mathematical models to 
optimise temperature profiles. The following scientific objectives were set: 
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 Formulate a temperature dependent cell cycle model for the HFN 7.1 murine 
hybridoma cell line. 
 Design and perform HFN 7.1 (fed)-batch cell culture experiments that would 
allow evaluating the temperature effect. 
 Study the model structure using GSA (Section 3.3.11.) and identify the most 
significant model parameters. 
 Re-estimate the subset of significant parameters from a set of (fed)-batch 
experiments. 
 Predict temperature shift fed-batch cultures and compare to the experimental 
data. 
7.3. Methodology 
The model development followed overall the methodology proposed in the 
biological systems framework (Figure 2.7). Experimental and modelling aspects were 
integrated in the model development. Cell culture protocols and used experimental 
set-ups can be found in Section 3.2 and analytical techniques can be found in 
Section 3.3.  
The model was implemented in gPROMS®. The employed model analysis tools, 
GSA software and parameter estimation procedure, can be found in Section 3.3.11. 
The identified significant parameters were re-estimated from representative batch 
and fed-batch cultures. Specifically, the batch and fed-batch covered the two 
temperatures (37 °C and 33 °C), which were set at the start of the cultures (t=0h) 
after seeding. 
The model was validated against two independent fed-batch experiments with 
temperature shift (from 37 °C to 33 °C) at different culture times (i.e. 30 and 76h). 
7.4. Model Development & Experimental Validation 
Based on the literature review and experimental observations the cell cycle 
model was formulated using an unstructured-segregated approach. As addressed in 
chapter 2, the unstructured segregation provides fast computational times, is 
experimentally less intense and can be rapidly developed. The model was 
formulated using first principles and applying the existing model development 
framework (Kiparissides et al., 2011; Kontoravdi et al., 2007a; Sidoli et al., 2004). 
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Similarly, the model cell cycle structure was adapted and further developed from 
previous contributions (Basse et al., 2003; Lam et al., 2008; Uchiyama and Shioya, 
1999). The cell cycle description includes the G0, G1, S, G2/M phases (XG0, XG1, XS, 
XG2M) and it is stated as ordinary differential equations (7.1)-(7.4). 
𝑑(𝑋𝐺1𝑉)
𝑑𝑡
= 2𝑘𝐺2𝑀−𝐺1𝑋𝐺2𝑀𝑉 − 𝑘𝐺1−𝑆𝑋𝐺1𝑉 − 𝑘𝐺1−𝐺0𝑋𝐺1𝑉 − 𝑘𝑑𝑋𝐺1𝑉 − 𝐹𝑂𝑈𝑇𝑋𝐺1 
(7.1) 
𝑑(𝑋𝑆𝑉)
𝑑𝑡
= 𝑘𝐺1−𝑆𝑚𝑠𝑡𝑟𝑒𝑠𝑠𝑋𝐺1𝑉 − 𝑘𝑆−𝐺2𝑀𝑋𝑆𝑉 − 𝑘𝑑𝑋𝑆𝑉 − 𝐹𝑂𝑈𝑇𝑋𝑆 
(7.2) 
𝑑(𝑋𝐺2𝑀𝑉)
𝑑𝑡
= 𝑘𝑆−𝐺2𝑀𝑋𝑆𝑉 − 𝑘𝐺2𝑀−𝐺1𝑋𝐺2𝑀𝑉 − 𝑘𝑑𝑋𝐺2𝑀𝑉 − 𝐹𝑂𝑈𝑇𝑋𝐺2𝑀 
(7.3) 
𝑑(𝑋𝐺0𝑉)
𝑑𝑡
= 𝑘𝐺1−𝑆(1 − 𝑚𝑠𝑡𝑟𝑒𝑠𝑠)𝑋𝐺1𝑉 + 𝑘𝐺1−𝐺0𝑋𝐺1𝑉 − 𝑘𝑑𝑋𝐺0𝑉 − 𝐹𝑂𝑈𝑇𝑋𝐺0 
(7.4) 
The viable cell population (XV) and dead cell population (XD) are calculated from 
the sum over all the cell cycle phases, Equations (7.5) and (7.6) respectively. The 
cell cycle fractions (fi) are calculated dividing by the viable cell population, Equation 
(7.7). 
𝑑(𝑋𝑉𝑉)
𝑑𝑡
=
𝑑(𝑋𝐺0𝑉)
𝑑𝑡
+
𝑑(𝑋𝐺1𝑉)
𝑑𝑡
+
𝑑(𝑋𝑆𝑉)
𝑑𝑡
+
𝑑(𝑋𝐺2𝑀𝑉)
𝑑𝑡
 
(7.5) 
𝑑(𝑉𝑋𝐷)
𝑑𝑡
= 𝑋𝑉𝑘𝑑𝑉 − 𝑋𝐷𝑘𝑙𝑦𝑠𝑉 
(7.6) 
𝑓𝑖=𝐺0,𝐺1,𝑆,𝐺2𝑀 =
𝑋𝑖
𝑋𝑉
 
(7.7) 
The transition between the proliferating subpopulations (XG1, XS, XG2M) are 
declared (kG1-S, kS-G2M, and kG2M-G1) in Equations (7.8)-(7.10) as previously derived 
(Uchiyama and Shioya, 1999); while the transition to G0 from G1 is triggered by two 
types of stresses: a temperature dependent stress (kG1-G0) and/or a metabolic stress 
(mstress). The temperature stress (kG1-G0) is assumed to occur at a constant rate (rT) 
when the temperature is lowered from 37 °C to 33 °C, Equation (7.11). The 
metabolic stress (mstress) is defined as the product of the substrate limitation, toxic 
metabolite inhibition, and a resistance to such stresses (fres), Equation (7.12). When 
the metabolic stress takes values below 1, it will divert a fraction of the typically 
proliferating cells transiting from G1-S to the arrest phase G0.  
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𝑘𝐺1−𝑆 = (𝜇 +
𝐹𝑂𝑈𝑇
𝑉
) (
2 − 𝑓𝐺1
𝑓𝐺1
) 
(7.8) 
𝑘𝑆−𝐺2𝑀 = (𝜇 +
𝐹𝑂𝑈𝑇
𝑉
) (
1 + 𝑓𝐺2𝑀
𝑓𝑆
) 
(7.9) 
𝑘𝐺2𝑀−𝐺1 = (𝜇 +
𝐹𝑂𝑈𝑇
𝑉
) (
1
𝑓𝐺2𝑀
) 
(7.10) 
𝑘𝐺1−𝐺0 = {
𝑖𝑓 𝑇 = 33°𝐶 = 𝑟𝑇
𝑒𝑙𝑠𝑒 = 0  
 
(7.11) 
𝑚𝑠𝑡𝑟𝑒𝑠𝑠 = {
𝑖𝑓 𝑓𝑖𝑛ℎ1𝑓𝑖𝑛ℎ2𝑓𝑙𝑖𝑚1𝑓𝑟𝑒𝑠 > 1 = 1
𝑒𝑙𝑠𝑒 = 𝑓𝑖𝑛ℎ1𝑓𝑖𝑛ℎ2𝑓𝑙𝑖𝑚1𝑓𝑟𝑒𝑠  
 
(7.12) 
The transitions between the proliferating subpopulations, Equations (7.8)-(7.10), 
are growth associated (μ). The growth rate (μ), Equation (7.13), is stated as a 
function of a characteristic time to complete every cell cycle phase (tG1, tS, tG2M). 
Several biological contributions were considered to affect the characteristic cell cycle 
times, Equation (7.14): a temperature factor (kT), the substrate availability (flim1), and 
the presence of toxic metabolites (finh1/inh2). The temperature factor (kT), Equation 
(7.15), is supported by the consistently reported slower proliferation at lower 
temperatures (Kumar et al., 2007); while the substrate and toxic metabolite (lactate 
[Lac], ammonia [Amm]) effect for the employed hybridoma cell line are reported 
(Ozturk et al., 1992). These effects are included using Monod kinetics (Kontoravdi, 
2006). 
𝜇 =
𝑙𝑛 (2)
𝑡𝐺1 + 𝑡𝑆 + 𝑡𝐺2𝑀
 
(7.13) 
𝑡𝐺1,𝐺2𝑀 =
𝑡𝐺1,𝐺2𝑀 𝑖𝑛𝑖𝑡𝑖𝑎𝑙𝑘𝑇
𝑓𝑙𝑖𝑚1𝑓𝑖𝑛ℎ2𝑓𝑖𝑛ℎ1
𝑛 ; 𝑡𝑆 =
𝑡𝑆 𝑖𝑛𝑖𝑡𝑖𝑎𝑙 + 𝑘𝑇
𝑓𝑙𝑖𝑚1𝑓𝑖𝑛ℎ2𝑓𝑖𝑛ℎ1
𝑛 
(7.14) 
𝑘𝑇 = {
𝑖𝑓 𝑇 = 33°𝐶 = 𝑘𝑇
𝑒𝑙𝑠𝑒 = 1  
 
(7.15) 
𝑓𝑙𝑖𝑚1 =
[𝐺𝑙𝑛]
𝐾𝐺𝑙𝑛 + [𝐺𝑙𝑛]
 
(7.16) 
𝑓𝑖𝑛ℎ1 =
𝐾𝐿𝑎𝑐
𝐾𝐿𝑎𝑐 + [𝐿𝑎𝑐]
 ; 𝑓𝑖𝑛ℎ2 =
𝐾𝐴𝑚𝑚
𝐾𝐴𝑚𝑚 + [𝐴𝑚𝑚]
 
(7.17) 
The death rate (kd) was based on previous reports (Jang and Barford, 2000; 
Kontoravdi, 2006) and it was modified to consider the glutamine limitation (flim1), 
Equation (7.18). 
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𝑘𝑑 =
𝑘𝑑𝑀𝐴𝑋 
(1 + 𝑓𝑙𝑖𝑚1
𝐾𝑑𝐴𝑚𝑚
[𝐴𝑚𝑚]
)
 
(7.18) 
The bioreactor works under the assumptions of perfect mixing and operates 
under both batch and fed-batch mode, Equation (7.19). Thus, volume (V) changes 
are considered due to substrate feeding (FGlc, FGln) or sampling (FOUT). Substrate and 
metabolites changes are calculated accounting for the cell metabolism and a mass 
balance around the bioreactor. Glutamine concentration ([Gln]) changes are due to 
glutamine uptake (QGln), glutamine degradation into ammonia (Kdeg) and presence of 
glutamine in the feed ([Glnfeed]), Equation (7.20). The glutamine uptake, (QGln) in 
Equation (7.21), depends on the cell growth at a specific yield on glutamine (YGln), an 
uptake limiting function with Monod kinetics (fupt), and a maintenance term (mGln) 
(Tatiraju et al., 1999). The ammonia mass balance ([Amm]), Equation (7.22), is 
linked to the degration and consumption of glutamine producing ammonia on a 
constant yield basis (YAmm). 
𝑑𝑉
𝑑𝑡
= 𝐹𝐺𝑙𝑐 + 𝐹𝐺𝑙𝑛 − 𝐹𝑂𝑈𝑇 
(7.19) 
𝑑([𝐺𝑙𝑛]𝑉)
𝑑𝑡
= −𝑄𝐺𝑙𝑛𝑋𝑉𝑉 − 𝐾𝑑𝑒𝑔[𝐺𝑙𝑛]𝑉 + 𝐹𝐺𝑙𝑛[𝐺𝑙𝑛𝐹𝑒𝑒𝑑] − 𝐹𝑂𝑈𝑇[𝐺𝑙𝑛] 
(7.20) 
𝑄𝐺𝑙𝑛 = (
𝜇
𝑌𝐺𝑙𝑛
) 𝑓𝑢𝑝𝑡 + 𝑚𝐺𝑙𝑛 ; 𝑓𝑢𝑝𝑡 =
[𝐺𝑙𝑛]
𝐾𝐺𝑙𝑛 + [𝐺𝑙𝑛]
 ; 𝑚𝐺𝑙𝑛 =
𝛼1[𝐺𝑙𝑛]
𝛼2 + [𝐺𝑙𝑛]
 
(7.21) 
𝑑([𝐴𝑚𝑚]𝑉)
𝑑𝑡
= 𝑄𝐺𝑙𝑛𝑌𝐴𝑚𝑚𝑋𝑉𝑉 + 𝐾𝑑𝑒𝑔[𝐺𝑙𝑛]𝑉 − 𝐹𝑂𝑈𝑇[𝐴𝑚𝑚] 
(7.22) 
Similar to glutamine, Glucose ([Glc]) concentration in Equation (7.23) varies due 
to the uptake rate (QGlc), the maintenance consumption (mGlc), and the glucose 
concentration in the feed ([Glcfeed]). Glucose consumption has been shown to be 
temperature dependent (Reuveny et al., 1987), lactate inhibited (Nolan and Lee, 
2011), and dependent on the presence of essential biosynthetic (glutamine) 
precursors (Zhao et al., 2009); these effects were combined in Equation (7.24). In 
addition, it was assumed that cells in the quiescent state G0 consumed glucose at a 
maintenance rate due to the minimal cell growth observed in this phase (Jenkins and 
Hovey, 1993). The lactate mass balance ([Lac]), Equation (7.25), is linked to the 
consumption of glucose producing lactate on a variable yield basis (YLac). The 
variable yield of lactate on glucose (YLac) was reduced by a feedback inhibition as 
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previously reported (Ozturk et al., 1992), Equation (7.26). Finally, the monoclonal 
antibody balance ([mAb]) is stated as growth associated and cell cycle segregated 
with specific productivities (qi), Equation (7.27). 
𝑑([𝐺𝑙𝑐]𝑉)
𝑑𝑡
= −𝑄𝐺𝑙𝑐𝑋𝑉(1 − 𝑓𝐺0)𝑉 − 𝑚𝐺𝑙𝑐𝑋𝑉𝑓𝐺0𝑉 + 𝐹𝐺𝑙𝑐[𝐺𝑙𝑐𝐹𝑒𝑒𝑑] − 𝐹𝑂𝑈𝑇[𝐺𝑙𝑐] 
(7.23) 
𝑄𝐺𝑙𝑐 = (
𝜇
𝑌𝐺𝑙𝑐
) 𝑓𝑢𝑝𝑡𝑓𝑖𝑛ℎ1
𝑘𝑇  
(7.24) 
𝑑([𝐿𝑎𝑐]𝑉)
𝑑𝑡
= 𝑌𝐿𝑎𝑐𝑄𝐺𝑙𝑐𝑋𝑉(1 − 𝑓𝐺0)𝑉 − 𝑌𝐿𝑎𝑐𝑚𝐺𝑙𝑐𝑋𝑉𝑓𝐺0𝑉 − 𝐹𝑂𝑈𝑇[𝐿𝑎𝑐] 
(7.25) 
𝑌𝐿𝑎𝑐 = 𝑌𝐿𝑎𝑐 𝑖𝑛𝑖𝑡𝑖𝑎𝑙𝑓𝑖𝑛ℎ1
(𝑚+𝑘𝑇) 
(7.26) 
𝑑([𝑚𝐴𝑏]𝑉)
𝑑𝑡
= 𝜇[𝑞𝐺1𝐺0(𝑋𝐺1 + 𝑋𝐺0) + 𝑞𝑆𝑋𝑆 + 𝑞𝐺2𝑀𝑋𝐺2𝑀] − 𝐹𝑂𝑈𝑇[𝑚𝐴𝑏] 
(7.27) 
An important aspect of the proposed model is the cell behaviour at the 
temperature transition. Particularly, the cell growth (μ) has been formulated as 
temperature dependent and a cell adaptation is expected to take place when the 
reactor temperature is switched (i.e. from normal conditions 37 °C to mild 
hypothermia 33 °C). However, the temperature shift is not expected nor 
experimentally observed to be instantaneously reflected in the cell growth. The 
dynamic and adaptive process of cell growth has been described. For example, 
previous reports describe a gradual decrease in the S phase after a temperature 
shift (Moore et al., 1997), a partial blockage in G2/M  (Shi et al., 2005), and an 
eventual increase in the G1 phase (Swiderek and Al-Rubeai, 2007). In order to 
capture the dynamic and adaptive process, the model considers the state of the cells 
at the moment when the temperature shift takes place. Thus, herein it is assumed 
that after a temperature shift, the existing cell population will proliferate at a transitory 
rate. The existing population will proliferate at a fast rate in the G1 and S phase (i.e. 
tG1/S calculated using T= 37 °C) and G2/M will be affected immediately (i.e. tG2 
calculated using T= 33 °C). However, every new born cell of the existing population 
will proliferate under the new reactor temperature (i.e. tG1/S/G2 calculated using T= 33 
°C), Figure 7.1. 
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Figure 7.1. Cell cycle model schematic representation. 
Thus, the existing population will remain metabolically active at the transition 
conditions until this population disappears (either because it completes the cell cycle, 
gets arrested at G0 or dies). In addition, in the case of a temperature shift the cells at 
G0 will consume glutamine at the transition conditions until the end of the culture. 
The assumed glutamine enhanced metabolism of G0 cells is supported by the active 
biosynthetic state (but not growth) and due to glutamine’s key role in cell metabolism 
(Becerra et al., 2012; Rossler et al., 1996; Sanfeliu and Stephanopoulos, 1999). 
Moreover, an enhanced metabolism is supported if G0 cells are committing to 
apoptosis, which is energy intensive (Eguchi et al., 1997). On the other hand, the 
metabolism of all new born cells will be immediately affected and calculated at the 
new reactor temperature. 
7.5. Model Analysis & Re-estimation of Significant Model 
Parameters 
The next step in the model development was to evaluate the model structure and 
output variability using GSA (Section 3.3.11.). A total of six outputs were evaluated 
(Xv, fG1, fS, fG2M, fG0, and mAb) at six time points (12, 24, 36, 48, 96, and 144h) of a 
fed-batch culture. The time points were selected in order to evaluate different phases 
of the process including a temperature shift during exponential growth phase at 40 
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hours. Specifically the time points from the lag phase (12h), early exponential (24h), 
exponential phase (36h), exponential after the temperature shift (48h), stationary 
phase (96h), and decline phase (144h) were evaluated. A total of 40,000 scenarios 
were evaluated varying the 26 parameters ±50% from their nominal value. The 
majority of the initial nominal values were set to literature values as previously 
reported (Kontoravdi et al., 2005). As outlined in chapter 3, the output of the 
scenarios was used to estimate the SIs using the GUI-HDMR software. The 
significant parameters were determined using a 0.1 cut-off value attributed to 10% 
experimental errors (Sidoli et al., 2005). Thus, a total of 9 significant parameters 
were identified (Table 7.1). 
The viable cell density (XV) showed a decreasing sensitivity (though remaining 
significant) throughout the evaluated time points to the variation of the cell cycle 
times (tSinitial, tG2Minitial), whereas the resistance to the metabolic stresses (fres) was 
significant at the stationary and decline phase. Differently, the sensitivity towards the 
yield of biomass on glutamine (YGln) peaked at 36h, just before the glutamine feed 
was started. The mAb output was sensitive throughout to the same cell cycle times 
as XV. In addition, the G1/G0 phases (qG1G0) and S phase (qS) specific productivities 
were found significant at early stages of the culture, while the cell cycle temperature 
factor (kT) and the cell cycle times’ sensitivity to lactate inhibition (n) were significant 
during both the stationary and the decline growth phase. Similarly, the proliferative 
cell cycle fractions (fG1, fS, fG2M) showed also sensitivity to the cell cycle temperature 
factor (kT) after the temperature shift. The recurrent identification of the cell cycle 
temperature factor as sensitive for several outputs supports the importance of finding 
a balance between growth and productivity when using temperature to optimise fed-
batch processes. Moreover, the cell cycle fractions (fG1, fS, fG2M) were sensitive to the 
resistance to the metabolic stresses (fres) after 36h. In general, each proliferative cell 
cycle fraction was highly sensitive throughout to the corresponding initial time 
estimate to complete the phase (tG1initial,tSinitial,tG2Minitial). In addition, the cell fractions 
(fG1, fS, fG2M) showed sensitivity to the preceding cell cycle phase time. The cell cycle 
time estimates were associated with most of the studied outputs, which stresses the 
importance of considering the cell cycle heterogeneity. The non-proliferative cell 
fraction (fG0) was highly sensitive throughout the culture to the resistance to 
metabolic stresses (fres).  
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The identified 9 significant parameters were re-estimated simultanuosly from the 
selected representative batch and fed-batch cultures. The batch and fed-batch 
covered the two temperatures (37 °C and 33 °C), which were set at the start of the 
cultures after seeding. In addition, the batch experiments covered nutrient 
exhaustion (Sellick et al., 2011), while the fed-batch allowed the study of the 
accumulation of toxic metabolites. The re-estimated parameters are reported with 
the 95% confidence intervals (Table 7.1). In general, the confidence intervals reflect 
a good estimation, except for the cycle specific productivities (qG1G0, qS). The large 
confidence intervals of the specific productivities reflect a weak estimation of these 
parameters, which can be attributed to the observed growth associated (to the 
proliferating cell cycle fractions) antibody production of HFN 7.1 cells. The model 
predictions for the batch and fed-batch cultures used for the parameter estimation 
are compared to the experimental data in the next section. Similarly, the model 
predictions are compared to two experiments with temperature shift at different 
culture times (i.e. 30 and 76h).  
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Table 7.1. GSA Indexes and parameters values for the temperature dependent cell cycle model. Outputs: XV=viable cell density, [mAb]=antibody titre, fG1=G1 cell fraction, 
fS=S cell fraction, fG2M=G2/M cell fraction, and fG0=G0 cell fraction. 
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Table 7.1 (Continued). GSA Indexes and parameters values for the temperature dependent cell cycle model. Outputs: XV=viable cell density, [mAb]=antibody titre, fG1=G1 cell 
fraction, fS=S cell fraction, fG2M=G2/M cell fraction, and fG0=G0 cell fraction. 
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7.6. Results & Discussion 
The simulation results are performed with the same set of parameters (after 
parameter estimation from the representative batch and fed-batch cultures, Section 
7.5, Table 7.1) and only varying the operation mode or the timing for the temperature 
shift. 
7.6.1. Temperature shifted batch cultures 
The 37 °C batch shake flask culture showed the typical batch operation profiles 
(Figure 7.2). Briefly, the viable cell concentration (Xv) increased exponentially after 
seeding and peaked around the time glutamine (Gln, key substrate) was exhausted 
(around 36h). After glutamine depletion a significant death rate was observed with 
the concurrent increase of the lumped G1/G0 cell cycle fraction (fG1G0), while the other 
cell cycle fractions (fS and fG2M) showed a decrease. The consumption of substrates 
(i.e. Glc, Gln) was accompanied by the production of toxic metabolites (i.e. Lac, 
Amm) and the antibody concentration (mAb) correlated to the viable cell 
concentration.  
The model predictions captured in general all the trends, although some 
deviations were observed (Figure 7.2). The cell density and antibody titre were well 
predicted (Figure 7.2A), whereas the viability prediction deviated from the 
experimental values towards to the end of the culture. Overall, the cell cycle trends 
were captured, including the shifts in the trends after the glutamine exhaustion 
(Figure 7.2B). At early stages of culture (12h), deviation from the model predictions 
for the S and G2/M cell cycle fractions were observed. However, these early 
deviations could be partially attributed to the oscillatory behaviour (specific cell cycle 
transitions) between the cell cycle fractions. Alas, the model herein considers the cell 
cycle population as homogenous and represents the average cell behaviour within a 
cell cycle phase. Thus, sharp oscillations or specific transitions cannot be captured 
by the model. In order to capture such cell cycle changes, another internal 
coordinate needs to be employed in a segregated formulation (as in chapter 6). 
Nonetheless, the substrate profiles and lactate production were well predicted by the 
model (Figure 7.2C), while the ammonia profile was consistently over-estimated 
though following the correct trend (Figure 7.2D). This deviation can be explained due 
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to the constant yield of ammonia on glutamine (YAmm) used in the model. However, 
the constant yield of ammonia on glutamine has been reported to be dependent on 
temperature and pH (Ozturk and Palsson, 1991; Seo et al., 2013). Particularly, pH is 
not controlled in the shake-flask cultures.  
The 33 °C batch shake flask culture included the effect of temperature reduction 
at the start (i.e. 0h) of the culture (Figure 7.3). Similar profile trends were observed 
when compared to the 37 °C culture, although the 33 °C batch culture time was 1.5-
fold longer. The main differences included a lower cell peak density (1.8-fold lower 
compared to the 37 °C batch) and a corresponding lower final mAb titre (1.4-fold 
lower). As in previous cases the substrates and metabolites showed a correlation. 
However, the lactate production was further increased towards the end of the culture 
(with increasing dispersion) despite the apparent low glucose consumption. The cell 
cycle fractions did not show significant changes at early stages (12h), coinciding with 
the invariable cell density. However at 24h, a significant and sharp change in the cell 
cycle fraction was observed with the start of the exponential phase. After the sharp 
oscillations, the cell cycle fractions remained rather constant. Once glutamine was 
exhausted, the dispersion of the lumped G1/G0 and G2/M cell cycle fractions 
increased. The increased dispersion indicated that the cells were gathering in one of 
these two phases, which could suggest a cell arrest. 
The model predictions captured most of the observed experimental trends of the 
33 °C batch culture. The viable cell density and mAb prediction profiles showed a 
good fit to the data (Figure 7.3A). However, the cell viability was overestimated, 
particularly towards the end of the culture. The model prediction of the cell cycle 
fractions included a sharp oscillation due to the temperature shift, which seemed to 
be partially in agreement with the experimentally observed (Figure 7.3B). Alas, the 
timing of the predicted oscillation appeared earlier than the observed experimentally. 
The experimentally observed oscillation could be as well attributed to a cohort or 
synchronised cell population initiating the cell cycle. Thus, as previously mentioned, 
the model is not able to capture such events due to its structure. Further differences 
were observed in the predictions of the G1/G0 and G2/M cell cycle fractions. 
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Figure 7.2. Batch shake flask cultures at 37 °C. A) Cell growth, viability and mAb profiles; B) Cell cycle 
distribution; C) Glucose and lactate profiles; D) Glutamine and Ammonia profiles. Notation: dots represent 
experimental data (n=3, error bars=standard deviation), lines represent the simulation results. 
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Figure 7.2. (Continued). Batch shake flask cultures at 37 °C. A) Cell growth, viability and mAb profiles; B) 
Cell cycle distribution; C) Glucose and lactate profiles; D) Glutamine and Ammonia profiles. Notation: dots 
represent experimental data (n=3, error bars=standard deviation), lines represent the simulation results. 
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Figure 7.3. Batch shake flask cultures shifted to 33 °C at the start of cultivation. A) Cell growth, viability and 
mAb profiles; B) Cell cycle distribution; C) Glucose and lactate profiles; D) Glutamine and Ammonia profiles. 
Notation: dots represent experimental data (n=3, error bars=standard deviation), lines represent the simulation 
results. 
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Figure 7.3. (Continued). Batch shake flask cultures shifted to 33 °C at the start of cultivation. A) Cell growth, 
viability and mAb profiles; B) Cell cycle distribution; C) Glucose and lactate profiles; D) Glutamine and Ammonia 
profiles. Notation: dots represent experimental data (n=3, error bars=standard deviation), lines represent the 
simulation results. 
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The substrate and metabolite prediction profiles captured the experimental 
results (Figure 7.3C-D). However, the lactate prediction could not account for the 
constant increase towards the end of the culture (Figure 7.3C). Similarly as for the 
cell cycle fractions (G1/G0, G2/M), the lactate profile also showed an increasing 
dispersion towards the end of the culture. This increasing dispersion suggests some 
differences in the cells’ behaviour reflected at both the metabolic and the cell cycle 
level. Such differences can be partially explained due to the rather uncontrolled pH 
operation of the batch flask cultures (Osman et al., 2001; Trummer et al., 2006). 
7.6.2. Temperature shifted fed-batch cultures 
The second set of experiments used for the parameter estimation included fed-
batch cultures performed in controlled bioreactors. The 37 °C fed-batch culture was 
carried out in duplicate and provides the baseline of typical fed-batch operation 
profiles (Figure 7.4).  
As expected the continuous feed of substrates (glucose, glutamine, vitamins, 
trace elements, and other amino acids) resulted in an increase of the viable cell 
concentration (2.1-fold compared to the 37 °C batch culture). Similarly, a prolonged 
stationary phase with a high viability was maintained due to the feeding. Glucose 
and glutamine (Glc, Gln) were consumed throughout the culture, which resulted in 
high toxic metabolite (Lac, Amm) concentration towards the end of the culture 
(Ozturk et al., 1992). Particularly, ammonia reached 5.5-fold higher concentrations 
compared to the 37 °C batch. After 72h, when ammonia reached toxic concentration, 
the lactate concentration seemed to plateau. These events showed a correlation with 
the start of the G0 cell cycle phase arrest and increase of the G0 fraction until the end 
of the cultivation. The lactate profile showed a large experimental variation, which 
was attributed to the pH control strategy using CO2 sparging and varying amount of 
base (2M NaOH). Lactate production and base addition in pH controlled bioreactors 
accompanied by high osmolarity have been shown in industrial fed-batch processes 
to result in big differences in the final lactate profile, without affecting the growth 
profile (Le et al., 2012). As observed herein, the measured lactate differences did not 
affect significantly the other measured variables (Xv, viability, mAb titre, cell cycle 
distribution) as reflected in the good reproducibility. 
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Figure 7.4. Fed-batch bioreactor cultures at 37 °C. A) Cell growth, viability and mAb profiles; B) Glucose 
and lactate profiles; C) Glutamine and Ammonia profiles; D) G1/G0 phase; E) S phase; F) G2/M phase. 
Notation: dots represent experimental data (n=2, error bars=standard deviation), lines represent the simulation 
results. 
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Figure 7.4. (Continued). Fed-batch bioreactor cultures at 37 °C. A) Cell growth, viability and mAb profiles; 
B) Glucose and lactate profiles; C) Glutamine and Ammonia profiles; D) G1/G0 phase; E) S phase; F) G2/M 
phase. Notation: dots represent experimental data (n=2, error bars=standard deviation), lines represent the 
simulation results. 
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The model simulation for the fed-batch at 37 °C showed a satisfactory prediction. 
The increase, peak, and decline of the viable cells were well described (Figure 7.4A). 
The viability showed a better fit than in batch cases, although at late stages was 
underestimated. Part of the difficulties to predict the viability correctly between the 
two operation modes (batch vs fed-batch) was attributed to the methods used to 
estimate this process variable. In batch culture, viable cells were counted manually 
(at Imperial College), whereas in fed-batch cells were determined automatically with 
a lower cell cut-off size set of 9 µm (at ETH Zurich). Initial 37 °C batch cultures 
performed in both flask (Imperial) and bioreactor (ETH) showed good agreement, 
except for cell viability profiles (which remained higher in the controlled bioreactor). A 
second source that could account for the viability differences are the 
hydromechanical stress rates, which are considerably smaller in shake flask (Peter 
et al., 2006). Thus, the cell lysis rate is expected to be different in the two systems, 
which is not considered in the model.  
The antibody titre prediction showed a good agreement to the experimental data, 
though minor differences were observed towards the end of the culture. The mAb 
differences can be attributed to protein degradation due to increased proteolytic 
activity during prolonged culture times (Sandberg et al., 2006). Overall, the substrate 
consumption showed a fair prediction (Figure 7.4B-C). The glutamine profile showed 
a good description, whereas glucose consumption seemed to be largely decreased 
at the end of the culture. Although the model did account for a decrease in the 
consumption rates, glucose consumption decrease seemed to be more severe 
experimentally. The metabolite profiles (Lac, Amm) showed a good prediction. 
Finally, the trend of cell cycle fractions (fG0, fG1, fS, fG2M) including the timing of G0 
increase triggered by metabolite accumulation was well described (Figure 7.4D-F).  
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Figure 7.5. Fed-batch bioreactor culture shifted to 33 °C at the start of cultivation. A) Cell growth, viability 
and mAb profiles; B) Glucose and lactate profiles; C) Glutamine and Ammonia profiles; D) G1/G0 phase; E) S 
phase; F) G2/M phase. Notation: dots represent experimental data (n=1), lines represent the simulation results. 
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Figure 7.5. (Continued). Fed-batch bioreactor culture shifted to 33 °C at the start of cultivation. A) Cell 
growth, viability and mAb profiles; B) Glucose and lactate profiles; C) Glutamine and Ammonia profiles; D) G1/G0 
phase; E) S phase; F) G2/M phase. Notation: dots represent experimental data (n=1), lines represent the 
simulation results. 
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A 33 °C fed-batch culture with initial temperature shift (at time point 0h) 
completed the experiments used for the parameter estimation. Similar to the 33 °C 
batch, this experiment set the baseline for this temperature and operation mode 
(Figure 7.5). Briefly, a significant lower cell concentration was reached (2.6-fold 
lower than the 37 °C fed-batch culture) with a comparable viability to the 37 °C fed-
batch. Glucose consumption resulted in lower lactate concentration; whereas 
ammonia concentration reached comparable levels to 37 °C fed-batch, despite the 
lower glutamine consumption. Most importantly, a cell arrest in the G0 cell cycle 
fraction was evident from the beginning of the culture, which increased steadily 
throughout the cultivation time. Thus, cell cycle arrest was identified herein to be 
triggered by hypothermia. 
The 33 °C fed-batch simulation predictions showed a good agreement to the 
experimental data. The viable cell density was satisfactorily predicted, although it 
was slightly over-estimated during the decline phase (Figure 7.5A). Cell viability and 
antibody concentration were well described by the model. Similarly, the substrates 
(Glc, Gln) showed a fair fit to the data, as well as the lactate profile (Figure 7.5B-C). 
Although the ammonia prediction captured the trend, it underestimated the ammonia 
production after 72h (Figure 7.5C). Such discrepancy can be due to the fact that the 
model considers ammonia to be produced only by glutamine consumption and 
degradation. However, ammonia can be produced from other sources such as from 
asparagine consumption (McCracken et al., 2014). In addition, amino acid 
consumption has been reported to be affected by temperature (Furukawa and 
Ohsuye, 1998), which is something considered indirectly by the model through the 
growth rate but it might require further revision. All the cell cycle fraction predictions 
(Figure 7.5D-F) captured the trends. 
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7.6.3. Prediction of temperature shift time fed-batch cultures 
The model prediction power was tested against two fed-batch experiments with 
temperature shifts from 37 °C to 33 °C during the exponential growth phase (30h, 
Figure 7.6) and the early stationary phase (76h, Figure 7.7). 
Overall, the model prediction for the temperature reduction after 30 hours was 
well in agreement with the experimental data. The viable cell profile captured the 
experimental trend with minor discrepancies (Figure 7.6A). Before the temperature 
shift, the viable cell density was slightly over-estimated, whereas after the shift it was 
under-estimated (though within the experimental error). The viable cell profile was 
comparable to the 37 °C fed-batch culture, though with a lower maximum cell peak 
density (85% of the 37 °C fed-batch). The antibody concentration was slightly 
underestimated during the stationary phase (in agreement with the under-estimated 
cell density), though predicting the final mAb titre. In contrast, the cell viability was 
closely predicted throughout the culture. The obtained mAb titre was 90% of the 
reported for the 37 °C fed-batch.  
After the temperature shift, the glucose consumption was decreased with a 
corresponding lower lactate production. The model captured to satisfaction both 
profiles (Figure 7.6B). Similarly, the ammonia production was high and well 
predicted, despite the systematic difference between the glutamine model prediction 
(after 48h) and the experimental data (Figure 7.6C). The observed difference in the 
glutamine profile suggests that glutamine was consumed at a higher rate than 
predicted. The dual effect of the toxic metabolite accumulation and temperature shift 
was reflected in the increase of the G0 fraction (after the temperature shift time) and 
further rise throughout the culture (Figure 7.6D). Furthermore, the temperature shift 
was followed by changes in the proliferating cell cycle fractions. Overall, all the cell 
cycle trends were satisfactorily captured, while early differences in the S and G2/M 
fraction predictions (similarly as observed in the 37 °C fed-batch culture) were 
observed (Figure 7.6E-F). 
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Figure 7.6. Temperature shifted fed-batch cultures to 33 °C at 30h. A) Cell growth, viability and mAb 
profiles; B) Glucose and lactate profiles; C) Glutamine and Ammonia profiles; D) G1/G0 phase; E) S phase; F) 
G2/M phase. Notation: vertical grey dotted line indicates time of the temperature shift, dots represent 
experimental data (n=2, error bars=standard deviation), black lines represent the simulation results.  
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Figure 7.6. (Continued). Temperature shifted fed-batch cultures to 33 °C at 30h. A) Cell growth, viability 
and mAb profiles; B) Glucose and lactate profiles; C) Glutamine and Ammonia profiles; D) G1/G0 phase; E) S 
phase; F) G2/M phase. Notation: vertical grey dotted line indicates time of the temperature shift, dots represent 
experimental data (n=2, error bars=standard deviation), black lines represent the simulation results. 
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Figure 7.7. Temperature shifted fed-batch culture to 33 °C at 76h. A) Cell growth, viability and mAb 
profiles; B) Glucose and lactate profiles; C) Glutamine and Ammonia profiles; D) G1/G0 phase; E) S phase; F) 
G2/M phase. Notation: vertical grey dotted line indicates time of the temperature shift, dots represent 
experimental data (n=1), black lines represent the simulation results. 
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Figure 7.7. (Continued). Temperature shifted fed-batch culture to 33 °C at 76h. A) Cell growth, viability and 
mAb profiles; B) Glucose and lactate profiles; C) Glutamine and Ammonia profiles; D) G1/G0 phase; E) S phase; 
F) G2/M phase. Notation: vertical grey dotted line indicates time of the temperature shift, dots represent 
experimental data (n=1), black lines represent the simulation results. 
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The second model prediction considered a fed-batch culture with temperature 
shift from 37 °C to 33 °C at 76 hours (Figure 7.7). The delayed temperature shift time 
was expected to result in higher cell concentrations compared to the previous shift 
times. The viable cell density reached 95% of the peak cell density when compared 
to the 37 °C fed-batch. The model prediction captured the viable cell density 
throughout, as well as the viability and mAb titre (Figure 7.7A). Despite achieving a 
higher cell density than in the 30h temperature shift fed-batch, the mAb titre 
remained at 90% of the achieved in the 37 °C fed-batch culture. The glucose and 
lactate profiles were well predicted with a systematic under-estimation of the glucose 
profile after the temperature shift (Figure 7.7B). Similarly, the glutamine profile 
showed a systematic difference, though in this case the glutamine profile was 
overestimated (Figure 7.7C). Such differences suggest a preference to consume 
glutamine over glucose under the culture conditions, which the model cannot fully 
capture. Nonetheless, the glutamine predicted trend was correct and it was 
accompanied with a fair prediction of the ammonia profile. The G0 fraction was 
triggered before the temperature shift due to metabolic effectors (Figure 7.7D) and 
was further enhanced by the temperature shift. The overall trend of the G0 fraction is 
correct with some differences at late stages of culture. Towards the end of the 
culture, the G0 fraction decreased with a simultaneous increase in the G1 fraction, 
which the model did not account for. As in the previous cases, the other cell cycle 
fraction prediction showed a good agreement to the experimental data, particularly 
after the temperature shift sharp changes (Figure 7.7E-F). 
The proposed model was able to capture overall the experimental trends of both 
batch and fed-batch cultures. In particular, the model considered the relationship 
between temperature and the cell cycle (growth), which impacted the productivity 
and basic metabolism. Some discrepancies were observed mostly related to the 
metabolism. In general, the glucose consumption seemed to be decreased along the 
culture further than the model predictions. Similarly, ammonia production was 
modelled to depend only on glutamine (consumption and degradation), which 
resulted in an underestimation in some cases. Thus, the metabolic relations need to 
be further redefined in order to improve the predictions. Despite those differences, 
the model was able to successfully predict two temperature shift scenarios. The 
model prediction captured the overall trends at the cell cycle level, growth, and 
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metabolism. Most importantly, the cell cycle predictions included the non-proliferating 
phase G0. The G0 cell cycle phase has received considerable attention in a number 
of studies (Alrubeai et al., 1992; Hendrick et al., 2001; Kaufmann et al., 1999; Moore 
et al., 1997; Trummer et al., 2006) due to the possibility to increase productivity in 
commercially relevant cell lines. Moreover, the cell cycle regulation via temperature 
control is of industrial interest as this is the method of choice for improving 
productivity (Kumar et al., 2007). Although the HFN 7.1 cells showed a growth 
associated antibody production (reflected in a weak estimation of cell cycle specific 
productivities - qG1G0, qS), other cell lines productivities has been associated to 
specific cell cycle phases (Alrubeai and Emery, 1990; Alrubeai et al., 1992; Dutton et 
al., 2006). Thus, the developed model is readily applicable and provides a mean to 
systematically optimise the cell cycle-to-productivity-relationship. 
7.7. Conclusions 
The development of an unstructured model of metabolic and temperature 
dependent cell cycle arrest in hybridoma batch and fed-batch cultures was presented 
this chapter.   
The model formulation used first principles, experimental observations, and the 
existing model development framework. Commonly used experimental 
measurements (metabolic profiles and process variable information) and fast cell 
cycle analytical techniques (such as DNA staining and proliferation marker) allowed 
capturing the basic heterogeneity of the system. In addition to temperature effects, 
metabolic stresses such as substrate depletion or toxic metabolite accumulation are 
considered on the cell cycle level to account for different process modes (batch and 
fed-batch).  
A set of batch and fed-batch experiments were designed at two culture conditions 
to baseline the performance under both culture operation modes and temperatures. 
The integrated modelling and experimental approach allowed re-estimating the 
significant parameters from the baseline experimental data. Moreover, the model 
predictive power was successfully tested in two temperature shifted cultures using a 
fed-batch operation mode. However, few metabolic relations were identified for 
further refinement in order to improve the predictions. Nonetheless, the presented 
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modelling approach can capture the complex dynamic relations of the mammalian 
culture systems, thus advantages the commonly industry-adopted design of 
experiment (DoE) approach. Furthermore, the model-based temperature profile 
optimisation to improve productivity can account not only for the cell cycle regulation 
but also for other factors such as the mAb proteolytic degradation and downstream 
impurities (e.g. lysed cells). The importance of the results presented herein lies on 
the development of relevant modelling-experimental approaches to assist the 
mammalian cell culture process development with focus on temperature control. 
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CHAPTER 8 
8. Conclusions & Future Directions 
The development of integrated modelling and experimental approaches that 
facilitate the study of cell cultures including the cell cycle heterogeneity was 
presented in this thesis. The presented experimental approach combined analytical 
techniques and assays that allowed capturing the heterogeneity of different cell 
culture systems. Specifically, the cell cycle blueprint (cell cycle distribution, cyclin 
expression and transition profiles) for an industrial cell line was elucidated using flow 
cytometry (chapter 4). In addition, the study of the effect of culture conditions 
(chapter 5) resulted in the identification of significant links between the cell cycle and 
apoptosis. The experimental blueprint was used to formulate a first of its kind cyclin 
and DNA distributed cell cycle model (chapter 6). Following the model development 
framework (Kiparissides et al., 2011; Kontoravdi et al., 2010; Sidoli et al., 2005), the 
model was systematically studied and refined through the model analysis tools. The 
methodology was similarly applied to the industrial relevant subject of temperature 
profile selection in cell culture systems, while considering an unstructured-
segregated cell cycle model (chapter 7). A number of key conclusions can be drawn 
from the above findings: 
 The cell cycle blueprint as herein defined and elucidated serves as an 
experimentally quantifiable tool to develop biologically accurate cell cycle 
models. 
 Cyclins are key regulatory molecules that can act as model distributed 
variables to capture the cell cycle biology with adequate detail and enable 
a mechanistic link with the cell programmed death. 
 As previous contributions, the effect of culture conditions (such as 
substrate and metabolite concentrations and cultivation temperature) was 
confirmed on both the cell cycle machinery and the induction or repression 
of programmed cell death. Despite the difficulties due to the complex and 
multiple connections of the cell cycle and apoptosis, the simultaneous 
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study of both events can help to refine (and include further biological 
detail) the presented cell cycle models. 
 Different types of cell cycle models were formulated applying the model 
development framework. The framework provides a systematic tool to 
assist the parallel model and experimental development allowing the 
cross-check and flow of information, which facilitates the process. 
 A computational fast and biologically accurate cyclin and DNA distributed 
cell cycle model was presented herein for the first time. The model can be 
further refined and used in model-based applications of industrial 
relevance. Most importantly, the proposed modelling approach is not 
limited to industrial scenarios but it is transferable to clinical environments, 
as evidence of the generalisation of this result.  
 The development of a temperature-dependent cell cycle unstructured 
model exemplified the modelling-experimental approach in an industrial 
relevant problem. The temperature profile can be optimise using the model 
to improve productivity while accounting for the systems dynamics. 
 Overall, the presented contributions of this thesis are in the area of 
systematically developing meaningful mathematical models with predictive 
capabilities accounting for the cell cycle segregation in bioprocesses. This 
experimental and modelling approach avoids repetitive trial and error, 
while efficiently closing the gaps between experimentation and model 
formulation.  
In addition, this final chapter aims to provide a broader look to the thesis 
contributions, as well as suggest future research directions. 
8.1. How to Capture the Heterogeneity 
The study of the cell culture heterogeneity has been enabled by the development 
of analytical techniques. In particular, flow cytometry is a powerful technique that 
unveils single cell attributes. Alas, the full potential of flow cytometry has still not 
been exploited in the bio-industry (Kuystermans et al., 2012). In this thesis, a modest 
fraction of flow cytometry’s potential is used to develop relevant cell cycle models. In 
chapter 4 & 5, flow cytometry was used to elucidate the GS-NS0 cell cycle blueprint. 
The blueprint was later (chapter 6) used for the development of the cyclin and DNA 
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distributed cell cycle model. However, the relevance of the cell cycle blueprint goes 
beyond the model formulation as it acts as an accurate indicator of the culture’s 
state. Thus, the development of automated flow cytometry (Kuystermans et al., 
2012; Sitton and Srienc, 2008) will assist the establishment of this technique as a 
routine analysis. Alas, the adoption of flow cytometry will also result in a 
considerable increase in the data to analyse. Despite the availability of flow 
cytometry software packages, an area that needs further development is the flow 
cytometry data quantification. Currently, flow cytometric data are used for semi-
quantitative studies by sequentially gating and selecting subpopulations, thus 
resulting mainly in the identification of positive/negatively expressing fractions of a 
given attribute. However the quantitative differences in the expression, as reflected 
in the fluorescence intensity, are not fully utilised. As presented in this thesis, the 
quantification of the flow cytometric data can provide additional information, which 
can be later used in systematic approaches/studies. 
 
Figure 8.1. Cell cycle model development. 
In general, the heterogeneity of the cell culture systems can be captured 
nowadays, though the question of how and to what extent still remains. In order to 
answer these questions, a multi-disciplinary (modellers and experimentalists) 
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expertise is usually required, while considering the end application. Herein, two 
different cell cycle models were presented. First, a segregated approach (chapter 6) 
proved to capture the biology of the system while remaining computationally 
tractable. However, in order to support this model formulation, intense 
experimentation is required. The second model formulation (chapter 7) due to its 
unsegregated nature requires a less intense experimentation. Overall, a top-down 
design approach is advised in order to capture the system heterogeneity, unless the 
need for a detailed segregation is known beforehand. Regardless of the selected 
level of segregation, the biological model framework can be applied to assist the 
development (Figure 8.1) in all the cases. The basic segregation, defined as which 
cell cycle fractions to consider, should be addressed early in the model development. 
Though this seems to be driven both by the cell line behaviour (e.g. the cell is 
prompted to enter – or not – the quiescent state G0, or if there is a significant 
variability in the G2/M phase), as well as the availability for cell markers. Similarly, 
the detailed cyclin segregation depends on both the availability of bio-markers and 
the patterns of expression; as in some cases, the cyclin expression pattern might not 
render the cyclin suitable for modelling purposes (e.g. the herein reported cyclin D 
expression).  
8.2. Linking Cell Cycle & Apoptosis 
The cell cycle relevance lays at growth, proliferation, cell death and product 
quality levels. Particularly, the intimate link between the cell cycle and apoptosis has 
been reported (Meikrantz and Schlegel, 1995). The herein reported cell cycle 
blueprint and gene expression profiles are expected to be cell line and culture 
condition dependent (e.g. temperature, medium formulation, serum, growth factors, 
etc.). Nonetheless in chapter 5, the link between the cell cycle and apoptosis was 
suggested at different points. Moreover, the consideration of apoptotic related gene 
expression, cell cycle regulators, and cyclin expression mapped an important 
relationship that requires further study. The bivariate graphs of relative gene 
expression versus relative cyclin expression proved to provide insight on the link 
between the two cell events (cell cycle progression and apoptosis). An apparent bi-
stable (Lavrik et al., 2009; Pomerening, 2008) pattern was identified between p21 
and all the studied cyclins (D, E and B), as well as between trp53bp2 and cyclin B. 
Although these are preliminary results (and other associations need to be 
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considered), the observed links render some of these biomarkers as promising 
coupling points between a mechanistic accurate cell cycle and apoptosis model. 
The simultaneous study of cyclin expression and apoptosis related gene 
expression can aid the understanding of these intimately related processes. 
However, the experimental conditions to study the relation should be carefully 
considered, as well as the timing of events. The experimental conditions to study 
jointly these two events are narrow (e.g. exhaustion of substrate, toxic metabolite 
concentrations, among other) and within a short spam. Thus, the experimental set-
up requires careful consideration to avoid the recurrent disruption of the cell culture 
environment while performing a frequent sampling (as occurs in shake flask 
cultures), as it may affect the reliability and reproducibility of the results.  
8.3. Metabolism & Segregation 
A last aspect that was identified through the developed models is the link 
between the cell metabolism and the cell cycle. A classical modelling approach 
utilises Monod kinetics to model the growth rate, which is stated substrate and/or 
metabolite dependent. In this thesis, a similar approach was adopted by declaring 
the cyclins and DNA growth rates as substrate dependent. Such relation was 
supported by the experimentally observed differences in the expression levels in the 
presence or absence of glutamate for the GS-NS0 cell line. However, the undefined 
nature of the used medium (serum containing) limits the generalisation of the 
observed results. As observed in the medium shift study, the results of the 50% (v/v) 
medium blend were comparable to the 100% fresh medium, despite the significant 
differences in glucose and glutamate concentrations. This was attributed to the non-
quantified growth factors present due to the use of serum in the medium formulation. 
Thus, the use of chemically defined media can enable a more comprehensive study 
of industrial relevance. 
On the contrary, the use of a chemically defined medium does not guarantee or 
imply a simpler analysis. As presented in the unstructured-segregated cell cycle 
model for the HFN 7.1 cell line, the cell metabolism was one of the most challenging 
aspects to capture (despite the use of a chemically defined medium). The use of a 
chemically defined medium needs to be accompanied with a complete metabolic 
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profiling, at least until the key substrates and metabolites are fully identified. This 
also poses a challenge as the amount of data increases (amino acids, metabolites, 
vitamins, trace elements) and the need to develop systematic techniques to identify 
early significant relationships for modelling purposes are therefore required. 
However, even the extreme case of considering all the possible entities in the 
metabolic profile does not guarantee to be able to model the cell metabolism 
accurately. Although metabolic flux analysis (MFA) has become a key tool for the 
study of mammalian cell cultures, the cell metabolism is still an open research area. 
The applicability of MFA to mammalian cells is limited due to their complexity, 
adaptation to changing environments (Gòdia and Cairó, 2002; Niklas and Heinzle, 
2012), as well as neglecting the intrinsic heterogeneity (Wang and Bodovitz, 2010) of 
the systems. Thus, cell metabolic studies need to start incorporating the real drive 
behind the metabolic and adaptation processes. Such change and drive in the 
metabolism goes back to the energy metabolism (and metabolite availability), which 
includes the anabolic and catabolic pathways. Thus, considering both the available 
metabolites and the energy requirements (and energy favourable pathways) could 
provide answer to the frequently unresolved changes in cell metabolism. Finally, the 
energy based model can be linked both to the expression of cell cycle regulatory 
molecules (cyclin) and/or to the up/down-regulation of apoptosis related gene 
expression. Overall, the simultaneous advancement of analytical techniques and 
computational power (as well as data mining and solution algorithms) will pave the 
way for the development of biologically accurate models moving away from the 
heuristic approaches.  
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Appendices 
I. Appendix I. 
Glucose and lactate profiles for the batch temperature shift experiments. 
 
Figure AI.1. Batch temperature shift glucose and lactate profiles. 
Productivity profiles divided in three culture phases: 0-1 day, 1-3 day, 3-5 day. 
 
Figure AI.2. Batch temperature shift productivity profiles divided in culture phases. 
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II. Appendix II. 
The S phase general representation depends on both DNA and cyclin B. Then 
the governing equations are stated below following the symbol and functions of 
chapter 6.  
G1/G0 phase: (AII.1) 
     
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S phase: (AII.2) 
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G2/M phase: (AII.3) 
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The model approximation is based on: (i) the fact that all cells enter stage S in 
the same conditions (DNA=1, cycB=0) and (ii) the form of functions rSDNA(DNA), 
rScycB(cycB) with the same explicit time dependence function flimGlu. The S stage 
equation is hyperbolic in both internal coordinates so the characteristics along each 
coordinate can be described by the following ordinary differential equations: 
  lim,ScycB Glu
dcycB
r cycB S CycBgrow f
d
  
 
(AII.4) 
  lim,SDNA Glu
dDNA
r DNA S DNAgrow f
d
  
 
(AII.5) 
where  is the age of the cell in the S stage. Combining the above equations: 
 
 
,
,
ScycB
SDNA
r cycB SdcycB CycBgrow
dDNA r DNA S DNAgrow
   
(AII.6) 
which can be integrated to give 
* ( )cycB FF DNA  (AII.7) 
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The bivariate function NS(cycB,DNA) can be replaced by the univariate NS(DNA) 
using the following relation: 
     , , , ( ) S SN cycB DNA t N DNA t cycB FF DNA  
(AII.8) 
The error of the above approximation is only restricted to the cycB-distribution in 
S stage and it is related to the initial condition. However, it should be noted that the 
approximation is exact when all initial S cells abandon S stage i.e. for almost the 
entire time of practical simulations. Even at the initial time period the error can be 
very small depending on the initial condition. Therefore the modified problem takes 
the form of Equation (6.1)-(6.3) with 2/
(1) S G McycB FF . 
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III. Appendix III. 
The herein formulated PBM is multivariable (cyclin E, DNA, cyclin B) and 
multistage (G1/G0, S, G2/M). A schematic representation of the cell cycle model is 
presented (Figure AIII.1). 
 
Figure AIII.1. Cell cycle model schematic representation. 
As observed, it is possible to define/select a maximum content on each 
distributed domain (i.e. cycE, DNA, cycB), as well as the discretisation interval (i.e. 
number of intervals or bins within each domain). The discretisation intervals will 
mainly affect the resolution of the results (the higher number of bins within each 
domain, the higher the resolution). However, for each bin an ordinary differential 
equation is introduced, which will increase the computational effort. Although a high 
resolution is in general desired, it should account for your experimental resolution. 
Therefore, for each domain the following resolution was selected: G1/G0=0.5 %cycE, 
S= 0.05 DNA, and G2/M=1 %cycB. 
The cell conservation test guide the selection of a suitable maximum content on 
each domain that would minimise the numerical cell losses (i.e. cells that reach the 
maximum content of a given domain and are numerically lost). However, since the 
transition from S to G2/M is deterministic S(DNA=2)=1, it does not affect the cell 
conservation. Thus, only the maximum content of the cyclin E1 and B1 domains was 
varied. The DNA domain was fixed to 20 bins, keeping a resolution of 0.05 DNA (i.e. 
DNA duplication from 1 to 2, over 20 bins). The maximum content of the cyclin 
domains were increased in order to ensure that over 99% of the cells remained in 
the system (were conserved) after 120h of simulation. To evaluate the conservation, 
the birth term was fixed to 1 to avoid generation, therefore the cells that transit from 
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G2/M to G1/G0 would not duplicate and the number of cells (or cell density) in the 
system should remain constant. In addition, the death rate was fixed to zero 
(kdmax=0) in order to neglect cell death, as it would normally be a source for cell 
losses. The interaction with the nutrients was also neglected (flimGlu/Glc/Lac=1), which 
allows to maintain the rates (ri=G1,S,G2, Гj=G1,G2) at maximum levels. Finally, a uniform 
distribution is applied for all domains (cyclin E1 between 0-95 %cycE, DNA between 
1-2, and cyclin B1 between 0-95 %cycB). Both by applying a uniform distribution and 
maintaining maximum rates, the system is evaluated against a worst case scenario. 
The cell conservation was evaluated under the above mentioned conditions and 
while varying the full range of 24 parameters ±50% (Sidoli et al., 2006) from their 
nominal values. The maximum content was increased, both for cyclin E1 and cyclin 
B1 keeping the resolutions constant, until the desired conservation was achieved 
(Table AIII.1). 
Table AIII.1. Conservation test. 
 Case 1 Case 2 Case 3 Case 4 
Phase  
(distributed variable) 
G1/G0 
(cycE) 
G2/M 
(cycB) 
G1/G0 
(cycE) 
G2/M 
(cycB) 
G1/G0 
(cycE) 
G2/M 
(cycB) 
G1/G0 
(cycE) 
G2/M 
(cycB) 
# bins 100 100 150 150 200 200 250 250 
Maximum content 50 100 75 150 100 200 125 250 
Conservation (120h) 73% 95.6% 99.1% 99.8% 
The cell conservation for each of the cases was evaluated at three time points 
(36, 72, 120h) as presented in Figure AIII.2. Based on the results, cyclin E1 and 
cyclin B1 were distributed over 200 bins (Case 3, Table AIII.1) and DNA over 20 
bins, to ensure above 99% cell conservation. 
 
Figure AIII.2. Conservation test study. 
